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1. INTRODUCTION 
1.1. Botryosphaeriaceae  
 Species of Botryosphaeriaceae occur in most parts of the world under various ecological 
niches, and are found as endophytes, parasites and saprophytes on a vast number of both annual 
and perennial plants (Barr, 1972; von Arx, 1987). Several species of this family are significant 
plant pathogens causing leaf spots, fruit rots, dieback, perennial cankers, and eventual death in 
economically important woody perennial crops and ornamental plants as well as both in native 
and introduced forest tree species (Farr and Rossman, 2011). The taxonomic history of 
Botryosphaeria is complex, and the genus has been subjected to numerous taxonomic 
rearrangements in the systematic position of both the family and the genera included (Denman et 
al., 2000). Species identification in Botryosphaeria has been complicated due to the lack of 
sufficient diversity among teleomorph features of species within this genus. Additionally, the 
difficulty of finding teleomorphs in nature or obtaining them under laboratory conditions, has 
forced the identification of these fungi to be primarily based on anamorphic characters (Jacobs 
and Rehner, 1998; Denman et al., 2000; Phillips, 2002). Consequently, many different anamorph 
genera have been linked to Botryosphaeria and its characterization to species level has not always 
been accurate, which has, for many years, raised even more confusion regarding their association 
and pathogenicity on many hosts. The implementation of DNA-based identification techniques 
and phylogenetic analyses of nucleotide sequences helped to resolve some of the taxonomic 
conflicts previously existing in Botryosphaeria. In particular, a phylogenetic study based on 28S 
rDNA sequences showed Botryosphaeria to be polyphyletic comprising several phylogenetic 
lineages (Crous et al., 2006). Since then, Botryosphaeria was restricted to species with Fusicoccum 
anamorphs, which currently include Botryosphaeria dothidea (Mough. ex Fr.) Ces. & De Not 
(anamorph: Fusicoccum aesculi Corda), Botryosphaeria corticis (Demaree & M.S. Wilcox) Arx & E. 
Müll. (anamorph: Fusicoccum sp.), Fusicoccum ramosum (Pavlic, Burgess, M.J. Wingfield), and 
Fusicoccum atrovirens (J.W.M. Mehl & B. Slippers). However, the study could not fully resolve the 
status of the Diplodia/Lasiodiplodia group. Two years later, Phillips et al. (2008) partially solved the 
Diplodia/Lasiodiplodia conflict based on a multigene phylogenetic analysis, which introduced four 
genera into this group revising the taxonomic status of numerous dematiaceous Botryosphaeriaceae, 
including some that infect grapevines. As a consequence of this and other studies (Pavlic et al., 
2004; Abdollahzadeh et al., 2010), it is currently well accepted that Lasiodiplodia is a distinct 
lineage in the Botryosphaeriaceae. Based on these recent findings and until completion of novel 
taxonomic studies in Botryosphaeriaceae, the nomenclature proposed by both Crous et al. (2006) 
and Phillips et al. (2008) should be followed in order to avoid adding more confusion within this 
family. 
 
1.2 Secondary metabolites in plant-microbe interactions  
 There are no effective fungicide controls for Botryosphaeria dieback. The best defense 
against this commonly occurring disease is to ensure plants are in optimal health by providing the 
appropriate cultural requirements for the particular plant species, avoiding plant stress and injury, 
and employing appropriate sanitation measures. For this reason a study on plant-pathogen 
interactions is interesting because all substances involved in this mechanism could be involved in 
the disease control.  
They could be used: 
 to understand the mechanisms of pathogenicity and virulence, 
 to understand the mechanisms of action, 
 in plant resistant mechanisms and possible utilization for screening of disease improved 
plant lines, 
 as natural compounds with antimicrobial, insecticidal and herbicidal activities. 
The interaction between plant pathogens and their hosts is extremely complex. There are many 
factors affecting the plant disease development as plant and pathogen physiology, metabolism of 
the host plant, physical environment and the way it impacts the plant growth and development, 
biochemistry and genetics of the pathogen-plant interactions. Moreover phytopathogenic fungi 
employ an array of strategies to distress, weaken or kill the host plant in order to gain access to 
nutrients. One of these strategies is the production of secondary metabolites. They are organic 
compounds that are not directly involved in the normal growth, development, or reproduction of 
an organism but they could have an important role in the development of diseases. This toxins 
are compounds produced by the pathogens and their effect on plants is characterized by the 
appearance of specific symptoms; wilting and general growth suppression, as well as chloroses, 
necroses, and spotting of aerial portions are the most common. They belong to different classes 
of natural compounds polyketides, terpenoids, peptides, glycoproteins, polysaccharides, organic 
acids, fatty acids and derivatives (Berestetskiy, 2008). The role of a toxin as a disease determinant 
is proved by the occurrence of the toxin in an infected plant and the ability of the toxin alone to 
elicit at least part of the symptoms of the disease (Hamid and Strange, 2000). Some of the toxins 
have general phytotoxic properties and are active toward a broad range of plant species. Those 
are non-host-specific toxins. They contribute to the virulence or symptom development in the 
disease in which they occur, but are not primary determinants of host range (Walton, 1996). 
Other toxins are host-specific ones and affect only certain plant varieties or genotypes (Osbourn, 
2001). The host-specific toxins (HSTs) are playing role in determining the host range of 
specificity of plant pathogens and can act as agent of virulence of those pathogens (Walton, 
1996). 
 
1.2.1. Phytotoxin insensitivity of plants and disease resistance 
The resistance mechanism to toxin producing fungi can be based on the ability of an R 
gene product to inactivate a toxin which normally induces the disease symptoms, or inhibits the 
induction of active defense responses (Takken et al., 2000). Genetic control of sensitivity to 
HSTs, and susceptibility to the producing pathogens, is highly divers and includes dominance, 
semidominance, recessiveness, and maternal inheritance (Walton, 1996). Genetic and biochemical 
studies revealed that toxins are the determinants of specificity. In such cases resistance or 
susceptibility to the fungus correlates with insensitivity or sensitivity to the toxin (Knogge, 1996). 
But sensitivity to the toxins and susceptibility to the pathogens are not always fully correlated. 
There are several possibilities for selective agents as HSTs nonhost specific toxins, living 
pathogens and chemicals (Slavov, 2005). Two criteria must be satisfied before a toxin is used as a 
screening agent: 
1. the toxin produced by the pathogen must be involed in the disease development; 
2. the toxin must act directly at the cellular level (Hammerschlag, 1984; Yoder, 
1980). 
 
1.2.2. Mechanism of action  
 Some of the most potent phytotoxins are synthesized by microbes. By studies at the 
biochemical level important insights into the destructive modes of action of the phytotoxins have 
been gained (Duke et al., 2001). The strategies for exerting virulence can be manifold. In general, 
necrotrophic pathogens use toxins to elicit plant cell death and derive nutrition from the dead 
tissue, whereas biotrophic pathogens rely on living plant tissue. Phytotoxins may interact with a 
range of cellular targets, alter gene expression or undermine membrane integrity. A number of 
phytotoxins inhibit the activity of plant enzymes, thereby disrupting the biosynthesis of crucial 
metabolites. Other fungi interfere with the plants’ physiology by producing plant hormones, such 
as gibberelin or gibberellic acid (Kawaide, 2006). Finally, plant cells may be damaged by the 
production of reactive oxygen species (ROS)(Duke et al., 2011). 
Several microbial secondary compounds either inhibit an amino transferase or appear to have 
such a mode of action. Recently mode of action of ascaulitoxin aglycone (Table 1), was 
determined. It was produced by Ascochyta caulina (P. Karst.) Aa & Kestern, a fungus being studied 
as a potential mycoherbicide, is a potent phytotoxin that has profound effects on amino acid 
metabolism as determined by metabolic profiling (Evidente et al., 1998). Feeding treated plants 
with most amino acids reversed the effects of the toxin. However, in vitro assays found that the 
toxin did not inhibit alanine aminotransferase nor alanine:glyoxylate aminotransferase, leading the 
authors to speculate that it might inhibit another amino transferase or one or more amino acid 
transporters. 
Rhizobitoxine (Table 1) is a phytotoxin produced by some Bradyrhizobium strains (Duke et al., 
2011). It inhibits β-cystathionase, which is required for methionine synthesis (Owens et al., 1968). 
However, it also directly inhibits production of ethylene from methionine (Owens, 1973) by 
inhibition of 1-aminocyclopropane-1-carboxylate synthase (Owens et al., 1971). Since synthesis 
of the essential plant hormone ethylene is dependent on methionine, one could assume that 
ethylene synthesis would be greatly inhibited in plants treated with this compound. 
Acivicin (Table 1) is an analogue of glutamine and inhibits a number of glutamine-dependent 
enzymes, including glutamate synthase (Brunner et al., 2007). It also inhibits 
amidophosphoribosyltransferase, phosphoribosylformylglycinamidine synthase, GMP synthase, 
and γ-glutamyltranspeptidase (Conti et al., 2003; Natsumeda et al., 1989; Rodriguez-Suerez et al., 
2007). 
Thaxtomin A (Table 1) belongs to a group of cyclic dipeptides (2,5-diketopiperazines) which arise 
from the condensation of 4-nitrotrytophan and phenylalanine groups. It are produced by several 
species of the gram-positive filamentous bacteria in the genus Streptomyces (e.g., S. scabies and S. 
eubacteria) that cause scab disease in potato and in several taproot crops. Thaxtomin A affects the 
formation of the cellulose synthase complexes on the outside of the plasma membrane, leading to 
its dissociation from the cortical microtubule cytoskeleton (King and Calhoun, 2009). 
Tentoxin (Table 1), a cyclic tetrapeptide from the plant pathogen Alternaria alternate (Keissl.:Fr.) 
Beih. bot. Zbl., inhibits chloroplast development, which phenotypically manifests itself as 
chlorotic tissue (Bischofff et al., 2009; Halloin et al., 1970). Two fundamental processes are linked 
with this phenotype. This first is inhibition of energy transfer of the chloroplast-localized CF1 
ATPase (Duke et al., 1982; Selman and Durbin, 1978). One would think that this process alone 
could account for the chlorosis, but tentoxin also completely inhibits the transport of nuclear-
coded enzyme polyphenol oxidase (PPO) into the plastid, even in etioplasts which should have 
no CF1 ATPase activity (Reimer and Selman, 1978). Without this processing, PPO has no 
enzyme activity. 
The diphenyl ether compound cyperin (Table 1), a metabolite of Preussia fleischhakii (Auersw.) 
Cain, Phoma sorghina (Sacc.) Boerema, Dorenb. & Kesteren and Ascochyta cypericola (Feld et al., 
1989; Weber and Gloer, 1988; Stierle et al., 1992), inhibits plant enoyl (acyl carrier protein) 
reductase (ENR), which is the target site of a synthetic diphenyl ether called triclosan. Inhibition 
of ENR results in light-independent disruption of membrane integrity (Venkatasubbaiah et al., 
1992). 
Ophiobolins A (Table 1), tricyclic sesquiterpene phytotoxins from certain species of Bipolaris and 
other fungal genera (Dechslera), cause many symptoms on plants that were considered to be largely 
due to effects on the plasma membrane (Iacobellis and Bottalico, 1981). It effects on maize root 
ion leakage correlate well with its direct antagonism of calmodulin (Au et al., 2000). Its effects on 
calmodulin cause inhibition of transport of nuclear-coded proteins into both the mitochondrion 
and the plastid (Kuhn et al., 2009). Recently ophiobolin displays higher in vitro growth-inhibitory 
effects in mammalian than in plant cells and displays in vivo antitumor activity (Bury et al., 2013). 
Functional actin filaments are required for normal mitosis, as well as other cell functions related 
to the cell cytoskeleton. Cytochalasins (A-H) (Table 1) are actin-binding metabolites of several 
fungal species, such as Phoma exigua Sacc. and Zygosporium masonii Hughes (Styer and Cutler, 1984). 
Binding actin prevents actin polymerization into filaments, thus inhibiting the processes that 
require actin filaments, such as mitosis and other plant processes (Schinko et al., 2009; Wyss et 
al., 1980). Moreover, cytochalasins and their derivatives show in vitro growth inhibitory effects in 
cancer cells (van Goietsenoven et al., 2011). 
Hydantocidin (Table 1), a spironucleoside from Streptomyces hygroscopicus, is highly phytotoxic 
(Steinberg and Burgess, 1992). It is phosphorylated in vivo, and the derivative, 5'-
phosphohydantocidin (5PH), inhibits adenylosuccinate synthetase (ASS) (Nakajima et al., 1991; 
Heim et al., 1996; Siehl et al., 1996; Fonne-Pfister et al., 1996), an enzyme required for purine 
synthesis. ASS converts IMP to AMP. 5PH inhibits ASS by competitively inhibiting it through 
binding the IMP substrate binding site, forming a dead-end complex (Cseke et al., 1996). ASS is 
also inhibited by ribofuranosyl triazolone, a phytotoxic product of an Actinomadura species 
(Walters et al., 1997). 
Compounds with internal disulfide bridges can covalently bind proteins, sometimes inactivating 
the protein function. They accomplish this by reaction of the disulfide bond with the cysteine 
components of proteins. Some fungal phytotoxins such as sirodesmin PL from Leptosphaeria 
maculans (Sowerby) P. Karst. and gliotoxin (Table 1) have such internal disulfide bridges that 
conjugate proteins (Rodriguez-Foneca et al., 1995; Rouxel et al., 1998; Chai and Waring, 2000). 
These compounds are also implicated in generation of reactive oxygen species by redox cycling 
(Rouxel et al., 1998). Such compounds are generally broadly cytotoxic. 
Anhydro-D-glucitol (Table 1), produced by the plant pathogenic fungus Fusarium solani (Mart.) 
Sacc., is mildly phytotoxic (Wright, 1951). When phosphorylated by the plant, it is a close analog 
of fructose-1,6-bisphosphate, thereby inhibiting fructose-1,6-bisphophate aldolase activity, which 
is required for production of glyceraldehyde-3-phosphate and dihyroxyacetonephosphate in 
glycolysis (Tanaka et al., 1996). 
 
1.3. Botryosphaeriaceae involved in grapevine trunk dieseases (GTDs) 
 In recent years an increasing number of Botryosphaeriaceae species have been associated 
with grapevine decline worldwide (van Niekerk et al., 2006; Úrbez-Torres et al., 2007; Úrbez-
Torres, 2001) (Table 2). Several diseases caused by these pathogens in grapevines are known, or 
have been known in the past, under a variety of names such as black dead arm (BDA), 
Botryosphaeria canker, excoriose, Diplodia cane dieback and bunch rot (van Niekerk et al., 2006; 
Hewitt, 1988; Phillips, 1998; Phillips, 2002). External symptoms of these diseases include death 
of the cordons, canes, shoots and buds, canker formation, stunting, delayed bud burst, bud 
necrosis, bleached canes, reduced bunch set and bunch rots, all of which have  been extensively 
documented (van Niekerk et al., 2006; Hewitt, 1988; Phillips, 1998; Phillips, 2002; Larignon et al., 
2001; Castillo-Pando et al., 2001; Taylor et al., 2005; Winderlich et al., 2008; Savocchia et al., 
2007).  
Internal symptoms on the trunks or canes of declining vines such as brown wood streaking and 
wedge-shaped discolourations are commonly associated with Botryosphaeriaceae species (van 
Niekerk et al., 2006; Phillips, 2002; Larignon et al., 2001; Castillo-Pando et al., 2001; Savocchia et 
al., 2007). Some of the symptoms, both external and internal, are shown in Figure 1. 
Neofucicoccum parvum (Pennycook & Samuels) Crous, Slippers & A.J.L. Phillips isolateted together 
other four Botryosphaeriaceous in Spain from symptomatic plants, showed to produce in liquid 
culture secondary metabolites (Martos et al., 2008). Four toxic metabolites were isolated from the 
organic extract and identified by spectroscopic and physical methods as (3R,4R)-(-)-4-hydroxy- 
and (3R,4S)-(-)-4-hydroxy-mellein, isosclerone, and tyrosol (Table 3). They were reported as 
being produced by N. parvum for the first time (Evidente et al., 2010). When assayed on tomato 
cuttings all four metabolites were toxic, producing symptoms ranging from slight to severe leaf 
wilting. (3R,4R)-(-)-4-Hydroxymellein and isosclerone were the most toxic (Evidente et al., 2010). 
Diplodia seriata De Not., isolated from the Vitis vinifera L. cv. Cabernet Sauvignon, produced in 
liquid culture  mellein, (3R,4R)-4-hydroxymellein, (3R)-7-hydroxymellein and, as new compound, 
(3R,4R)-4,7-dihydroxy-mellein (Djoukeng et al., 2009). A bioassay of vine cv. Gamay leaves 
found that (3R,4R)-4,7-dihydroxy-mellein was the most active metabolite, causing full leaf 
necrosis. Moreover using a HPLC DAD-MS analysis mellein detected in infected vine wood 
inoculated with D. seriata (Djoukeng et al. 2009). 
  
1.4. Botryosphaeriaceae pathogen of forest plants 
Different species belong to genera Diplodia and Sphaeropsis associated with disease of 
forestal plants. They induce heavy loss of forests and ornamental heritage, with consequent 
alteration of the typical landscape. These diseases are related to the production by fungi of several 
phytotoxins belonging to different chemical classes (Evidente et al., 2010) (Table 4). 
Diplodia cupressi, A.J.L. Phillips & Alves associated with the so-called ‘‘canker’’ disease of species 
of Cupressus in the Mediterranean area, produced at least six tri- and tetra-cyclic unrearranged 
pimaranes, namely, sphaeropsidins A–F (Sparapano et al., 2004), and two phytotoxic dimedone 
methyl ethers, sphaeropsidone and epi-sphaeropsidone (Evidente et al., 1998). Relationships 
between sphaeropsidin and sphaeropsidon chemical structures and their phytotoxic and 
antimicrobial activities have already been extensively studied (Sparapano et al., 2004; Weber et al., 
2007; Evidente et al., 2011a and b;). Moreover sphaeropsidins A-C and 10 semisynthetic 
derivatives were evaluated for their in vitro anticancer activities (Lallemand et al., 2012). 
Sphaeropsis sapinea (Fr.) Dyco & Sutton, isolated from infected cypress trees, produced in liquid 
culture two main metabolites, named sapinofuranones A and B. They were characterised as two 
epimeric 2(3H)-dihydrofuranones and proved to be phytotoxic on non host plants such as 
tomato and on host plants as cypress and pine (Evidente et al., 1999). Successively from the same 
organic extract was obtained a new metabolite, namely sapinopyridione. The structure of a 3,3,6-
trisubstituted-2,4-pyridione was assigned to sapinopyridione that can be formulated as the 6-
methyl-2-(2-methyl-1-oxobutyl)-1-oxa-5-azaspiro[2.5]oct-6-ene-4,8-dione and its absolute 
configuration was  also established as 2R,3R,10R (Evidente et al., 2006a). 
Other strain of S. sapinea isolated in Sardinia from declining Pinus radiata L.plants showed to 
produce in liquid cultures well know (R)-(-)-mellein, (3R,4R)-(-) and (3R,4S)-(-)-4-
hydroxymelleins. When assayed on P. radiata and tomato cuttings, mellein and a mixture of 
(3R,4R)-(-) and (3R,4S)-(-)-4-hydroxymellein in a ratio of 6.5:1 caused chlorosis and necrosis on 
the needles that depend on concentration and time. The mixture showed antifungal activity when 
assayed on phytopathogenic species (Cabras et al., 2006) 
Diplodia mutila (Fr.) Mont. and D. corticola (A.J.L. Phillips, A. Alves & J. Luque) are endophytic 
fungi, widespread in Sardinian oak forests, and considered main causes of cork oak (Quercus suber 
L.) decline (Franceschini et al., 1999). The main phytotoxic metabolite, namely diplopyrone, was 
isolated from D. mutila culture filtrates. It was characterized as new monosubstituted 
tetrahydropyranpyran-2-one, named diplopyrone. Diplopyrone, assayed at different 
concentrations, was toxic to Q. suber (Evidente et al., 2003). Subsequently the nonempirical 
assignment of its absolute configuration has been approached by two different methods and 
assigned as 4a(S), 8a(S), 6(R), 9(S) (Giorgio et al., 2005). 
From culture filtrates of D. corticola was isolated two new 5’-monosubstituted tetrahydro-2H-
bifuranyl-5-ones, named diplobifuranylones A and B, together diplopyrone, sphaeropsidins A-C, 
(3S,4R)-trans- and (3R,4R)-cis-4-hydroxymellein, sapinofuranone B and its (S,S)-enantiomer. 
Diplobifuranilones did not show phytotoxic and brine shrimp (Artemia salina L.) lethality activities 
(Evidente et al., 2006b). Successively other two metabolites were isolated from the same culture 
filtrates. They were structurally closed to sapinofuranones A and B (Table 4), and named 
diplofuranones A and B (Evidente et al., 2007). 
Diplodia africana Damm & Crous was detected as the main pathogen involved in the aetiology of 
cankers and branch dieback of Phoenicean juniper (Juniperus phoenicea L.) trees in Sardinia 
(Linaldeddu et al., 2011). For this pathogen, the production of two new phytotoxic 
dihydrofuropyran-2-ones, named afritoxinone A and B, along with six others known metabolites 
such as oxysporone, sphaeropsidin A, epi-sphaeropsidone, R-(-) mellein, (3R,4S)-4-
hydroxymellein and (3R,4R)-4-hydroxymellein was reported (Evidente et al., 2012). The 
phytotoxic activity of afritoxinones A and B and oxysporone was evaluated on host and non-host 
plan. Oxysporone proved to be the most phytotoxic compound. Recently, the absolute 
configuration (AC), which is strongly related with the biological activity of naturally occurring 
compounds (Evidente et al., 2011; Evidente et al., 2013) was also determined for oxysporone. 
The AC was assigned by chiroptical methods such as optical rotatory dispersion (ORD), 
electronic circular dichroism (ECD) and vibrational circular dichroism (VCD) (Mazzeo et al., 
2013). 
2. AIM OF THESIS 
 The aim of the present thesis was the study of Botryosphaeriaceae species involved in GTDs 
and canker and dieback in forest plants, by chemical and biological characterization of the 
phytotoxins produced in order to understand the role of these natural products in the 
phatogenesis process and therefore to use them against specific diseases. The steps proposed to 
achieve this goal are summarized in the following points: 
- Isolation and chemical characterization of the phytotoxic metabolites produced in vitro by 
Neofusicoccum australe Slippers, Crous & M.J. Wingf. (haplotypes H4), associated with grapevine 
cordon dieback and two different strains of Lasiodiplodia mediterranea Linaldedd, Deidda & 
Beraf-Tebbal associated with wedge-shaped lesions of the vascular tissues on grapevine. 
- Isolation and chemical characterization of the phytotoxic metabolites produced in vitro by 
Diplodia quercivora Linaldeddu & A.J.L. Phillips found on declining Quercus canariensis Willd. 
trees in Tunisia and by N. australe (haplotypes H1) associated with branch dieback of 
Phoenicean juniper. 
- Isolation of oxysporone, a phytotoxic metabolite produced in vitro by the fungus Diplodia 
africana, pathogen of Phoenicean juniper, and its structure-activity relationship study by 
hemisynthesis of some its derivatives for the evaluation of their phytotoxic and antifungal 
activities.  
  
3. MATERIALS AND METHODS 
3.1. Fungi 
The species object of this thesis were isolated from wood tissues of symptomatic host plants: 
Vitis vinifera, Juniperus phoenicea  and Quercus canariensis. As reported in Table 5, identified in the 
laboratories of Dipartimento di Agraria, Sezione di Patologia vegetale ed Entomologia, Università 
degli Studi di Sassari and Dipartimento di Scienze Agrarie e Forestali, Università degli Studi di 
Palermo (Italy). Successively they were characterized on the basis of morphological characters 
and analysis of Internal Transcribed Spacer (ITS) of rDNA. and part of the translation elongation 
factor 1-α gene (EF1-alpha). Fungal DNA extraction, PCR amplification reactions, and DNA 
sequencing were carried out. 
Representative sequences of isolate were deposited in GenBank as reported in Table 5. Pure 
cultures of all strains were maintained on potato-dextrose-agar (PDA, Fluka, Sigma-Aldrich 
Chemic GmbH, Buchs, Switzerland) and stored at 4°C in the collection in the respective 
departments Table 5. 
 
3.2. General Procedures 
Melting point was measured on a Mettler Toledo FP90 Central Processor (Greifensee, 
Switzerland) associated with a Zeiss Axioskop microscope (Oberkochen, Germany). 
Optical rotations were measured in CHCl3, unless otherwise noted, on a Jasco P-1010 
digital polarimeter, while the ECD spectra were recorded on a JASCO J-815 (Tokyo, Japan) 
spectrometer in EtOH; IR spectra were recorded as deposit glass film on a Thermo Electron 
Corporation Nicolet 5700 FT-IR spectrometer (Waltham, MA, USA) and UV spectra were 
measured in MeCN, unless otherwise noted, on a JASCO V-530 spectrophotometer. 
1H and 13C NMR spectra were recorded at 400 and 100 MHz in CDCl3 respectively, unless 
otherwise noted, on on Bruker spectrometers (Karlsrhue, Germany). The same solvent was used 
as internal standard. Carbon multiplicities were determined by DEPT (Distortionless 
Enhancement by Polarization Transfer) spectra. DEPT, COSY45 (Correlation Spectroscopy), 
HSQC (Heteronuclear Single Quantum Coherence spectroscopy), HMBC (Heteronuclear 
Multiple-Bond Vorrelation spectroscopy), and NOESY (Nuclear Overhauser Effect 
spectroscopy) experiments (Breitmaier et al., 1987) were performed using Bruker microprograms. 
Coupling constants (J) are in Hertz. The following symbols were used: s: singlet; brs: 
broad singlet; d: doublet; dd: double doublet; ddd: doublet of double doublet; t: triplet; q: quartet; 
m: multiplet. 
HRESI (High Resolution Electrospray Ionization Mass Spectroscopy) and ESI (Electrospray 
Ionization Mass Spectroscopy), and APCIMS (Atmospheric-pressure chemical ionization) spectra 
were recorded on Waters Micromass Q-TOF Micro (Milford, USA) and Agilent Technologies 
6120 Quadrupole LC/MS instruments (Milan, Italy), respectively. 
Analytical and preparative TLC were performed on silica gel (Merck, Kieselgel 60, F254, 0.25 
and 0.5 mm respectively Darmstadt, Germany), and on reversed phase (Merck, DC Kieselgel 60 
RP-18, F254, 0.20 mm) plates. The spots were visualized by exposure to UV radiation (253 nm), or 
by spraying first with 10% H2SO4 in MeOH and then with 5% phosphomolybdic acid in EtOH, 
followed by heating at 110 °C for 10 min. 
Colum chromatographic (CC) were performed on silica gel (Merck, Kieselgel 60, 
0.0630.200 mm). 
 
  
4. EXPERIMENTAL SECTION 
4.1. Production, extraction and purification of phytotoxins by Neofusicoccum australe 
strain BOT48.  
The fungus was grown in 2 L Erlenmeyer flasks containing 400 mL of Czapek medium 
amended with corn meal (pH 5.7). Each flask was seeded with 5 mL of a mycelia suspension and 
then incubated at 25°C for 4 weeks in darkness. The culture filtrates (12 L) were acidified to pH 4 
with 2 M HCl and extracted exhaustively with EtOAc. The organic extracts were combined, dried 
with Na2SO4, and evaporated under reduced pressure to give a brown-red oil residue (6 g), having 
a high phytotoxic activity on grapevine leaves by the puncture leaf bioassay at 4 mg/mL. The 
residue was submitted to a bioassay-guided fractionation through CC on silica gel eluted with 
CHCl3/i-PrOH (95:5). Eleven homogenous fraction groups were collected (Scheme 1) and 
screened for their phytotoxic activity. The residue (154.1 mg) of the fifth fraction, was further 
purified by CC on silica gel, eluted with petroleum ether/Me2CO (7:3). The residue (38.4 mg) of 
the fifth fraction was further purified by TLC on silica gel, eluent n-hexane/Me2CO (7:3) yielding 
a homogeneous amorphous solid [1, 23.7 mg, Rf 0.53, eluent n-hexane/Me2CO (7:3) and Rf 0.50, 
eluent CHCl3/i-PrOH (95:5)], which was named cyclobotryoxide. The residue (100.7 mg) of the 
sixth fraction from the initial column was further purified by CC on silica gel, eluted with 
CHCl3/MeOH (97:3). The residue (40.8 mg) of the third fraction was purified by TLC on silica 
gel, eluent n-hexane/Me2CO (7:3) yielding a further quantity of 1 (8.7 mg, total 5.2 mg/L). The 
residue (20.1 mg) of the fourth fraction was purified by two successive TLC steps on silica gel, 
eluted with the CHCl3/i-PrOH (95:5) and EtOAc/n-hexane (55:45), yielding a homogeneous 
amorphous solid identified, as 3-methylcatechol [3, 4.4 mg, 0.8 mg/L, Rf 0.50 eluent CHCl3/i-
PrOH (92:8) and Rf  0.61, eluent EtOAc/n-hexane (55:45)]. The residue (86.9 mg) of the eighth 
fraction of the initial column was purified by two successive steps using CC and TLC on silica 
gel, eluted both with CHCl3/i-PrOH (95:5), yielding a homogeneous amorphous solid identified 
as tyrosol [4, 1.7 mg, 0.31 mg/L, Rf 0.23 eluent CHCl3/i-PrOH (95:5) and Rf  0.48, eluent 
EtOAc/n-hexane (6:4)]. 
 
4.1.1. Cyclobotryoxide (1) 
Cyclobotryoxide (1, Figure 2) obtained as homogeneous amorphous solid had: [α]D
25 -73 (c 
= 0.3); ECD (c = 6.5 x 10-4 M)  Δε  -74.4 (310), +14,73 (276); UV λmax nm (log ε) 272 (4.02); 
IRνmax cm
-1 3346, 1712, 1640, 1613, 1462, 1243; 1H and 13C NMR: Table 6. HRESIMS(+) m/z: 
193.1509 [C8H10O4Na, calcd. 193.1518, M+Na]
+; ESIMS (-) m/z 169 [M+H]- 
 
4.1.2. 3-Methylcathecol (3) 
3-Methylcathecol (3, Figure 2) obtained as homogeneous amorphous solid had: UV λmax 
nm (log ε) 292 (3.59); IRνmax cm
-1 3318, 1503, 1201; 1H and 13C NMR were similar to 
those reported (Ahamad et al., 2001). ESIMS (+) m/z 147 [M+Na]+; ESIMS (-) m/z: 123 
[M-H]-. 
 
4.1.3. Tyrosol (4) 
Tyrosol (4, Figure 2) obtained as homogeneous amorphous solid had: 1H NMR was 
similar to data reported (Capasso et al., 1992). ESIMS (+) m/z: 161 [M+Na]+; ESIMS (-) m/z: 
137 [M-H]-. 
 
4.1.4. Acetylation of cyclobotryoxide (2) 
Cyclobotryoxide (1, 5.0 mg), dissolved in pyridine (30 µL), was converted into the 
corresponding 5-O-acetyl derivative by acetylation with Ac2O (30 µL) at room temperature for 10 
min. The reaction was stopped by addition of MeOH and an azeotrope formed by addition of 
benzene was evaporated in a N2 steam. The oily residue (6.0 mg) was purified by TLC on silica 
gel, eluent n-hexane/Me2CO (6:4) yielding derivative 2 (Figure 2) as a homogeneous solid (4.1 
mg, Rf 0.39). It had: UV λmax nm (log ε) 272 (3.98); IR νmax cm
-1 1747, 1654, 1624, 1240, 1207; 1H 
NMR δ: 6.18 (1H, br s, H-5), 3.76 (3H, s, OCH3), 3.63 (1H, dd, J=1.8 and 1.0 Hz, H-6), 3.50 
(1H, d, J=1.8 Hz, H-1), 2.19 (3H, s, MeCO), 1.76 (3H, br s, Me); ESIMS (+) m/z: 235 [M+Na]+. 
  
4.2. Production, extraction and purification of phytotoxins by Lasiodiplodia mediterranea 
strain BL101. 
The fungus was grown as previously reported in paragraph 4.1. In this case, 3L of culture 
filtrates were acidified to pH 2 with 2 M HCl and extracted as as previously reported in paragraph 
4.1. The phytotoxic extract (2.3 g, brown-red oil) of L. mediterranea strain BL101, was obtained as 
previously reported in paragraph 4.1. The residue was submitted to a bioassay-guided 
fractionation through CC on silica gel, eluted with CHCl3/i-PrOH (95:5). Height homogenous 
fraction groups were collected (Scheme 2) and screened for their phytotoxic activity. The residue 
(18.7 mg) of the first fraction was purified by TLC on silica gel eluted with n-hexane/Me2CO 
(95:5) yielding a uncolored oil identified as (1R,2R)-methyl ester of jasmonic acid [11, Figure 3, 
3.4 mg, 1.1 mg/L, Rf 0.81 eluent CHCl3/i-PrOH (95:5) and Rf 0.13 eluent n-hexane/Me2CO 
(95:5)]. The residue of the active second fraction (27.7 mg)  was purified by TLC on reversed 
phase eluted with EtOH/H2O (6:4) to give three main bands. The first band obtained as an 
uncoloured oil [1.6 mg, 0.6 mg/L, Rf 0.30 eluent EtOH/H2O (6:4)], was characterized as 
lasiojasmonates B and C (8 and 9, Figure 4), obtained as an inseparable mixture. The second band 
corresponded to another uncolored oil [5.2 mg, 1.7 mg/L, Rf 0.40 eluent EtOH/H2O (6:4)] was 
characterized as lasiojasmonate A (5, Figure 4). The third band corresponded to an amorphous 
solid [5.2 mg, 1.7 mg/L, Rf 0.50 eluent EtOH/H2O (6:4)], was characterized as 16-O-
botryosphaerilactone A and C acetylates (6 and 7, Figure 3). The residue (587.4 mg) of the third 
fraction of the original column appeared to be the main metabolite, obtained as a pure yellow oil 
[Rf 0.43 eluent CHCl3/i-PrOH (95:5) and Rf 0.50, TLC on reversed phase, eluent EtOH/H2O 
(6:4)]. It was identified as (1R,2R)-jasmonic acid (10, Figure 3). The residue (294.4 mg) of the 
fourth fraction  was dissolved in EtOAc and then washed with a saturated solution of NaHCO3 
to remove jasmonic acid (110.3 mg, 236.6 mg/L). The organic phase was dried with Na2SO4, and 
evaporated under reduced pressure affording a brown oil residue (175.8 mg). This residue was 
further purified by CC on silica gel, eluted with solvent CHCl3/MeOH (93:7), yielding six 
homogeneous fraction groups. The residue (48.3 mg) of the second fraction was purified by TLC 
on reversed phase eluted with EtOH/H2O (6:4), yielding an amorphous white solid [6.6 mg, 2.2 
mg/L, Rf 0.68 eluent EtOH/H2O (6:4)], which was characterized as (3R,4S)-botryodiplodin (14, 
Figure 3), and an uncolored oil [27.6 mg, 9.2 mg/L, Rf 0.64 eluent EtOH/H2O (6:4)], which was 
characterized as botryosphaerilactone A (12, Figure 3). The residue (18.3 mg) of the fifth fraction 
of the same column was purified by TLC on reversed phase eluted with EtOH/H2O (6:4) 
yielding a homogeneous amorphous solid [4.4 mg, 1.7 mg/L, Rf 0.76 eluent EtOH/H2O (6:4)], 
which was identified as the (3S,4R,5R)-4-hydroxymethyl-3,5-dimethyldihydro-2-furanone (13, 
Figure 3). 
 
4.2.1. Lasiojasmonate A (5)  
 Compound 5, obtanined as uncolored oil, had: [α]D
25 -15 (c = 0.4); UV λmax nm (log ε) 204 
(3.98); IR νmax cm
-1 1747, 1695, 1634, 1240, 1207; 1H and 13C NMR spectra: Table 7; HRESIMS 
(+) m/z: 359.1913 [M+Na]+ (calcd. for C19H28NaO5 359.1834); APCIMS (+) m/z: 337 [M+H]
+. 
 
4.2.2. 16-O-Acetylbotryosphaerilactones A and C (6 and 7) 
Compounds 6 and 7, obtained as inseparable mixture and as amorphous solids, had: UV 
λmax nm (log ε) 203 (4.01); IR νmax cm
-1 1764, 1731, 1681, 1438, 1379; 1H NMR: Table 8; ESIMS 
(+) m/z: 651 [2M+Na]+, 314 [M+Na]+; APCIMS (+) m/z: 172 [C9H16O3]
+, 145 [C7H13O3]
+, 127 
[C7H11O2]
+, 113 [C7H13O]
+. 
 
4.2.3. Lasiojasmonates B and C (8 and 9) 
Compounds 8 and 9, obtained as an inseparable mixture and as uncolored oil, had: UV 
λmax nm (log ε) 205 (4.00); IR νmax cm
-1 1765, 1701, 1624, 1238, 1211; 1H NMR: Table9.; ESIMS 
(+) m/z: 487.1682 [M+Na]+ (calcd. for C26H40NaO7 487.2672); APCIMS (+) m/z: 482 
[M+H2O]
+, 465 [M+H]+, 322 [C19H30O4]
+, 145 [C7H13O3]
+, 127 [C7H11O2]
+, 113 [C7H13O]
+. 
4.2.4. (1R,2R)-Jasmonic acid (10) 
Compound 10, obtained as yellow oil, had: [α]D
25 -75 (c = 0.3, MeOH); UV λmax nm (log ε) 
206 (3.72); IR νmax cm
-1 3571, 1749, 1707, 1636, 1259; [lit, Aldridge et al., 1971: [α]D
25 -73 (c = 0.1, 
MeOH); lit, Nielsen and Smedsgaard, 2003: UV absorption (nm) in % of UV-max (MeOH) end; 
lit, Husain et al., 1993: νmax cm
-11740, 1700]; 1H and 13C NMR were similar to data previously 
reported (Husain et al., 1993); ESIMS (+) m/z: 233 [M+Na]+; APCIMS (+) m/z 211 [M+H]+. 
 
4.2.5. (1R,2R)-Methyl jasmonate (11) 
Compound 11, obtained as uncolored oil, had: [α]D
25 -58 (c = 0.4); UV λmax nm (log ε) 205 
(3.67); IR νmax cm
-1 1754, 1678, 1426, 1165; [lit, Nishida et al., 1985: [α]D
25 -58 (c = 0.2, MeOH); lit, 
Nielsen and Smedsgaard, 2003: UV absorption (nm) in % of UV-max (MeOH) end; lit, Takeda 
et. al, 2006: IR (neat) νmax: 1738, 1438, 1198, 1160 cm
-1]; 1H NMR spectrum was similar to data 
reported (Takeda et al., 2006); ESIMS (+) m/z: 247 [M+Na]+; APCIMS (+) m/z 225 [M+H]+. 
 
4.2.6. Botryosphaerilactone A (12) 
 Compound 12, obtained as uncolored oil, had: [α]D
25 -4.0 (c = 0.3, MeOH); UV λmax nm (log 
ε) 209 (3.81); IR εmax cm
-1 3458, 1764, 1678, 1613, 1453, 1187; [lit: [α]D
25 -1.2 (c= 0.77, MeOH); 
UV (MeOH) λmax (log ε) 286 (1.30) nm; IR (neat) νmax 3438, 1770 cm
-1 (Rukachaisirikul et al., 
2009)]; 1H and 13C NMR were very similar to those reported previously (Rukachaisirikul et al., 
2009); ESIMS (+) m/z: 567 [2M+Na]+, 295 [M+Na]+; ESIMS (-) m/z 271 [M-H]-; APCIMS (+) 
m/z: 145 [C7H13O3]
+, 129 [C7H13O2]
+, 127 [C7H11O2]
+, 111 [C7H11O]
+. 
 
4.2.7. (3S,4R,5R)-4-Hydroxymethyl-3,5-dimethyldihydro-2-furanone (13) 
 Compound 13, obtained as homogeneous amorphous solid, had: [α]D
25 -18 (c = 0.3); UV λmax 
final absorption; IR νmax cm
-1 3427, 1747, 1635; 1456, 1385, 1183; [lit, Ravi et al., 1979: IR λmax cm
-
1 3400, 1770; 1H NMR spectrum was similar to data previously reported]; 13C NMR δ: 179.0 (s, C-
2), 76.1 (d, C-5), 60.7 (t, C-8), 52.7 (d, C-4), 37.6 (d, C-3), 20.1 (q, C-6), 14.2 (q, C-7); ESIMS (+) 
m/z: 167 [M+Na]+; ESIMS (-) m/z: 143 [M-H]-. 
 
4.2.8. (3R,4S)-Botryodiplodin (14) 
Compound 14, obtained as amorphous white solid, had: UV λmax nm (log ε) 205 (3.92); IR 
νmax cm
-1 3457, 1707, 1467, 1343; 1H NMR was similar to data previously reported (Ramezani et 
al., 2007); ESIMS (+) m/z: 167 [M+Na]+; APCIMS (+) m/z: 145 [M+H]+, 127 [M-OH]+. 
 
4.2.9.  Acetylation of botryosphaerilactone A (6 and 7) 
 Botryosphaerilactone A (12, Figure 3, 5.0 mg), was converted into the corresponding 16-O-
acetyl derivatives by acetylation as previously reported in paragraph 4.1.4. The oily residue (6.0 
mg) was purified by TLC on silica gel, eluted with n-hexane/Me2CO (6:4), yielding a mixture of α 
and β anomers acetyl derivatives [6 and 7, Figure 3, 4.1 mg, Rf 0.39 eluent n-hexane-Me2CO 
(6:4)], in a ratio of α/β 90:10. 
 
4.2.10.  Acetylation of (3R,4S)-botryodiplodin (14a) 
(3R,4S)-botryodiplodin (14, 2.0 mg) was acetylated with pyridine (35 µL) and Ac2O (35 
µL) in the same conditions previously reported (par. 4.1.4). The residue (2.4 mg) was purified by 
TLC on silica gel, eluent CHCl3/i-PrOH (95:5), to give 2,3-trans-botryodiplodin acetate [0.8 mg, 
Rf 0.88 eluent CHCl3/i-PrOH (95:5)], whose physic and spectroscopic data were very similar to 
those previously reported (Arsenault and Althaus, 1969). 
 
4.2.11. Alkaline hydrolysis of lasiojasmonates A-C 
Lasiojasmonate A (5, 3.0 mg) was dissolved in MeOH (200 µL) and H2O (10 µL) and 
hydrolysed with K2CO3 (6.0 mg). The mixture was stirred at 60 °C for 2h to the procedure 
previously reported (Farmer et al., 1992). Then the mixture was diluted with H2O (2 mL) and 
acidified to pH 4.0 with 2 M HCl and extracted with EtOAc (2 mL x3). The organic extracts 
were combined, dried (Na2SO4) and evaporated under reduced pressure. The residue (2.8 mg) 
was purified by TLC on silica gel, eluent CHCl3/i-PrOH (95:5). Jasmonic acid (0.8 mg) was 
compared by TLC, OR and 1H NMR with the authentically sample of (1R,1R)-jasmonic acid. 
Jasmonates B and C (8 and 9) were hydrolyzed in the same conditions used to treat 5, yielding 
(1R,1R)-jasmonic acid ascertained as above reported. 
 
4.3. Production, extraction and purification of metabolites by Lasiodiplodia 
mediterranea strain B6. 
The fungus was grown in 1L Roux flasks containing 250 mL of Czapek medium amended with 
2% corn meal (pH 5.7). Each Roux was inoculated with about 5 mL of a mycelial suspension and 
incubated at 25°C for 21 days in darkness. The culture filtrates were obtained by sterile-filtering 
the culture in a vacuum on a 500 ml Stericup (0.45 µm HV Durapore membrane, Millipore ) and 
stored at -20°C 
The phytotoxic extract (989.8 mg, brown oil) was obtained as previously reported (par.4.1) from 
5 L of culture filtrates and submitted to a bioassay-guided fractionation through CC on silica gel, 
eluted with CHCl3/i-PrOH (95:5) to give seven homogeneous fractions (Scheme 3). The residue 
of the second fraction, major bioactive, (603.5 mg) was submitted to CC on silica gel eluted with 
CHCl3/i-PrOH (95:5) witch afforded six fractions. The third fraction of this column (323.0 mg) 
was further purified by CC on silica gel eluted with n-hexane-EtOAc (1:1) to furnish six 
homogenous fractions. The residue of the second fraction (150.3 mg)of the last column was 
purified by preparative TLC on silica gel eluted with CHCl3/i-PrOH (93:7) yieldind two main 
fractions. The residue of the first fraction (21.3 mg) was further purified by TLC on silica gel 
eluted with n-hexane/Me2CO (7:3 3x) to give two pure compounds as uncoloured oil [17, Figure 
5, 5.8 mg/L, Rf 0.24 eluent n-hexane/Me2CO (7:3 3x) and Rf 0.41 eluent CHCl3/i-PrOH (92:8)] 
and [18, Figure 5, 0.8 mg/L, Rf  0.20 eluent n-hexane/Me2CO (7:3 3x), and Rf 0.35 eluent 
CHCl3/i-PrOH (92:8)] identified as botryosphaerodiplodin and (5R)-5-hydroxylasiodiplodin 
respectively. 
The residue of the second fraction (65.3 mg) was subsequently purified by preparative TLC on 
silica gel eluted with CHCl3/i-PrOH (92:8) yielding a homogeneous amorphous solid [14, Figure 
5, 6.4 mg/L, Rf 0.62 eluent CHCl3/i-PrOH (92:8) and Rf 0.76, TLC on reversed phase, eluent 
EtOH/H2O (6:4)] identified as (3R,4S)-botryodiplodin. 
The residue of the fourth fraction of the first column (130.5 mg) was purified by preparative TLC 
on silica gel eluted with CHCl3/i-PrOH (92:8) to give an homogenous oil, [15 and 16, Figure 6, 
4.5 mg/L, Rf  0.31 eluent CHCl3/i-PrOH (92:8) and Rf 0.12 eluent n-hexane/EtOAc (1:1)] as an 
inseparable mixture and jasmonic acid [10, Figure 5, 3.4 mg/L, Rf 0.45 eluent CHCl3/i-PrOH 
(92:8) and Rf 0.50, TLC on reversed phase, eluent EtOH/H2O (6:4)]. 
 
4.3.1. Lasiolactols A and B (15 and 16) 
 Compounds 15 and 16 (Figure 6), obtained as homogenous oil, had: [α]D
25 +9 (c = 0.2); 
UV λmax: end absorbtion. IRνmax cm
-1 3300, 1651, 1637, 1541, 1085; 1H and 13C NMR: Table10.; 
HRESIMS: Table 11.  
 
4.3.2. Botryosphaeriodiplodin (17) 
Compound 17 (Figure 5), obtained as uncoloured oil. had: [α]D
25 -12 (c = 0.2); UV λmax nm 
(log ε) 205 (3.70), 247 (2.61), 283 (2.43); IR νmax cm
-1 3350, 1697, 1602, 1469, 1273 [lit, 
Rukachaisirikul el al., 2009: [α]D
26 -9.8 (c = 0.7); UV (MeOH) λmax nm 205 (3.20), 247 (2.44), 283 
(2.19); IR νmax cm
-1 (neat): 3440, 1684]; 1H and 13C NMR were very similar those reported 
(Rukachaisirikul el al., 2009); ESIMS (+) m/z: 639 [2M+Na]+, 347[M+K]+, 331 [M+Na]+, 309 
[M+H]+. 
 
4.3.3. (5R)-5-Hydroxylasiodiplodin (18) 
Compound 18 (Figure 5), obtained as uncolored oil, had: [α]D
25 -12 (c = 0.2); UV λmax nm 205 
(3.70), 247 (2.61), 283 (2.43); IR νmax cm
-1 3350, 1697, 1602, 1469, 1273 [lit, Rukachaisirikul el al., 
2009]: [α]D
26 -9.8 (c = 0.7); UV (MeOH) λmax nm 204 (3.20), 245 (2.44), 284 (2.19); IR νmax cm
-1 
3440, 1684]; 1H and 13C NMR were very similar those reported (Rukachaisirikul el al., 2009); 
ESIMS(+) 639 [2M+Na]+, 347[M+K]+, 331 [M+Na]+, 309 [M+H]+. 
 
4.3.4. Methylation of botryodiplodin  
At botryodiplodin (17, 3.7 mg) dissolved in MeOH (1.0 mL) was added an etheral solution of 
CH2N2. The reaction mixture was left at room temperature for 6 h. The solvent was evaporated 
under a N2 stream giving a oil residue (3.8 mg). This latter was purified by preparatve TLC on 
silica gel eluted with CHCl3/i-PrOH (95:5) to give 13-O-methylbotryosphaeriodiplodin (19, Figure 
7, 3.5 mg, Rf 0.69 eluent CHCl3/i-PrOH (95:5) as uncolored oil. It had: UV λmax nm (log ε) 206 
(3.13), 249 (2.52), 282 (2.29); IR νmax cm
-1 3370, 1715, 1700, 1697, 1451, 1260; 1H NMR: Table 12; 
ESIMS (+) m/z 361 [M+K]+, 345 [M+Na]+, 323 [M+H]+. 
 
4.3.5. 7-O-(S)-α-Methoxy-α-trifluoromethyl-α-phenylacetate (MTPA) ester of 13-O-
Methylbotryosphaeriodiplodin (20) 
(R)-(-)-MPTA-Cl (20 μL) was added to 19 (1.0 mg) dissolved in dry pyridine (20 μL). The 
reaction was stirred at room temperature over night, and then stopped by adding MeOH. 
Pyridine was removed by a N2 stream. The residue (7.3 mg) was purified by preparative TLC on 
silica gel eluted with CHCl3/i-PrOH (98:2) to give 7-O-(S)-α-methoxy-α-trifluoromethyl-α-
phenylacetate ester of 19 (20, Figure 7, 0.9 mg, Rf 0.66 eluent CHCl3/i-PrOH (98:2) as 
homogeneous oil. It had: UV λmax nm (log ε) 206 (3.58), 249 (2.42), 282 (2.16); IR νmax cm
−1 1742, 
1646, 1453, 1257, 1154; 1H NMR: Table 12; ESIMS (+) m/z 577 [M+K]+, 561 [M+Na]+, 539 
[M+H]+. 
 
4.3.6. 7-O-(R)-α-Methoxy-α-trifluoromethyl-α-phenylacetate (MPTA) ester of 13-O-
Methylbotryosphaeriodiplodin (21) 
(S)-(+)-MPTA-Cl (20 μl) was added to 19 (1.0 mg) dissolved in dry pyridine (20 μl). The 
reaction was carried out under the same conditions used for preparing 20 from 19. The residue 
(8.1 mg) was purified by preparative TLC on silica gel eluted with CHCl3/i-PrOH (98:2) to give 
7-O-(R)-α-methoxy-α-trifluoromethyl-α-phenylacetate ester of 19 (21, Figure 7, 1.2 mg, Rf 0.66 
eluent CHCl3/i-PrOH (98:2) as homogeneous oil. It had: UV λmax nm (log ε) 206 (3.56), 250 
(2.40), 281 (2.16); IR νmax cm
−1 1751, 1587, 1461, 1265, 1168; 1H NMR: Table 12; ESIMS (+) m/z 
577 [M+K]+, 561 [M+Na]+, 539 [M+H]+. 
 
4.4. Production, extraction and purification of phytotoxins by N. australe strain BL24  
The fungus was grown as previously reported in paragraph 4.1.The phytotoxic extract 
(400 mg, brown oil) was obtained as previously reported (par.4.1) from 7 L of culture filtrates and 
submitted to a bioassay-guided fractionation through CC on silica gel, eluted with CHCl3/i-PrOH 
(95:5) to give ten homogeneous fractions (Scheme 4). The residue (11.3 mg) of sixth fraction, was 
purified by TLC on silica gel, eluent CHCl3/i-PrOH (95:5), yielding a homogeneous amorphous 
solid identified as tyrosol [4, Figure 8, 2.8 mg, 0.4 mg/L Rf 0.23 eluent CHCl3/i-PrOH (95:5), Rf 
0.48 eluent EtOAc/n-hexane (6:4)]. The residue (20.6 mg) of the seventh fraction was further 
purified by two successive steps by TLC on silica gel, eluent CHCl3/i-PrOH (95:5) and by 
reversed phase TLC, eluent EtOH/H2O (6:4), yielding two homogeneous amorphous solids 
identified as botryosphaerone D [22, Figure 8, mg 4.8, 0.7 mg/L Rf 0.24 eluent CHCl3/i-PrOH 
(95:5) and Rf 0.56,TLC on reversed phase, eluent EtOH/H2O (6:4)] and (3S,4S)-3,4,8-trihydroxy-
6-methoxy-3,4-dihydro-1(2H)-naphthalenone [23, Figure 8, 1.5 mg, 0.2 mg/L, Rf 0.24 eluent 
CHCl3/i-PrOH (95:5) and Rf 0.65, TLC on reversed phase, eluent EtOH/H2O (6:4)]. 
  
4.4.1. Botryosphaerone D (22) 
Botryosphaerone D, obtained as homogeneous amorphous solid, had: [α]D
25
 +18 (c = 0.2 
); ECD (c = 5.16 10-4 M) Δε: +17.7 (286), +8.5 (239), -46.2 (214); UV (CH3OH) λmax nm (log ε): 
222 (4.27), 288 (4.19); IR νmax cm
-1 3307, 1622, 1310, 1126; [for the botryosphaerone D (Xu et al., 
2011), [α]25D  +13 (c 2.0, MeOH); UV (MeOH) λmax nm (log ε): 230 (2.19), 297 (2.78); IR (KBr) 
νmax cm
-1 3428, 1626, 1311, 1126]; 1H and 13C NMR data were very similar to those already report 
(Xu et al., 2011); ESIMS (-) m/z: 251 [M-H]-, 233 [M-H2O-H]
-, APCIMS (+) m/z: 253 [M+H]+. 
 
4.4.2.  3,4,8-Trihydroxy-6-methoxy-3,4-dihydro-1(2H)-naphthalenone (23) 
The compound 23, obtained as homogeneous amorphous solid, had: [α]D
25
 +53 (c = 0.2); 
ECD (c = 5.8 10-4 M) Δε: +11.1 (280), +7.6 (238), -38.6 (214); UV (MeOH) λmax nm (log ε): 214 
(4.26), 230 (4.09), 238 (4.04), 280 (4.14), 317 (3.79); IR νmax cm
-1 3384, 1739, 1625, 1362, 1169; [lit, 
Pittayakhajonwut et al., 2008: [α]D
25
 +49.38 (c = 0.048, MeOH); UV (MeOH) λmax nm (log ε): 216 
(4.21), 230 (4.04); 237 (3.95), 281 (4.10), 321 (3.82); IR (KBr) νmax cm
-1 3494, 3405, 2958, 2927, 
2855, 1729, 1636, 1578, 1459, 1432, 1403, 1375, 1360, 1291, 1164, 1128, 1075, 1031, 843); 1H and 
13C NMR data very similar to those already report]; ESIMS (-) m/z: 223 [M-H]-, 207 [M-OH]-, 
APCIMS (+) m/z: 225 [M+H]+. 
4.5. Production, extraction and purification of phytotoxins by Diplodia quercivora 
strain BL9. 
The fungus was grown as previously reported in paragraph 4.1. The phytotoxic extract 
(11.5 g, brown-red oil) of D. quercivora strain BL9, was obtained as previously reported in 
paragraph 4.1 from 21.6 L of culture filtrate. The residue was submitted to a bioassay-guided 
fractionation through CC on silica gel, eluted with n-hexane/Me2CO (8:2). Eight homogeneous 
fraction groups were collected (Scheme 5). The residue of the third fraction (1.03 g) was purified 
by CC on silica gel eluted with CHCl3/n-hexane/Me2CO (4.5:4.5:1) yielding five homogeneous 
fractions. The residue of the third fraction of this column (323.0 mg) was crystallized with 
EtOAc/n-hexane (1:5) to give white crystals, which being a new compound was named 
diplopimarane [24, Figure 9, 142.7 mg, 6.6 mg/L, Rf 0.7 eluent n-hexane/EtOAc (7:3)]. The 
residue of the fourth fraction of the first column (2.938 g) was crystallized with EtOAc/n-hexane 
(1:5) to give sphaeropsidin A [32, Figure 10, 2.081 g, Rf 0.5 eluent n-hexane/Me2CO (7:3) and Rf 
0.7 eluent n-hexane/EtOAc (6:4)] as white crystals. The residue of the fifth fraction of the same 
CC (2.567 g) was purified by CC on silica gel eluted with CHCl3/i-PrOH (95:5) yielding five 
homogeneous fractions. The residue of the second fraction of the last CC (421.8 mg) was 
crystallized with EtOAc/n-hexane (1:5) giving further quantities of sphaeropsidin A (278.7 mg). 
The residue of the fourth fraction (689.1 mg) was purified by CC on silica gel, eluent n-
hexane/EtOAc/ Me2CO (6:2.5:1.5) giving three main metabolites as white solids identified as 
(+)-epiepoformin [34, Figure 10, 301.2 mg, 13.9 mg/L, Rf 0.42 eluent n-hexane/EtOAc/ Me2CO 
(6:2.5:1.5) and Rf 0.44 eluent n-hexane/EtOAc (6:4)], sphaeropsidin C [33, Figure 10, 53.3 mg, 
2.46 mg/L, Rf 0.52 eluent n-hexane/EtOAc/ Me2CO (6:2.5:1.5) and Rf 0.63 eluent n-
hexane/EtOAc (6:4)] and a further quantity of sphaeropsidin A (32, 203.2 mg, total yield 119.0 
mg/L). 
 
4.5.1. Diplopimarane (24) 
Compound 24,obtained as white crystals, had: Mp 136 °C; [α]D
25 +25.8 (c = 0.6); UV λmax 
nm (log ε) 285 (3.34), 228 sh (3.90); IR νmax cm
-1 3497, 3457, 3239, 1609, 1571, 1440, 1342, 1289, 
1205; 1H and 13C NMR: Table 13; HRESIMS (+) spectrum m/z: 325.1785 [C19H26O3Na, calcd. 
325.1780, M+Na]+; ESIMS (+) m/z 623 [2M-4H+Na]+, 339 [M-2H+K]+, 325 [M+Na]+, 323 [M-
2H+Na]+; ESIMS(-) m/z 301 [M-H]-; APCIMS (+) m/z 285 [M-OH+H]+, APCIMS (-) m/z 301 
[M-H]-. 
  
4.5.2. 6-O-Methyl and 6,7-O,O’-Dimethyldiplopimarane (25 and 26).  
To compound 24 (12.0 mg) dissolved in MeOH (1.5 mL), was slowly added an ethereal 
solution of CH2N2 until a yellow color was persistent. The reaction mixture was left at room 
temperature for 78h. The solvent was evaporated under a N2 stream giving a oil residue (12.4 
mg). This latter was purified by preparative TLC on silica gel, eluent n-hexane/EtOAc (8:2) to 
give 25 and 26 as uncoloured oils (3.5 and 3.9 mg, Rf 0.3 and 0.5, respectively). 6-O-
methyldiplopimarane (25, Figure 9) had: UV λmax nm (log ε) 227sh (3.80), 281 (3.35); IR νmax cm
-1 
3502, 1731, 1640, 1429; 1H NMR:  Table 14; ESIMS (+) m/z 655 [2M+Na]+, 355 [M+K]+, 339 
[M+Na]+; APCIMS (-) m/z 315 [M-H]-, 301 [M-Me]-. 6-O-O-dimethyldiplopimarane (26, Figure 
9) had: UV λmax nm (log ε) 228 sh (3.00), 280 (3.02); IR νmax 3497, 1730, 1628, 1576, 1451 cm
−1; 1H 
NMR: Table 14; ESIMS (+) m/z 369 [M+K]+, 353 [M+Na]+; APCIMS (+) m/z 331 [M+H]+. 
 
4.5.3.  6,7,14-O,O’,O’’-Triacetyldiplopimarane (27) 
Diplopimarane 24 (2.3 mg), dissolved in pyridine (30 μL), was converted into the 
corresponding 6,7,14-O,O’O’’-triacetyl derivative (27, Figure 9) by acetylation with Ac2O (30 μL) 
at room temperature for 1 h. The reaction was workup as previously reported (par. 4.3.4.). The 
oily residue (2.5 mg) was purified by TLC on silica gel, n-hexane/EtOAc (8:2) yielding derivative 
27 [1.0 mg, Rf 0.6 eluent n-hexane/EtOAc (8:2)] as a uncolored oil. Triacetyldiplopimarane had: 
UV λmax nm (log ε) 222 sh (3.81), 271 (3.43); IR νmax cm
−1 1773, 1725, 1626, 1423, 1374; 1H NMR: 
Table 14; ESIMS (+) m/z 467 [M+K]+, 451 [M+Na]+; APCIMS (+) m/z 429 [M+H]+. 
 
4.5.4.  6-O-p-Bromobenzoyl Ester of Diplopimarane (28) 
To diplopimarane 24 (5.0 mg), dissolved in CH3CN (750 µL), DMAP (7.3 mg) and p-
bromobenzoyl chloride (7.0 mg) were added. The reaction mixture was stirred at room 
temperature for 2 h, and then evaporated under reduced pressure. The residue (20.0 mg) was 
purified by TLC on silica gel, eluent CHCl3/-i-PrOH (97:3) giving 28 [Figure 9, 1.0 mg, Rf 0.8 
eluent CHCl3/i-PrOH (97:3)] as uncoloured oil. It had: UV λmax nm (log ε) 203 (3.57), 245 (3.65), 
280 (3.31); IR νmax cm
−1 3464, 3406, 1727, 1583, 1437, 1269, 1010; 1H NMR: Table 14; ESIMS (+) 
m/z 525 [M+2+K]+, 523 [M+K]+, 509 [M+2+Na]+, 507 [M+Na]+; ESIMS (-) m/z 485 [M+2-H]-
,483 [M-H]-, 301 [M-p-BrC6H4-CO]
-; APCIMS (+) m/z 469 [M+2+H-H2O]
+, 467 [M+H-H2O]
+, 
285 [M-p-BrC6H4CO2]
+; APCIMS (-) m/z 485 [M+2-H]-, 483 [M-H]-, 285 [M-p-BrC6H4-CO2]
+, 
314 [M-p-BrC6H4]
-; 301 [M-p-BrC6H4-CO]
-. 
 
4.5.5. 15,16-Dihydrodiplopimarane (29) 
Diplopimarane 24 (5.8 mg) dissolved in MeOH (200 μL) was added to a presaturated 
suspension of 10% Pd/C in MeOH (600 μL). Hydrogenation was carried out at room 
temperature and atmospheric pressure with continuous stirring over night. The reaction was 
stopped by filtration, and the clear solution evaporated under a N2 stream. The residue (6.1 mg) 
was purified by preparative TLC on silica gel, eluted with n-hexane/EtOAC (8:2), to yield 5.0 mg 
of 29 (Figure 9)as yellow oil [Rf 0.7 eluent n-hexane/EtOAC (8:2)]. It had: UV λmax nm (log ε) 225 
sh (3.81), 312 (3.38); IR νmax cm
-1 3643, 3239, 3498, 1728, 1691, 1556, 1456; 1H NMR: Table 14; 
ESIMS (+) m/z 595 [2M-2H2O+Na]
+, 309 [M-H2O+Na]
+, 287 [M-H2O+H]
+. 
 
4.5.6. 14-O-(S)-α-Methoxy-α-trifluoromethyl-α-phenylacetate (MTPA) ester of 6,7-O,O’-
Dimethyldiplopimarane (30) 
(R)-(-)-MPTA-Cl (20 μL) was added to 26 (1.5 mg) dissolved in dry pyridine (20 μL). The 
reaction was stirred at room temperature for 2 h and then stopped by adding MeOH. Pyridine 
was removed by a N2 stream. The purification of the crude residue (7.3 mg) by preparative TLC 
on silica gel, eluted with n-hexane/EtOAc (9:1) gave 30 (Figure 11)as homogeneous oil [0.7 mg, 
Rf 0.83 eluent n-hexane/EtOAc (9:1)]. It had: UV λmax nm (log ε) 207 (3.98), 233 (4.22), 281 
(3.16); IR νmax cm
-1 1742, 1646, 1453, 1257, 1154; 1H NMR:Table 15; ESIMS (+) m/z 569 
[M+Na]+, 585 [M+K]+. 
 
4.5.7. 14-O-(R)-α-Methoxy-α-trifluoromethyl-α-phenylacetate (MTPA) ester of 6,7-O,O’-
Dimethyldiplopimarane (31) 
(S)-(+)-MPTA-Cl (20 μl) was added to 26 (1.5 mg) dissolved in dry pyridine (20 μl). The 
reaction was carried out under the same conditions used for preparing 30 from 26. The 
purification of the crude residue (8.1 mg) by preparative TLC on silica gel, eluted with n-
hexane/EtOAc (9:1) gave 31 (Figure 11)as homogeneous oil [1.2 mg, Rf 0.83 n-hexane/EtOAc 
(9:1)].It had: UV λmax nm (log ε) 208 (3.98), 231 (4.22), 281 (3.16); IR νmax cm
-1 1751, 1649, 1461, 
1265, 1168; 1H NMR: Table 15; ESIMS (+) m/z 569 [M+Na]+, 585 [M+K]+. 
 
4.5.8. Conversion of Sphaeropsidin A into Diplopimarane. 
Within a solution of sphaeropsidin A (60 mg) in dry MeOH (30 mL) at 0 °C, gaseous HCl, 
generated in situ by reaction of 96% H2SO4 and NaCl, was gurgled. The reaction was stopped 
after 12 h by neutralization with 1N NaOH. The solution was extracted with EtOAc (3x 50 mL) 
and the organic extracts combined, dried and evaporated under reduced pressure. The residue (58 
mg) was purified by TLC on silica gel eluent n-hexane/EtOAc (7:3), giving the mixture of 24 and 
its C-14 epimer (16.3 mg) as the main product. 
 
4.5.9. Sphaeropsidin A and C (32 and 33). 
The 1H and 13C NMR and optical properties, recorded in the same condition were identical 
to those previously reported  (Evidente et al.,1996 and 1997). Sphaeropsidin A had: ESIMS (+) 
m/z 715 [2M+Na]+; 369 [M+Na]+; ESIMS (-) m/z 345 [M–H]-; APCIMS (+) m/z 347 [M+H]+; 
APCIMS (-) m/z 345 [M-H]-. Sphaeropsidin C had: ESIMS (+) m/z 371 [M + K]+; 355 [M + 
Na]+; ESIMS (-) m/z 331 [M–H]-; APCIMS (+) m/z 333 [M+H]+; 315 [M-OH]+; APCIMS (-) 
m/z 331 [M-H]-. 
 
4.5.10.  (+)-Epiepoformin (34) 
Compound 34, obtained as white amorphus solid, had: [α]D
25 +243 (c = 0.4, EtOH); ECD 
(c = 0.01, EtOH): [θ]25  +6100 (340), +220 (282), 12,530 (254); UV λmax nm (log ε) 210 (3.49), 238 
(3.51); IR νmax cm
-1 3408, 1664, 1439, 1371, 1271, 1033; [lit, Nagasawa et al., 1978): IR νmax cm
-1: 
3440 (OH), 1668 (C-O), 1282, 1042 (C-O), 830, 727. UV (EtOH) λmax nm (log ε): 237 (3.65); λmax 
10 % NaOH in EtOH nm (log ε): 232sh (3.82), 262 (3.53), 324sh (2.94). CD (c = 0.01, dioxane) 
[θ]25 (nm): 0 (385), +6300 (340), +140 (282), +11,600 (254); MS m/z 140.0448 (M+, 140.0472 
calcd for C7H8O8), 112, 111, 97, 83, 71)]; ESIMS (-) m/z 139 [M–H]
-; APCIMS (-) m/z 139 [M-
H]-. 
 
4.5.11. Crystal Structure Determination of Diplopimarane (24) 
Yellow, block-shaped single crystals of 24 were obtained by slow evaporation of a 
EtOAc-n-hexane (1:3) solution at ambient temperature. X ray data collection was performed at 
298 K on a Bruker-Nonius Kappa CCD diffractometer equipped with graphite-monochromated 
MoKα radiation (λ = 0.71073 Å, CCD rotation images, thick slices, φ and ω scans to fill 
asymmetric unit). Unit cell parameters were obtained from a least-squares fit of the θ angles of 79 
reflections in the range 4.217° ≤ θ ≤ 19.663°. A semiempirical absorption correction (multiscan, 
SADABS) was applied. The structure was solved by direct methods using SIR97 package 
(Altomare et al., 1999) and refined by the full matrix least-squares method on F2 against all 
independent measured reflections using SHELX97 software package (Sheldrick et al., 2008). All 
non-hydrogen atoms were refined anisotropically. Hydroxy hydrogen atoms were found in 
difference Fourier maps, all the other H atoms were placed in calculated positions  and refined 
according to a riding model (C-H in the 0.93-0.96 Å range; Uiso(H) = 1.2·Ueq (CAr), Uiso(H) = 
1.5·Ueq (CMe) of the carrier atom). The final refinement converged to R1 = 0.0591, wR2 = 0.1372 
for 2495 observed reflections having I > 2σ(I). Minimum and maximum residual electronic 
density was -0.314 and 0.366 eÅ−3. Crystal data for 24: empirical formula: C19H26O3; formula 
weight 302.40 g mol−1; crystal system: monoclinic; space group: P 21; unit cell dimensions: a = 
6.0156(7), b = 8.8811(11), c =  15.2432(10)Å, β = 95.315(7)°; reflections collected/unique: 
8445/3426 [R(int) = 0.0390]; data/restraints/parameters: 3426/1/211; goodness of fit on F2: 
1.077 ; final R indices [I > 2σ(I)]: R1 = 0.0591, wR2 = 0.1372; R indices (all data): R1 = 0.0907, 
wR2 = 0.1528; largest diff. peak and hole (e/Å3): 0.366 and -0.314. 
 
4.6. Production, extraction and purification of oxysporone (35) 
Oxysporone (35, Figure 12) was isolated from culture filtrate of D. africana strain DA1 
grown on a mineral defined liquid media named M1-D (Pinkerton and Strobel, 1976) as recently 
reported in details (Evidente et al., 2012). The purification of the organic extract obtained by its 
culture filtrate (12 L), carried out as previously described (Evidente et al., 2012), allowed to obtain 
oxysporone (35) as homogeneous oils (357.6 mg, 29.7 mg/L).  
4.6.1 Preparation of oxysporone derivatives 
4.6.2. 4-O-Acetyloxysporone (38) 
 Oxysporone (35, 30.5 mg), dissolved in pyridine (60 μL), was converted into the 
corresponding 4-O-acetyl derivative (38) by acetylation with Ac2O (60 μL) at room temperature 
for 2 h. The reaction was workup as previously reported (par.4.3.4.). The oily residue (38.2 mg) 
was purified by TLC on silica gel, eluent CHCl3/i-PrOH (95:5), yielding derivative 38 [Figure 13, 
25.8 mg, Rf 0.7 eluent CHCl3/i-PrOH (95:5)] as a homogeneous oil. It had: UV λmax nm (log ε) 
206 (3.00); IR νmax cm
−1 1789, 1731, 1652, 1230 1011; 1H NMR: Table 16; ESIMS (+) m/z 221 
[M+Na]+.  
 
4.6.3. 2,3-Dihydrooxysporone (39) 
Oxysporone (35, 15.0 mg), dissolved in MeOH (750 µL), was added to a presaturated 
suspension of Pt (5%) in MeOH (750 µL). Hydrogenation was carried out at room temperature 
and atmospheric pressure under stirred conditions. After 4 h the reaction was stopped by 
filtration and the clear solution then evaporated under reduced pressure. The residue (17.4 mg) 
purified by preparative TLC on silica gel, eluent CHCl3/i-PrOH (93:7), giving 39 [Figure 13, 11.0 
mg, Rf 0.3 eluent CHCl3/i-PrOH (93:7)] as homogeneous solid. It had: UV λmax nm (log ε): 205 
(2.91); IR νmax cm
-13426, 1767, 1165; 1H NMR: Table 16; ESIMS (+) m/z: 339 [2M+Na]+, 181 
[M+Na]+. 
 
4.6.4.  4,O-Dehydrooxysporone (40) 
To oxysporone (35, 15.1 mg), dissolved in CH2Cl2 (3.0 mL), Corey’s reagent (Corey and 
Suggs, 1975) (75.1 mg) was added and the reaction mixture was stirred at room temperature for 1 
h. The reaction was then stopped by filtration on a glass fennel and the clear solution obtained 
evaporated under reduced pressure. The residue (36.5 mg) purified by preparative TLC on silica 
gel, eluent CHCl3/i-PrOH (93:7), giving 40 [Figure 13, 4.3 mg, Rf 0.36 eluent CHCl3/i-PrOH 
(93:7)] as a homogeneous solid. It had: UV λmax nm (log ε) 205 (3.77); IR νmax cm
−1 1794, 1738, 
1681, 1005; 1H NMR: Table 16; APCIMS (+) m/z 155 [M+H]+; APCIMS (-) m/z 153 [M-H]-. 
 
4.6.5.  4-O-p-Bromobenzoyloxysporone (41) 
To oxysporone (35, 10.0 mg) dissolved in CH3CN (1.0 mL), DMAP (23.0 mg,) and p-
bromobenzoyl chloride (25.0 mg) were added. The reaction mixture was stirred at room 
temperature for 4 h, and then evaporated under reduced pressure. The residue (43.2 mg) was 
purified by TLC on silica gel, eluent CHCl3/i-PrOH (97:3), giving 41 [Figure 13, 10.6 mg, Rf 0.8, 
eluent CHCl3/i-PrOH (97:3)] as a white solid. It had: UV λmax nm (log ε): 203 (4.42), 245 (4.28); 
IR νmax cm
−1 1798, 1715, 1655, 1619, 1266, 1013; 1H NMR: Table 16; ESIMS (+) m/z 378 
[M+2+K]+, 376 [M+K]+, 362 [M+2+Na]+, 360 [M+Na]+; ESMS (-) m/z 338 [M+2-H]-, 336 [M-
H]-, 201 [p-BrC6H4 -CO2+2]
-, 199 [p-BrC6H4 -CO2]
-. 
 
4.6.6. 2-(4-Pyronyl)acetic acid (42) 
To oxysporone (35, 10.0 mg), dissolved in Me2CO (2.0 mL), at 0 °C , Jones’s reagent 
(Bowers et al., 1953) was added under stirring until to have a orange supernatant. After 10 min 
the reaction was stopped by addition of i-PrOH and ice. The suspension was diluted with iced 
H2O to obtain a brilliant green solution, which was extracted with EtOAc (3x 2mL). The organic 
extracts were combined, dried (Na2SO4), filtered and evaporated under reduced pressure. The 
residue (33.1 mg) was purified by TLC on reverse phase, eluent MeOH/H2O (1:1), giving 42 
[Figure 13, 4.1 mg, Rf  0.78 eluent MeOH/H2O (1:1)] as amorphous solid. It had: UV λmax nm (log 
ε): 204 (3.56), 251( 3.51); IR νmax cm
−1 3400, 1740, 1653, 1082; [lit, Nagata and Ando, 1989: νmax 
(KBr)/cm-1 3600-3300, 1725 and 1638]; 1H NMR was similar to that previously reported in D2O 
(Salvatore et al., 1994). 1H NMR: Table 16; ESIMS (+) m/z 177 [M+Na]+; APCIMS (+) m/z 155 
[M+H]+; APCIMS (-), m/z 153 [M-H]-.  
 
4.6.7. 4-O-Acetyl-2,3-dihydrooxysporone (43) 
Compound 38 (15.0 mg) dissolved in MeOH (750 µL), was added to a presaturated 
suspension of Pt (5%) in MeOH (750 µL). Hydrogenation was carried out at room temperature 
and atmospheric pressure under stirred conditions. After 5 h the reaction was stopped by 
filtration and clear solution was then evaporated under reduced pressure. The residue (18.5 mg) 
was purified by preparative TLC on silica gel, eluent CHCl3/i-PrOH (97:3), giving 43 [Figure 13, 
8.1 mg Rf 0.4 eluent CHCl3/i-PrOH (97:3)] as a homogeneous solid. It had: UV λmax nm (log ε): 
203 (4.01); IR νmax cm
−1 1733, 1243; 1H NMR: Table 16; ESIMS (+) m/z 223 [M+Na]+. 
 
4.6.8. 2-(2,3-Dihydro-4-pyronyl)acetic acid (44) 
To compound 39 (5.0 mg) in Me2CO (1.0 mL), at 0 °C, Jones’s reagent (Bowers et al., 
1953) was added under stirring as previously reported to convert 35 into for 42. The residue (13.2 
mg) of the work-up reaction was purified by TLC on reverse phase, eluent MeOH/H2O (1:1), 
giving 44 [Figure 13, 1.4 mg, Rf  0.70 eluent MeOH/H2O (1:1)] as amorphous solid. It had: UV 
λmax nm (log ε): 268 (3.72); IR νmax cm
−1 3416, 1725, 1659, 1612, 1601; [lit, Scott et al., 1972: λmax 
(EtOH) 267 nm (ε 7960); IR νmax (CHCl3) 3510, 1718, 1672, 1621]; 
1H NMR: Table 16; ESIMS 
(+) m/z 179 [M+Na]+; ESIMS (-) m/z 155 [M-H]-; APCIMS (+) m/z 157 [M+H]+; APCIMS (-) 
m/z 155 [M-H]-. 
 
4.6.9. Methyl ester of 2-(4-pyronyl)acetic acid (45) 
To compound 42 (2.5 mg) dissolved in MeOH (1.0 mL), was slowly added an ethereal 
solution of CH2N2 until a yellow colour was persistent. The solvent was evaporated under a N2 
stream  and the residue (3.1 mg) purified by preparative TLC on silica gel, eluent CHCl3/i-PrOH 
(93:7), giving 45 [Figure 13, 1.2 mg, Rf 0.5 eluent CHCl3/i-PrOH (93:7)] as a white solid. It had: 
UV λmax nm (log ε): 205 (2.91), 248 (2.95); IR νmax cm
−1 1731, 1650, 1610, 1438; 1H NMR: Table 
16; ESIMS (+) m/z 191 [M+Na]+; APCIMS (+) m/z 169 [M+H]+, 137 [M+CH3O]
+. 
  
4.7. Biological assays  
 
4.7.1. Phytotoxic activity 
Phytotoxic activity was tested on weedy plants: Quercus ilex L., Quercus suber L, Vitis vinifera 
L., and Lycopersicon esculentum L. The culture filtrates were assayed as such as. Organic extracts, 
chromatographic fractions and pure compounds were tested in a range of concentration from 4 
to 0.1 mg/mL. Samples were dissolved in a small amount of MeOH and diluted with distilled 
H2O up to the assay concentrations (the final content of MeOH was 4%). 
 
4.7.1.1. Leaf puncture assays  
Young holm oak, cork oak and tomato leaves were utilized for this assay. Compounds 
were first dissolved in MeOH, and then a stock solution with sterile distilled water was made. A 
droplet (20 µL) of test solution was applied on the adaxial sides of leaves that had previously 
been needle punctured. Droplets (20 µL) of MeOH in distilled water (4%) were applied on leaves 
as control. Each treatment was repeated three times. The leaves were kept in a moist chamber to 
prevent the droplets from drying. Leaves were observed daily and scored for symptoms after 7 
days. The effect of the samples on the leaves, consisting in necrotic spots surrounding the 
puncture,  were observed up to 15 days after droplet application. Lesions were estimated using 
APS Assess 2.0 software (Lamari, 2002) following the tutorials in the user’s manual. The lesion 
size was expressed in mm2. 
 
4.7.1.2. Cutting assays 
Detached leaves of grapevine with their petioles were immersed in 2 mL toxic solution 
until complete absorption and then transferred to distilled water. Toxicity symptoms were 
recorded 48 h later up to 7 days.  
Tomato cuttings were taken from 21 day old seedlings and each compound was assayed 
at 0.05, 0.1 and 0.2 mg/mL. Cuttings were placed in the test solutions (2 mL) for 72 h and then 
transferred to distilled water. Symptoms were visually evaluated up to 7 days.  
 
4.7.2.Zootoxic activity assays 
Compounds were assayed on brine shrimp larvae (Artemia salina L.). The assay was 
performed in cell culture plates with 24 cells (Corning) as already described (Favilla et al., 2006). 
The metabolites were dissolved in methanol and tested at 50 µg/mL. Tests were performed in 
quadruplicate. The percentage of larval mortality was determined after incubation for 24 and 36 h 
at 27 °C in the dark.  
4.7.3. Antifungal activity 
Antifungal activity was tested on the following species: Diplodia corticola A.J.L. Phillips, A. 
Alves & J. Luque (Ascomycetes), Athelia rolfsii (Curzi) C.C. Tu & Kimbr. (Basidiomycetes), Diplodia 
seriata, Neofusicoccum parvum, N. vitifusiforme van Niekerk & Crous, Slippers & A.J.L. Phillips and 
three Oomycetes: Phytophthora cinnamomi Rands, Phytophthora plurivora T. Jung & T.I. Burgess and 
Phytophthora citrophthora (R.E. Sm.& E.H. Sm.) Leonian. The sensitivity of all species to 
compounds was evaluated by transferring mycelial plugs (6-mm diameter) of each isolate, taken 
from the margin of actively growing 3-day-old colonies, to carrot agar medium supplemented 
with 100 µg/mL of each compound. Each disk was placed in the centre of a Petri dish with 
mycelia in contact with the medium. The plates were incubated at 20 or 25 °C depending on the 
pathogen in the dark until the target fungi used as negative control covered the plate’s surface. 
Then the two perpendicular diameters of all fungi were measured and the results were reported as 
inhibition of growth. Three replicates were tested for each isolate and each assay was performed 
twice. Metalaxyl-M (mefenoxam; p.a. 43.88%; Syngenta) was used as positive control for 
Oomycetes, while PCNB (Pentachloronitrobenzene), was used as positive control for 
Ascomycetes and Basidiomycetes. MeOH (0.5% v/v) were used as a negative control. Three 
replicate Petri dishes were used for each treatment. The dishes were inoculated, incubated and 
colony growth was determined as described above. 
4.7.4. Analysis of data 
Each experiment was repeated twice with three replicates. All data were processed with 
XLSTAT software (Addinsoft, Damrémont, Paris, France). Probit analysis was used to calculate 
the effective concentration values that inhibited mycelial growth by 50% (EC50). 
  
5. RESULTS AND DISCUSSION 
5.1. Chemical and biological characterization of phytotoxins from Neofusicoccum 
australe strain BOT48. 
The strain N. australe was associated with grapevine cordon dieback in Sardinia (Linaldeddu et al., 
2010) as showed in Figure 14. The lack information on secondary metabolites produced by N. 
australe involved in grapevine dieback, suggested to evaluate its ability to produce in vitro 
phytotoxins potentially involved in the pathogenesis process. For this reason the fungus was 
grown in liquid cultures and the organic extract, showing a high phytotoxic activity was purified 
by a combination of CC and TLC as detailed in the experimental section (par.4.1) yielding three 
metabolites (Figure 2). Metabolites were isolated as homogeneous amorphous solids and by 
preliminary 1H NMR investigation appeared to belong to different classes of natural compounds.  
Main metabolite, named cyclobotryoxide (1), had a molecular weight of 170 as deduced 
from its HRESIMS spectrum corresponding to a molecular formula of C8H10O4, indicating four 
hydrogen deficiencies. The same spectrum showed the sodium cluster [M+Na]+ at m/z 193.1509 
and when the same spectrum was recorded in negative mode the pseudomolecular ion [M-H]- at 
m/z 169. The UV spectrum (Figure 15) showed an absorption maximum at 275 nm, consistent 
with the theoretical one (272) calculated applying the Woodward rules for compound containing 
a suitable α,β,γ-trisubstituted α,β-unsaturated carbonyl group (Pretsch et al., 2000). IR spectrum 
showed bands characteristic of hydroxy and conjugated carbonyl groups (Nakanishi and 
Solomon, 1977). 
The 1H NMR spectrum of 1 (Figure 16) showed the presence of a doublet of doublets (J = 
3.0 and 1.0 Hz) and a doublet at δ 3.79 and 3.45 (J = 3.0 Hz), respectively, typical of the protons 
(H-6 and H-1) of a cis-disubstituted oxirane ring (Pretsch et al.,2000). The resonance at δ 4.88 
was assigned to a proton (H-5) of a secondary hydroxylated carbon. It coupled in the COSY 
spectrum (Berger et al.,2004) with the geminal hydroxy group observed as a doublet (J =11.0 Hz) 
at δ 3.60, with H-6 and long range (J < 1Hz) with a vinyl methyl group [CH3-C(4)] (Figure 17). 
The latter was observed as a broad singlet at δ 1.26. Furthermore, the 1H NMR spectrum showed 
a singlet at δ 4.05 assigned to a methoxy group (Pretsch et al.,2000). 
These partial structures were confirmed by data of the 13C NMR spectrum (Figure 18) 
which showed the presences of signals due to an α,β-unsaturated α-oxygenated carbonyl group (δ 
194.3, 165.5, 112.0), for the carbonyl (C-2) and two quaternary olefinic (C-3 and C-4) carbons. 
The methoxy and methyl groups resonated at δ 56.1 and 7.9, and were located at C-3 and C-4, 
respectively on the basis of the couplings observed in the HMBC spectrum (Figure 19)(Berger et 
al.,2004). The three oxygenated secondary carbons were observed at typical chemical shift values 
of δ 60.9, 54.2, 52.1, and they were assigned by the coupling observed in the HSQC spectrum 
(Figure 20) (Berger et al.,2004) to C-5, C-6 and C-1, respectively (Breitmaier et al., 1987). 
Thus, chemical shifts were assigned to all the protons and carbons and cyclobotryoxide was 
formulated as 5-hydroxy-3-methoxy-4-methyl-7-oxabicyclo[4.1.0]hept-3-en-2-one. 
This structure was confirmed by all the couplings and correlations observed in the HMBC 
and NOESY(Berger et al., 2004) spectra. The NOESY spectrum (Figure 21)showed, besides the 
expected correlations between H-1 and H-6 and the methoxy and the methyl groups, also those 
between the latter and the proton of hydroxy group at C-5 and between H-5 and H-6. The latter 
correlation was in agreement with an inspection of a Dreiding model of 1 as both relative 
configurations of C-5 (R* or S*) could generate an nOe effect between H-6 and H-5. However, 
only the relative R* configuration could be assigned to C-5 as it is consistent with the dihedral 
angle near 90° observed between H-5 and H-6, which, in agreement to the literature, was a very 
low value (1.0 Hz) measured for their coupling in the 1H NMR spectrum(Pretsch et al.,2000). 
The absolute configuration of 1 was determined by comparison of its ECD spectrum with 
those of the structurally related epoxycyclohexenones (Mennucci et al., 2007). In fact, its ECD 
spectrum (Figure 22) showed negative and positive Cotton effects at 310 and 270 nm, 
respectively. These effects were similar to related epoxycyclohexenones such as sphaeropsidone, 
terremutin, and panepoxydon (Mennucci et al., 2007; Evidente et al.,1998). 
On the basis of these results 1 was formulated as (1S,5R,6S)-5-hydroxy-3-methoxy-4-
methyl-7-oxabicyclo[4.1.0]hept-3-en-2-one. 
The structure assigned to cyclobotryoxide was further supported by preparation of 
derivative 2 by acetylation. The spectroscopic data of this derivative were fully consistent with the 
structure assigned to 1. The IR spectrum of 2 showed the absence of a hydroxy group and the 
presence of a band typical of an acetyl carbonyl group at 1747 cm-1(Nakanishi et al., 1977). Its 1H 
NMR (Figure 23)spectrum differed from that of 1 essentially in the downfield shift (Δδ 1.30) of 
H-5 observed as broad singlet at δ 6.18, and the absence of the doublet at δ 3.60 of the hydroxy 
proton, and the presence of the singlet of the acetyl group at δ 2.19. The ESIMS spectrum of 2 
recorded in the positive mode showed the sodium cluster [M+Na]+ at m/z 235. 
Cyclobotryoxide was characterized as a new naturally occurring compound belonging to a 
family of epoxycyclohexenones which have been isolated from bacteria, fungi, higher plants, and 
molluscs. These compounds have shown interesting biological properties such as antifungal, 
antibacterial, antitumoral, phytotoxic, and enzyme inhibitory activities (Mennucci et al., 2007). 
Furthermore, sphaeropsidone and epi-sphaeropsidone, belonging to the same family of natural 
compounds were previously isolated from Diplodia cupressi,(Evidente et al., 2011) a pathogenic 
fungus of cypress.  
Metabolites 3 was identified as 3-methylcatechol on the basis of its spectroscopic data 
which were the same as previously reported (Ahamad et al., 2001). 3-methylcatechol, a minor 
metabolite of toluene, showed toxicity in human and mammal cells (Shen et al.,1998 and Nakai et 
al., 2003). It was also isolated, together with other phenolic compounds, from the fermentation 
liquid of the endophytic fungus Penicillium sp. GT6105 from Kandelia candel.(Li et al., 2007). 
Metabolite 4 was identified as tyrosol, on the basis of its spectroscopic data, which was 
similar to that previously reported (Capasso et al., 1992). Tyrosol is a phytotoxic metabolite 
produced by plants and fungi including Botryosphaeriaceae species (Venkatasubbaiah et al., 1991; 
Capasso et al., 1992). Recently, tyrosol was also identified as a phytotoxic metabolite produced by 
N. parvum (Evidente et al., 2010). This fungus was isolated together with four other 
Botryosphaeriaceae from declining grapevines in Spain (Martos et al., 2008). 
When assayed on the leaves of different plant species at different concentrations as 
previously reported in experimental section, compounds 1, 3 and 4 showed varying degrees of 
phytotoxicity. The toxicity data obtained in the leaf-puncture bioassay on holm oak, cork oak, 
and grapevine cv. Cannonau leaves, are summarized in Table 17. Cyclobotryoxide (1) appeared to 
be the most active metabolite.(Figure 24). It had remarkable toxicity in a range of concentrations 
from 0.25 to 1.0 mg/mL, causing necrotic lesions to leaves of all species tested. At the lower 
concentrations its toxicity was progressively reduced. A marked decrease of activity was observed 
for its acetyl derivative (2) even at the highest concentration (1 mg/mL) tested, confirming that 
structural modifications could alter biological activity. At the lower doses, compound 2 was 
inactive on cork and holm oak. Compound 3 showed moderate activity on grape leaves, while on 
the other species tested it was weakly active or inactive. Compound 4, exhibited moderate 
phytotoxicity on grapevine leaves, whereas on the other species tested it was weakly active or 
inactive. 
Compounds 1 and 4 were also tested on grapevine detached leaves at 0.25 and 0.5 mg/mL. 
In this bioassay cyclobotryoxide caused symptoms at 0.5 mg/mL on the foliar lamina consisting 
in irregular internerval or marginal necrotic spots, slowly becoming coalescent, followed by 
distortion and withering of the leaf lamina. No visible symptoms were induced by tyrosol. 
 
5.2. Purification and chemical characterization of phytotoxins by Lasiodiplodia 
mediterranea strain BL101 . 
Lasiodiplodia mediterranea is a new specie recently characterized (Linaldeddu et al., 2014) 
associated with wedge-shaped lesions of the vascular tissues on grapevine in Sardinia (Linaldeddu 
et al., 2012). 
The nature of symptoms caused by this new species of Lasiodiplodia on grapevine (Figure 25) 
suggests that phytotoxic metabolites may be involved in the host-pathogen interaction. On the 
other hand, it is well-known that L. theobromae which is considered the type species of the 
Lasiodiplodia genus, biosynthesizes a variety of lipophilic and hydrophilic metabolites that exhibit 
interesting biological activities (Aldridge et al., 1971; Husain et al., 1993; Nakamori et al., 1994; 
Matsuura et al. , 1998; Yang et al., 2000; He et al., 2004; Miranda et al, 2008; Kitaoka et al., 2009; 
Pandi et al., 2010).  
Therefore the study of secondary metabolites was carried out on strain BL101. Its organic 
extracts were purified as detailed reported in the experimental section, yielding 10 metabolites 
(Figures 3 and 4.). The preliminary 1H NMR investigation showed that the metabolites belong to 
different classes of natural compounds. The structures of the known compounds (Figure 3) were 
confirmed by physical and spectroscopic methods (OR, IR, UV, 1H and 13C NMR, ESI and/or 
APCIMS) and by comparison of the obtained data with those reported in the literature for 
(1R,2R)-jasmonic acid and its methyl ester (10 and 11 Figures 26 and 27) (Husain et al., 1993; 
Yukimune et al., 2000), botryosphaerilactone A (12, Figure 28) (Rukachaisirikul et al., 2009), 
(3S,4R,5R)-4-hydroxymethyl-3,5-dimethyldihydro-2-furanone (13, Figure 29) (Ravi et al., 1979), 
and (3R,4S)-botryodiplodin (14, Figure 30) (Ramezani et al., 2007). Some other new 
spectroscopic data as ESI and/or APCI spectra and in particular the 13C NMR data for the 
trisubstituted dihydrofuranone 13 were detailed reported in the corresponding paragraphs of 
experimental section. In addition, the identification of 12 was also supported by data from its 
COSY, HSQC and HMBC spectra. Finally, as (3R,4S)-botryodiplodin (14) was obtained as an 
inseparable anomeric mixture (α/β, 65:35), its structure was confirmed by acetylation carried out 
in the usual conditions. In fact, this reaction yielded only the 2,3-trans-botryodiplodin acetate, 
whose physic and spectroscopic data were very similar to those previously reported (Arsenault 
and Althaus, 1969). 
Furthermore, the preliminary 1H and 13C investigation of 5 showed its close correlation 
with both jasmonic acid and 3,4,5-trisubstituted dihydrofuranone 13 and, being a new compound 
as described below, it was named lasiojasmonate A (Figures 31 and 32). These suggestions were 
also confirmed by the band typical of ketone ester and olefinic groups (Nakanishi and Solomons, 
1977) and the end absorption maximum (Scott, 1964) observed in the IR and UV spectra, 
respectively (Figures 33 and 34). It showed a molecular weight of 336 associated to the molecular 
formula of C19H28O5 with six hydrogen deficient as deduced from the HRESIMS spectrum. The 
1H NMR spectrum, also compared to that of jasmonic acid (Husain et al., 1993) and of standard 
commercially sample, showed the signal patterns of the jasmonyl residue. For the 2-pentenyl 
moiety the multiplets of the protons (H-10 and H-9) of the cis double bond, the two allylic 
methylene groups (H2-8 and H2-11) and the triplet (J = 7.4 Hz) of the terminal methyl group 
(Me-12) were observed at δ 5.45, 5.26, 2.37, 2.04 and 0.9, respectively. For the 2,3-disubstituted 
cyclopentanone residue the multiplets of H-1 and H-2, the double doublet (J =20.0 and 8.2 Hz) 
and the multiplet, and the multiplets of H2C-4 and H2C-5 were observed at δ 2.10, 1.90, 2.74 and 
2.37, and 2.33 and 1.50 respectively (Pretsch et al, 2000). 
As regard the signal system of the 4-hydroxy-3,5-dimethyl-3,4-dihydrofurane residue, which 
were also compared to those reported in literature (Ravi et al., 1979) (Figure 31) the protons of 
hydroxymethylene H2C-8’ showed, in particular, the typical AB system appearing as a mutiplet 
and double doublet (J = 11.0 and 5.7 Hz) at δ 4.26 and 4.21 significantly downfield shifted (Δδ 
0.43 and 0.46) at δ 4.26 and 4.21, as consequence of the esterification with the jasmonic acid. The 
other signals of the same moiety appeared as a double quartet (J = 11.0 and 7.1 Hz) for H-3’, two 
multiplets for H-4’ and H-5’ (the latter being overlapped with the signal of H-8’A)  and two 
doublets (J = 6.1 and 7.1 Hz)  for the two secondary methyl groups (Me-6’ and Me-7’) at δ 2.49, 
2.04, 4.26, and 1.47 and 1.28, respectively (Pretsch et al., 2000). All these attributions were 
confirmed by the coupling observed in the COSY and HSQC spectra (Figures 35 and 36) (Berger 
and Braun, 2004), with the last that also contributed to assign the chemical shifts of protonated 
carbons in the 13C NMR spectrum as reported in Table 7. The signals of the remaining quaternary 
carbons observed at δ 218.3 177.6 and 171.7 typical of a ketone and two ester carbonyl groups 
(Breitmaier and Voelter , 1987) were assigned to C-3, C-2’ and C-7  with the last two attributed 
on the basis of the couplings observed in the HMBC spectrum (Table 37) (Berger and Braun, 
2004) between C-2’ with H-3’, Me-7’ and H-8’B and C-7 with H2C-5, H2C-6 and H2C-8’. Very 
significant to support the jasmonate esterification of the 4-hydroxytmethyl-3,5-dimethyl-3,4-
dihydrofuranone was the coupling observed in the HMBC spectrum between C-7 with H2C-8’. 
On the basis of these results lasiojasmonate A was formulated as 4-hydroxymethyl-3,5-
dimethyldihydro-2-furanone jasmonate (5). 
The structure of 5 was confirmed by all the other couplings observed in the HMBC 
spectrum and by data from the HRESI and APCIMS spectra which showed, respectively, the 
sodium cluster [M+Na]+and the pseudomolecular ion [M+H]+ at m/z 359.1913 and 337. 
The relative stereochemistry of 5 as depicted in Figure 4 was deduced by the comparison of 
the couplings constant measured in its 1H NMR spectrum with those reported for (1R,2R)-
jasmonic acid (Husain et al., 1993) and (3S,4R,5R)-4-hydroxymethyl-3,5-dimethyldihydro-2-
furanone. This stereochemistry was also confirmed by the correlations observed in the NOESY 
spectrum (Berger and Braun, 2004). In fact, this spectrum showed the correlations between the 
protons of the cis double bond H-10 and H-9 and that this latter with the protons of allylic 
methylene H2-8, and that of H-3’ with H-5’. Thus, lasiojasmonate A can be formulated as 
(1R*,2R*,3’S*,4’R*,5’R*)-4-hydroxymethyl-3,5-dimethyldihydro-2-furanone jasmonate. 
Compounds 6 and 7 being two epimeric acetals showed both a molecular weight of 314, as 
deduced from their ESIMS. They were obtained as an inseparable mixture (α/β, 45:55). All the 
attempts done, using different chromatographic methods on direct and reverse phase and 
different solvent mixtures, failed. Their 1H NMR spectra (Figure 38) showed the presence of two 
doublets (J=2.3 and 4.6 Hz) typical of anomeric protons (H-10) for the β and α isomers at δ 4.67 
and 4.79, respectively. The comparison of this spectrum with that of botryosphaerilactone 12 
(Rukachaisirikul et al., 2009) indicate that 6 and 7 were the acetyl derivatives of 
botryosphaeriolactones A and C, or of their respective enantiomers. In fact, their 1H NMR 
spectra (Table 8) differed from that of 12 and botryosphaerilactone C (Rukachaisirikul et al, 2009) 
essentially for the downfield shift of H2C-16 (Δδ 0.46 and 0.35; and 0.41 and 0.40, for β and α 
isomers respectively) resonating as two double doublets for β anomer (6) at δ 4.15 and 4.04 
(J=11.0, 5.6 and 11.0, 7.9 Hz), while for the α anomer (7) at δ 4.21 and 4.06 (J=11.3, 4.5 and 11.3, 
7.6 Hz). Furthermore, two singlets of the acetyl groups resonated at δ 2.06 and 2.07 for 6 and 7 
respectively. The chemical shifts of all protons of two anomers were assigned (Table 8) by 
comparison of their 1H NMR spectra with that of 12. The epimeric nature of 6 and 7 was also 
confirmed by usual acetylation of botryosphaerilactone A with pyridine and acetic anhydride. As 
expected this reaction yielded both the β and α anomers being the latter (7) the main product of 
the reaction. 
The structures assigned to 6 and 7 were also confirmed by data of both ESI and APCI 
spectra. The ESIMS spectrum showed dimeric sodiated form [2M+Na]+and the sodium cluster 
[M+Na]+at m/z 651 and 314. The APCIMS spectrum showed ions originated from the 
pseudomolecular ion [M+H]+ recorded at m/z 337 by fragmentation mechanisms typical of 
asymmetrical ethers (Pretsch et al 2000) as reported in Figure 39. In fact, the pseudomolecular 
ion by cleavage of the acetalic bond C(10)-O (mechanism a) originated the γ-lactonyl and the 
trisubstituted tetrahydrofurane ions recorded at m/z 145 and 172, respectively. This latter, by loss 
of AcOH generated a fragment ion at m/z 113 (Figure 39). Furthermore, the pseudomolecular 
ion by the alternative cleavage of the acetalic bond C(8)-O (fragmentation mechanism b) 
generated the γ-lactonyl fragment ion observed at m/z 127 (Figure 39). 
Compounds 8 and 9 showed a molecular weight of 464, as deduced from their HRESIMS 
spectrum recorded in positive mode associated to the molecular formula of C26H40O7. They were 
obtained as an inseparable epimeric mixture (α/β, 30:70). As above reported for 6 and 7, all the 
attempts made using different chromatographic methods failed. By preliminary 1H NMR 
investigation, they appeared closely relate to both botryosphaeriolactones A and C and jasmonic 
acid, suggesting for 8 and 9 a structure of jasmonate esters and therefore were named 
lasiojasmonate B and C. Their 1H NMR spectra (Figure 40) showed the presence of two doublets 
(J=2.0 and 4.5 Hz) typical of anomeric protons (H-10’) at δ 4.68 and 4.80 for the β and α 
isomers, respectively. Significant differences from the 1H NMR spectra of botryosphaerilactones 
A and C were observed for the protons of the ABX systems HC-(13’)-H2C-(16’). As expected the 
H2-16’ protons were downfield shifted (Δδ 0.48, 0.41, and 0.43, 0.41 for 8 and 9) with respect to 
the values reported for the same protons in botryosphaerilactones A and C (Rukachaisiriku et al., 
2009). These protons appears as doublet of doublets (J=11.0, 7.2, and 6.9) and (J=11.0, 5.8 and 
11.3, 4.5) at δ 4.10 and 4.17, and δ 4.07 and 4.23 for 8 and 9. Thus, all the chemical shifts of all 
protons were assigned to 8 and 9 in comparison to those reported for 6 and 7 and jasmonic acid 
as reported in Table 9. Therefore, 8 and 9 can be formulated as 
(1R*,2R*,3’S*,4’R*,5’R*,10’R*,12’R*,13’R*,14’S*)- and 
(1R*,2R*,3’S*,4’R*,5’R*,10’S*,12’R*,13’R*,14’S*)-4-(4-hydroxymethyl-3,5-dimethyltetrahydro-
furan-2-yloxymethyl)-3,5-dimethyldihydro-2 furanone jasmonates. 
These structures were confirmed through fragmentation ions observed in APCIMS 
spectrum recorded in positive mode. Also in this case the spectrum exhibited ions originated by 
pseudomolecular ion by two different fragmentation mechanisms generated by the cleavage of 
the acetalic bond as reported in Figure 39. The cleavage of the bond C(8’)-O (mechanism c) 
generated the fragment ion m/z 127 and the 4-hydroxy-3,5-dimethyl-4-hydroxy jasmonate esters. 
This latter, generated  jasmonic acid and fragment ion m/z 113 and H2O (mechanism e). 
Alternatively, the pseudomolecular ion by cleavage of the acetalic bond C(10’)-O (mechanism d) 
generated two fragment ions recorded at m/z 145 and 322. 
The presence in lasiojasmonates A-C of (1R,2R)-jasmonic acid was confirmed by their 
mild alkaline hydrolysis carried out according Farmer et al. (1992). In fact jasmonic acid obtained 
from 5, 8 and 9, as detailed report in the Experimental section, and 10 showed the same Rf. by 
TLC analysis (silica gel eluent CHCl3/i-PrOH (95:5) Rf 0.43, and on reversed phase eluent 
EtOH/H2O (6:4) Rf 0.50) also by co-injection and OR and 
1H NMR recorded in the same 
conditions.  
In addition the keto-enolization process of C-2 of jasmonic acid, as report in literature by 
Miersch et al., (1987), was ruled out for the compounds 5,8-11 isolated from Lasiodiplodia sp. as 
resulted by their optical (OR) and/or spectroscopic (essential 1H NMR) properties. So that 
compounds 5, 8-11 are not artefact.  
Pathogenicity of the new species of Lasiodiplodia was verified by wound inoculation of 
excised canes under controlled laboratory conditions. Fifty days after inoculation, the lignified 
canes inoculated with the pathogen displayed dark-brown to black discoloration on bark and 
vascular tissues, measuring 7.4±2.7 cm (mean ± S.D.). In cross section all canes showed a wedge-
shaped necrotic sector. The pathogen was successfully re-isolated from the margin of 
symptomatic tissues, thus fulfilling Koch’s postulates. Artificially obtained symptoms were 
congruent with field observations. Control canes inoculated with sterile PDA plugs remained 
symptomless. 
The phytoxicity data obtained in the leaf-puncture assay on cork oak and grapevine leaves 
showed that (1R,2R)-jasmonic acid (10) was the only active metabolite. It had remarkable toxicity 
at 1.0 mg/mL causing necrotic lesions to leaves of both species tested (necrosis area: 7.04 and 
11.96 mm2 on grapevine and cork oak, respectively). All the other metabolites tested did not 
show any effect in this bioassay. 
All compounds, except 8 and 9, were also tested on grapevine detached leaves at 0.25 and 
0.5 mg/mL. In this bioassay only jasmonic acid caused veins necrosis, slowly diffusing to large 
areas of the leaf lamina at 0.5 mg/mL. When assayed on tomato cuttings at 0.1 mg/mL jasmonic 
acid caused withering within 7 days from treatment. None of the compounds showed activity in 
the assay performed for zootoxicity (Artemia salina) at 50 µg/mL. 
Jasmonic acid is the basic structure of a naturally occurring family of compounds named 
jasmonates which regulate many aspects of growth, development and defence, activating 
responses to wounding, herbivores and necrotrophic pathogens. Compound 10 and relate 
compounds were also produced by fungi (Miersch et al., 1999b and literature cited). In particular, 
Lasiodiplodia spp. are among the few fungal species which synthesize enantiomeric pure form of 
the different enantiomers as (1R,2S) diasteromer, called also (+)-7-iso-jasmonic acid, isolated 
from L. theobromae (Miersch et al., 1987). Jasmonic acid is biosynthesised by the octadecanoid 
pathway in plants (Schaller and Stinzi, 2009) and fungi (Tsukada et al., 2010). Recently jasmonate 
biosynthesis by a linolenate 9R-dioxygenase and an allene oxide synthase has been described in L. 
theobromae (Jernerèn et al., 2012). 
Botryosphaerilactone A and (3S,4R,5R)-4-hydroxymethyl-3,5-dimethyl-dihydro-2-
furanone (12 and 13) were recently reported as secondary metabolites of the endophytic fungus 
L. theobromae (synonym. Botryosphaeria rhodina) PSU-M35 and PSU-M114 isolated from leaves of 
Garcinia mangostana L. (Rukachaisirikul et al., 2009). When they were assayed against Staphylococcus 
aureus they did not show antibacterial activity (Rukachaisirikul et al., 2009). 
(3R,4S)-Botryodiplodin was first isolated from cultures of L. theobromae Pat. the causal 
agent of fruit rot in tropical fruits trees (Gupta et al., 1966). Subsequently, it was found in other 
cultures of phytopathogenic fungal species such as Penicillium roqueforti Thom strains (Nielsen et 
al., 2006), Penicillium stipitatum Thom (Fuska et al., 1988) and Macrophomina phaseolina (Cooke) 
Wint. (Ramezani et al., 2007). 
(3R,4S)-Botryodiplodin exhibits anticancer, antibacterial, antifungal, phytotoxic, 
mitogenic, and antifertility activities, and may play a role in plant diseases. Unusual structural 
properties allow oligomerization of (-)-botryodiplodin to pigments and cross-linking agents, 
which may be responsible for some of its biological activities (Shier et al., 2007).  
  
5.3. Chemical and biological characterization of phytotoxins by Lasiodiplodia 
mediterranea strain B6. 
A strain of L. mediterranea associated with dieback of grapevine in Sicily (Figure 41)(Burruano et 
al., 2008; Mondello et al.,2013) was grown. For the same reasons previously reported (par.5.2), a 
study of secondary metabolites was performed. The organic extracts were purified as detailed 
reported in the experimental section (par.4.3), yielding six metabolites (10, 14-18, Figures 5 and 
6). The structures of the known compounds (Figure 5) were confirmed by physical and 
spectroscopic methods (OR, IR, UV, 1H and 13C NMR, ESI MS) and by comparison of the 
obtained data with those reported in the literature for, botryosphaeriodiplodin 17 (Figure 42, 
Rukachaisirikul et al., 2009), (5R)-5-hydroxylasiodiplodin 18 (Figure 43, Matsuura et al.,1998), 
(1R,2R)-jasmonic acid 10 (Figure 26, Husain et al., 1193; Yukimune et al., 2000), (3S,4R,5R)-4-
hydroxymethyl-3,5-dimethyldihydro-2-furanone 13 (Figure 29, Andolfi et al., 2014). Furthermore, 
the preliminary 1H- and 13C-NMR investigation of 15 and 16 (Figures 44 and 45) showed its close 
correlation with botryosphaeriolactones A and C (Rukachaisirikul et al., 2009), and, being new 
compounds as described below, were named lasiolactols A and B. 
Compounds 15 and 16 were obtained as homogenous oil and as an inseparable mixture of 
two epimeric lactons in a ratio of β/α 75:25. Their molecular formulas were C14H26O5 with two 
degrees of unsaturation, as deduced from HRESIMS [m/z 313.1456 [M+K]+, and 297.1649 
[M+Na]+] (Table 11). The IR spectrum (Figure 46)exhibited absorption band of OH groups 
(3300 cm-1) (Nakanishi and Solomon, 1977). The UV spectrum (Figure 47) showed the absence 
of chromophores (Scott, 1964). The 1H-NMR spectrum (Figure 44) showed the presence of a 
broad singlet and of a doublet (J=4.1 Hz) typical of acetalic protons (H-2) for the 15 and 16 
compounds at  5.06 and 5.24 of lactols ring, resp. (Rukachaisirikul et al., 2009). Same spectrum 
displayed a double quartets at  4.20 (J=7.0, 6.1, H-5), a doublet of doublet quartet at  2.10 
(J=8.5, 7.2, 6.0 H-3), and a multiplet at  1.56 (H-4) attributed to 15 (Table 10). Moreover two 
secondary Me groups were inferred from two 3-H doublets at  1.14 (J=7.2, H3-7), and 1.33 
(J=6.1, H3-6) (Table 10). The 
13C-NMR spectrum (Figure 45)exhibited for 15 seven C-atom 
resonances of four CH (one of acetalic proton) at  103.8 (C-2), 43.9 (C-3), 54.9 (C-4), 76.5 (C-5), 
one CH2 at  62.7 (C-8) O-bearing, and two Me at  21.4 (C-6), and 19.2 (C-7) groups (Table10.). 
Comparative analysis of 1H- and 13C-NMR data with those of botryosphaeriolactones A and C 
suggested for 15 the presence of -lactol moiety (Andolfi et al., 2014). These data allowed to 
assign for 15 a partial structure of 4-hydroxymethyl-3,5-dimethyl-tetrahydrofuran-2-ol. The 2D 
NMR spectra data supported this hypothesis. In fact the COSY spectrum (Figure 48)exhibited 
correlations of the signal at  5.06 (H-2) with that at  2.10 (H-3), with this last with those at  
1.56 (H-4), and 1.14 (Me-7); of the signal at  1.56 (H-4) with those at  3.75-3.71 (CH2-8), and 
4.20 (H-5), and finally with this last with that at  1.33 (Me-6). The key HMBCs  103.8 (C-2) 
with those at  2.10 (H-3) and 1.14 (H-7),  43.9 (C-3) with those at  1.56 (H-4) and 4.20 (H-5), 
 54.9 (H-4) with those at  3.75 and 3.71(CH2-8), and  76.5 (C-5) with those at  2.10 (H-3), 
1.56 (H-4) and 1.33 (H-6) further supported this assignment. 
The 1H-NMR and 13C-NMR spectra in addition to the signals of acetalic methine, previous 
reported, showed the presence of signals attributed to 16 as report in Table 10. Therefore its 
structure was assigned on the basis of 2D NMR spectra and in comparison with that of 15.  
The structure of dimer -lactol was formulated for 15 and 16, considering HRESIMS data, 
below reported (Table 11), that gave a molecular formula containing twice the number of carbon 
and hydrogen atoms. Moreover the same spectrum exhibited ions originating by 
pseudomolecular ion through mechanism generated by fragmentation mechanisms typical of 
asymmetrical ethers (Pretsch et al., 2000). In particular the cleavage of the acetalic bond C(2)-O, 
by as previous report for 16-O-acetylbotryosphaerilactones A and C (Andolfi et al., 2014), 
originated 4-hydroxymethyl-3,5-dimethyl-tetrahydro-furan-2-ol (m/z 169.0818 [M-
C7H13O2+H+Na]
+) corresponding at molecular formula C7H14NaO3 and (2,4-dimethyl-
tetrahydro-furan-3-yl)-methanol (m/z 129.0897 [M-C7H13O3]
+) corresponding at molecular 
C7H13O2 (Table 11). 
The relative stereochemistry of 15 as depicted in Figure 6 was deduced by the comparison 
of the couplings constant measured in its 1H-NMR spectrum with those reported for same 
moiety in the botryosphaeriolactone A (Rukachaisirikul et al., 2009). This stereochemistry was 
also confirmed by the correlations observed in the NOESY spectrum (Figure 49, Berger and 
Braun, 2004). In fact, this spectrum showed the correlations between acetalic protons H-2 and 
H-3. So that a (2S,3S,4R,5R,2’S,3’S,4’R,5’R)-15 relative configuration was established. 
The relative stereochemistry of 16 was also confirmed by the correlations observed in the 
NOESY spectrum (Berger and Braun, 2004). In this case, NOESY spectrum didn’t show the 
correlations between acetalic protons H-2 and H-3. Therefore a (2R,3S,4R,5R,2’R,3’S,4’R,5’R)-2 
relative configuration was established. 
Compound 17, as previous report, was identified as botryosphaeriodipodin by comparison 
of their spectroscopic and optical proprieties with those report by (Rukachaisirikul et al., 2009). 
This compound was recently isolated from mycelia extract of endophytic fungus Botryosphaeria 
rhodina (PSU-M35) together other known lasiodiplodins (Rukachaisirikul et al., 2009). In this case 
the authors did not assign relative configuration at secondary hydroxylated C-7 of macrocyclic 
ring using NOEDIFF data because it was inadequate. Moreover, analysis of the absolute 
configuration of the same carbon was not performed as botryosphaeriodiplodin was obtained in 
low amount (Rukachaisirikul et al., 2009). 
The absolute configuration at C-7 of 17 was established for its 13-O-methyl derivative (19) 
by an advanced Mosher method (Ohtani et al., 1991). Analysis of differences in proton chemical 
shifts between the (S)- and (R)-MTPA ester of 19. This derivative was obtained by usually 
methylation of phenolic proton with ethereal solution of CH2N2.(Figure 7) Its 
1H-NMR spectrum 
(Figure 50) essentially differed from that of 17 only for the presence of other one methoxy group 
resonating as singlet at  3.78. ESIMS spectrum of 17, recorded in positive mode, showed the 
sodium cluster and pseudomolecural ion [M +Na]+ and [M+H]+ at m/z 345 and 323, respectively. 
19 was converted to (S)- and (R)-MPTA esters (20 and 21) esters by reaction with R-(-)-α-
methoxy-α-trifluoromethylphenylacetyl (MPTA) and S-(+)-MPTA chlorides, respectively. The 
chemical shift differences between 20 and 21 (ΔH=S-R, Figures 51-53) indicated an R 
configuration at C-7. The relative configuration at C-3 was assumed to be identical to that 
lasiodiplodin (Sultan et al., 2014). Thus, the structure of 17 was assigned to be (3R,7R)-7-
hydroxylasiodiplodin. 
The toxicity of compounds 15-17, 10 and 13 used in the leaf-puncture assay on grapevine 
leaves showed different values depending on the kind of compound, its concentration and their 
interaction. In particular, the phytotoxicity of all compounds has grown according to the 
concentration increase; moreover, the compound 10 resulted more toxic than the others. Its 
produced necrotic area of 5.3 mm2. Differences between toxicity values were resulted statistically 
significant (Figure 54). The compounds 15-17, 10 and 13 did not show in vitro antifungal and 
antioomycete activity against four assayed phytopathogens. Only Ridomil Gold SL completely 
inhibited the mycelial growth of Phytophthora citrophthora. 
 
5.4. Purification and chemical characterization of phytotoxins by Neofusicoccum australe 
strain BL24. 
Another strain of N. australe isolated from symptomatic juniper in Sardinia, strain BL24, (Figure 
55) was grown and its secondary metabolites were purified as detailed in the experimental section 
(par.4.4), yielding two well know metabolites (22 and 23) and tyrosol identified as described in 
paragraph 5.1. (Figure 8). 
The molecular weights of 22 and 23 were determined to be 252 and 224, respectively, as 
deduced from their ESI and APCIMS spectra recorded, respectively, in the positive and negative 
modes. 
The chemical shifts and multiplicities of all protons and corresponding carbons of 22 and 
23 were assigned by the couplings observed in their  NMR, COSY, HMBC, and HSQC spectra 
(Figures 56 and 57). Comparison of these and reported data identified 22 and 23 as 
botryosphaerone D (Xu et al., 2011) and (3S,4S)-3,4,8-trihydroxy-6-methoxy-3,4-dihydro-1(2H)-
naphthalenone (Pittayakhajonwut et al., 2008). 
The absolute configuration of botryosphaerone D (22), not previously reported, was also 
determined. Its ECD spectrum (Figure 58) was recorded under the same conditions and 
compared to that of 23 (Pittayakhajonwut et al., 2008). On the basis of coincident negative and 
positive Cotton effect at 214, and 230, and 280 nm, compound 22 was formulated as (3S,4S)-7-
ethyl-3,4,8-trihydroxy-6-methoxy-3,4-dihydro-1(2H)-naphthalenone. Botryosphaerone D (22), 
together with three other new naphthalenone polyketides, had previously been isolated from N. 
australe strain ZJ12-1A, a fungus obtained from sterilized root epidermis of Sonneratia apetala in 
China. This compound did not show any antimicrobial and cytotoxic activities (Xu et al., 2011). 
Finally, (3S,4S)-3,4,8-trihydroxy-6-methoxy-3,4-dihydro-1(2H)-naphthalenone (23) was reported 
as new naphthalenone produced from wood-decaying fungus Phaeosphaeria sp. (Pittayakhajonwut 
et al., 2008). 
The isolation of naphthalenone polyketides as 22 and 23 was not a surprise. In fact, they 
belong to a group of well known phytotoxins produced by pathogenic fungi for different agrarian 
crops such as scytalone, isosclerone, botrytone, and cis- and trans-3,4dihydro-2,4,8-
trihydroxynaphthalenones etc (Andolfi et al., 2011; Cimmino et al., 2011). 
When assayed by leaf-puncture bioassay on holm oak, cork oak, and grapevine cv. 
Cannonau leaves at different concentrations compounds 22, isolated as the main metabolite, 
appeared to be slightly toxic, even at the highest concentration. In addition, compound 23 did 
not show any phytotoxicity either (Table 18). 
 
5.5 Purification and chemical characterization of phytotoxins from Diplodia quercivora 
strain BL9. 
The strain of Diplodia quercivora (BL9) was recently described oak pathogen originally found 
on declining Quercus canariensis trees in Tunisia (Linaldeddu et al., 2013) (Figure 59). Given the 
great ecological impact of D. quercivora on oak trees worldwide, we decided to explore the 
secondary metabolite pattern of this pathogen for which there is no information on its ability to 
secrete in vitro metabolites which could play a crucial role in its interaction with host plants. 
The organic extract having a high phytotoxic activity, was bioguided purified as reported in 
detail in the experimental (par.4.5) yielding a new nor-ent-pimarane, named diplopimarane (24, 
Figure 9), along with the well known sphaeropsidins A and C, and (+)-epiepoformin (32-34, 
Figure 10). 
The identification of the well known phytotoxic metabolites sphaeropsidins A and C and 
(+)-epiepoformin was carried out by comparing their spectroscopic (essentially 1H and 13C NMR) 
and optical properties (OR) with those previously reported in literature for 32 (Evidente et 
al.,1996), 33 (Evidente et al., 1997) and 34 (Nagasawa et al., 1978), respectively. The data of ESI 
and APCI spectra, are detailed reported in the experimental and are in full agreement to those of 
EI MS reported in literature (Evidente et al., 1996; 1997; Nagasawa et al., 1978). 
Sphaeropsidins A and C were isolated from Diplodia cupressi, a canker causing agent of 
Mediterranean cypress, together with other minor ones B (Evidente et al., 1997), D, E (Evidente 
et al., 2002), and F (Evidente et al., 2003). Sphaeropsidin A was also isolated from Smardaea sp., a 
fungal endophyte of the Moss Ceratodonn purpureus (Hedw.) Brid., along with five isopimarane 
diterpenes, smardaesidins A-E, two new 20-nor-isopimarane diterpenes, and sphaeropsidins C-F 
(Wang et al., 2011). Studies on structure-activity relationships were also carried out by testing the 
natural sphaeropsidins and some their key hemisynthetic derivatives for their phytotoxic and 
antimicrobial activities (Sparapano et al., 2004 Evidente et al., 2011). More recently the anticancer 
activity of sphaeropsidin A was reported (Lallemand et al., 2012; Wang et al., 2011). 
Epiepoformin was isolated together with (+)-epiepoxydon from the culture filtrate of an 
unidentified fungus isolated from a diseased leaf of crape-myrtle (Lagerstroemia indica L. Pers.) 
showing marked inhibition activity against the germination of lettuce seeds (Nagasawa et al., 
1978). Moreover, it has been the subject of several synthetic attempts (Barreros et al., 2005; 
Carreno et al., 2005; Okamura et al., 2003; Tachihara and Kitahara, 2003), and its absolute 
configuration was also determined by time dependent density functional theory calculation of the 
optical rotation (Mennucci et al., 2007). 
Diplopimarane (24) showed a molecular formula of C19H26O3, as deduced from its 
HRESIMS, which was consistent with seven hydrogen deficiencies . The preliminary 
investigation of its 1H and 13C NMR spectra (Figures 60 and 61), in agreement with its MS data, 
and by comparison with those of sphaeropsidin A (9), (Evidente et al., 1996) showed that it could 
be a nor-ent-pimarane. In fact, a successive detailed investigation of its 1H NMR spectrum (Figure 
60) showed, as in sphaeropsidin A, the significant presence of the double doublet (J = 17.6 and 
11.0 Hz) and the two broad doublets (J = 11.0 and 17.6 Hz), and the singlet of the vinyl and the 
tertiary methyl groups at C-13 at δ 6.04 and 5.34 and 5.31, and 1.25, respectively (Pretsch et al., 
2000). In the same spectrum, two singlets resonating at δ 1.45 and 1.42 and due to the geminal 
methyls groups (Me-19 and Me-18) at C-4, were also present. The latter two methyls represent 
the head of the diterpenoid biosynthetic precursor. These results were confirmed by the 
couplings observed in the COSY spectrum, (Figure 62, Berger et al., 2004) as well as those 
observed in the HMBC spectrum (Figure 63, Berger et al., 2004) between C-13 with the protons 
(H-15 and H2-16) of the vinyl group and H-14, C-12 and C-14 with Me-17, and C-4 with both 
Me-18 and Me-19. The couplings observed in the HSQC spectrum (Figure 64, Berger et al., 2004) 
allowed us to assign the chemical shifts to the corresponding carbons (Figure 61) at δ 139.1, 
118.7, 28.6, 27.6 and 23.2 for C-15, C-16, C-19, C-18 and C-17, respectively (Breitmaier et al., 
1987). The most significant differences between 24 and sphaeropsidin A were the absence in the 
1H NMR spectrum of the singlet of H-5, the proton of one of headbridge carbons between rings 
A and B, as well as the absence of the tertiary hydroxylated carbon (C-9), the ketone carbonyl (C-
7) and the carboxyl group (C-20) in the 13C NMR spectrum. The latter in 32 also lactonized the 
hemiketal hydroxy group at C-6 generating ring D, which is obviously absent in 24. Thus, 
diplopimarane appeared to be a nor-pimarane. Furthermore, the 1H and 13C NMR spectra showed 
the significant presence of a secondary hydroxylated carbon (C-14) at δ 4.70 (d, J = 9.9 Hz) and 
76.0. This latter in the HMBC spectrum significantly coupled with H2-12, H-15 and Me-17. The 
other couplings observed in the COSY, HSQC and HMBC spectra also allowed us to assign 
chemical shifts to the protons and the carbons of the five methylene groups belonging to, 
respectively, three to A and two to C rings (Table 13). Considering the remaining three 
unsaturations and the presence of six quaternary aromatic carbons, two of which bear hydroxy 
groups, ring B appeared to be aromatized. The couplings observed in the HMBC spectrum 
confirmed the location of the two phenolic hydroxy groups at C-6 and C-7 and allowed us to 
assign the chemical shifts at δ 142.2, 141.5, 131.2, 127.0, 124.5 and 119.5 to C-6, C-7, C-8, C-10, 
C-9 and C-5, and to all the protons and carbons of diplopimarane, as reported in Table 13. On 
the basis of these results diplopimarane could be formulated as 2,8,8-trimethyl-2-vinyl-
1,2,3,4,5,6,7,8-octahydrophenanthrene (24). 
The structure assigned to 24 was supported by the data observed in its HRESIMS 
spectrum which showed the sodium cluster [M+Na]+ at m/z 325.1785, while the APCIMS 
spectrum showed the significant fragmentation ion [M-H2O]
+ at m/z 285 generated by the 
molecular ion by loss of water. When both the ESI and APCIMS spectra were recorded in 
negative mode the pseudomolecular ion [M-H]- was observed at m/z 301. 
The structure assigned to 24 was also supported by the preparation of some key derivatives 
(25-29, Figure 9). In particular, derivative 26 was also essentially prepared to convert it into the 
diastereomeric R and S MPTA (α-methoxy-α-trifluoromethylphenylacetyl) esters to assign the 
absolute configuration to 24 as below detailed reported. By treatment with ethereal solution of 
diazomethane, diplopimarane was converted into the 7-O-methyl and 6,7-O,O’-dimethyl ether 
derivatives (25 and 26, Figure 9), 26 being the main reaction product. Their 1H NMR spectra 
(Figures 65 and 66) essentially differed from that of 24 only for the presence of one and two 
methoxy groups resonating at δ 3.88 and 3.88 and 3.86. ESIMS spectrum of 25, recorded in 
positive mode, showed the sodiated dimeric form [2M+Na]+, the potassium and sodium clusters 
[M+K]+, [M+Na]+ and [M+H]+ at m/z 655, 355, 339. The APCIMS spectrum recorded in 
negative mode showed the pseudomolecular ion [M-H]- at m/z 315 and fragmentation ion [M-
Me]- at m/z 301 generated from the molecular ion by loss of methyl group. The ESI and 
APCIMS spectra of 26, recorded in positive mode showed the potassium and sodium clusters 
[M+K]+, [M+Na]+, and the pseudomolecular ion [M+H]+ at m/z 369, 353, and 331, respectively. 
Furthermore, 24 was also converted into the 6,7,14-O,O´,O”-triacetyl, and 7-O-p-Br-benzoyl (27 
and 28, Figure 9) esters by the reaction with anhydride acetic and pyridine and DMAP and p-Br-
benzoyl chloride, respectively. The IR of 27 significantly differed from that of 24 for the absence 
of hydroxy group and the presence of bands due to the ester groups (Nakanishi et al., 1977), Its 
1H NMR spectrum (Figure 67) differed from that of 24 for the significant downfield shift of H-
14 (Δδ 1.10), appearing as expected as a broad singlet at δ 5.80 and for the presence of the typical 
three singlets of the acetyl groups at δ 2.29, 2.24 and 1.92. Its ESI and APCIMS spectra, recorded 
in positive mode, showed the potassium and the sodium clusters [M+K]+, [M+Na]+ and the 
pseudomolecular ion [M+H]+ at m/z 467, 451, and 429, respectively. The IR spectrum of 28 
showed the presence of a signal due to the ester group while its 1H NMR spectrum (Table 68) 
differed from that of 24 for the typical signal pattern of the p-Br-benzoyl residue which resonated 
as two couples of doublets (J = 8.4 Hz) at δ 8.81 (2´, 6´) and 7.65 (3´, 5´). Its ESIMS spectrum, 
recorded in positive mode showed the typical isotopic bromine peaks for the potassium and 
sodium clusters [M+2+K]+, [M+K]+, [M+2+Na]+, [M+Na]+ at m/z 525, 523, 509 and 507. The 
APCIMS spectrum, recorded in the same mode, gave fragmentation peaks generated from the 
pseudomolecular ion and its isotopic peak by loss of H2O [M+H-H2O]
+, and [M+2+H-H2O]
+ at 
m/z 467 and 469 and also the peak generated from the molecular ion by the loss of the p-Br-
benzoate [M-p-BrC6H4CO2]
+ at m/z 285. The ESIMS spectrum, recorded in negative mode, 
showed the pseudomolecular ion and its isotopic ions [M-H]- and [M+2-H]- at m/z 483 and 485 
and the ion generated from the molecular ion by loss of the p-Br-benzoyl group [M-p-
BrC6H4CO]
- at m/z 301. The APCIMS spectrum, recorded in the same mode, gave the 
pseudomolecular ion and its isotopic ion [M-H]- and [M+2-H]- at m/z 483 and 485 and the peaks 
generated from the molecular ion by loss of p-Br-benzoate [M-p-BrC6H4CO2]
-, p-Br-benzoyl [M-
p-BrC6H4CO]
- and the p-Br-phenyl [M-p-BrC6H4]
- at m/z 285, 301 and 314, respectively. Finally 
24 was converted into 15,16-dihydro derivative (29) by catalytic hydrogenation. The 1H NMR 
spectrum (Figure 69) of 29 differed from that of 24 essentially for the absence of the signals of 
the vinyl group at C-13 while the signals of the corresponding ethyl group  were observed as a 
triplet (CH3-16) and a quartet (CH2-15) (J= 7.4 Hz,) at δ 0.71 and 1.04, respectively (Pretsch et al., 
2000). Its ESIMS spectrum, recorded in positive mode, showed ions generated from the sodiated 
dimeric form, the sodium cluster and the pseudomolecular ion by loss of water [2M-2H2O+Na]
+, 
[M-H2O+Na]
+ [M-H2O+H]
+ at m/z 595, 309, and 287, respectively. 
The relative configuration of diplopimarane was determined by X-ray diffractometric 
analysis of its suitable crystal obtained by a slow evaporation of EtOAc-n-hexane (1:3) solution. 
This stereochemistry, reported in the ORTEP view of 24 (Figure 70) allowed us to axially and 
equatorially locate the vinyl group at C-13 and the hydroxy group at C-14, respectively, in the C-
ring which assumes a half-chair conformation.  
Compound 24 crystallizes in the monoclinic P 21 space group with one molecule in the 
asymmetric unit. All bond lengths are in the normal range. The molecule consists of three 
condensed rings. The central ring B is planar and exhibit C-C distances typical of a fully 
substituted benzene ring. Accordingly with the minimum energy conformation for cyclohexene 
rings, both the two condensed rings (A and C) adopt the half-chair conformation. In the ring C 
the vinyl group at C-13 is located in the axial position, while the hydroxy group at C-14 is in the 
equatorial position. In the crystal packing the hydroxy groups are involved in intra and 
intermolecular OH∙∙∙∙O hydrogen bonds affording chains of molecules along b axis direction. 
The relative configuration of 24 was confirmed by the correlations observed in the 
NOESY spectrum (Berger et al., 2004) (Figure 71) between Me-17 and H-14, H-14 and H-12b, 
and H-15 with H-12a. 
The absolute configuration of 24 was determined by applying a modified Mosher’s method 
(Othani et al., 1989). Diplopimarane 6,7-O,O’-dimethyl ether (26) was converted into the 
corresponding S-MTPA and R-MTPA monoesters at C-14 (30 and 31, Figure 11) by reaction 
with R-(-)-α-methoxy-α-trifluoromethylphenylacetyl (MTPA) and S-(+)- MTPA chloride, whose 
spectroscopic data (Figures 72 and 73) were consistent with the structure assigned to 24. 
Subtracting the chemical shifts of the protons (Table 15) of 14-O-R-MTPA (31) from those of 
14-O-S-MTPA (30) esters, the Δδ (30-31) values for all the protons were determined as reported 
in Figure 74. The positive Δδ values are located on the right-hand side, and the negative values 
on the left-hand side of model A as reported in Othani et al. (1989). This model allowed the 
assignment of the S configuration to C-14 and consequently a R configuration to C-13. Thus, 24 
was formulated as (1S,2R)-2,8,8-trimethyl-2-vinyl-1,2,3,4,5,6,7,8-octahydro-phenanthrene-1,9,10-
triol.  
That diplopimarane belongs to the ent-pimarane subgroup of diterpens was also confirmed 
by conversion of sphaeropsidin A (32) into 24 by gaseous HCl treatment in MeOH at 0 °C. 
Different reaction products were obtained and, among them, 24 and its C-14 epimer were also 
obtained as an inseparable mixture. However, investigation of the 1H NMR spectrum of this 
mixture showed clearly the significant signals of diplopimarane at the chemical shifts reported in 
Table 13 together with those of its corresponding 14-epimer. In fact, this spectrum also showed 
six other singlets at δ 8.65, 5.83, 4.89, 1.44, 1.43 and 1.06 due to HO-6, HO-7, H-14 and Me-19, 
Me-18 and Me-17, and a doublet of doublets (J=15.0, 10.7 Hz) at 5.83 due to H-15 of 14-epi-
diplopimarane. Previously a similar conversion of the antibiotic LL-S491β then later turned out 
to be sphaeropsidin A, (Evidente et al., 1996) was reported but no detailed reaction conditions, 
products and stereochemistry at C-14 were indicated (Ellestad et al., 1972). 
Considering the structure of 24 and its formation by acid conditions from sphaeropsidin 
A, which is the main phytotoxic metabolite produced by D. quercivora, a probable mechanism of 
this conversion was reported in Figure 75. The first step could be the hydrolysis of the lactone D 
ring which generated the carboxylic group at C-10 and the ketone group at C-6. The protonation 
of the tertiary hydroxy group at C-9 and the successive elimination of water and CO2 generated 
the double bond between C-9 and C-10. Successively, the protonation of the ketone at C-7 and 
the non- stereoselective addition of water at C-14 of the double bond C-8 and C-14, followed by 
deprotonation generated the corresponding diol. Finally, keto-enol equilibrium between C-5 and 
C-6  generated 24 and its C-14 epimer. 
Two bioassays were used to investigate the phytotoxic activity of diplopimarane (24), its 
derivatives (25-29), sphaeropsidin A (32), sphaeropsidin C (33) and (+)-epiepoformin (34) as 
described in the experimental section. In the leaf-puncture bioassay, the phytotoxicity was 
evaluated on holm oak, cork oak, and tomato leaves. As shown in Table 19, none of these 
compounds, except 32 and 34, were active in this assay. Specifically, sphaeropsidin A (32) 
caused necrotic lesions on holm and cork oak (area lesion sizes of 10.85 and 15.03 mm2, 
respectively), whereas the lesions on tomato leaves appeared as dark green water-soaked 
spots surrounded by a yellow halo (area lesion sizes of 120.92 mm2). Epiepoformin exhibited 
similar activity to 32 on holm and cork oak (area lesion sizes of 6.68 and 9.49 mm2, 
respectively). When applied on detached leaves of tomato, 34 caused irregular necrotic lesions 
(13.49 mm2 area).  
In tomato cuttings bioassay, the compounds 24, 25, 29, 32 and 34 were active. 
Diplopimarane (24) caused stewing on stem within 48 h from the application at 0.2 and 0.1 
mg/mL. Both its derivatives 25 and 29 caused, to different extents, stewing on stem at 0.2 
and 0.1 mg/mL. Stewing and/or wilting symptoms were observed with sphaeropsidin A and 
C (32 and 33, respectively) and (+)-epiepoformin (34) at 0.2 and 0.1 mg/mL. 
The compounds 24, 32, 33 and 34 were preliminarily screened for antifungal and 
antioomycete activity in vitro against four plant pathogens at 100 µg/mL (see par.4.7.3.). Two 
synthetic fungicides: Metalaxyl-M and PCNB to which Oomycetes, Ascomycetes and Basidiomycetes 
are sensitive were used as positive control. The mycelial growth inhibition (as a percentage) 
was listed in Table 20. The compounds 24 and 32-34 showed a different spectrum of activity. 
Among the tested pathogens, P. cinnamomi and P. plurivora seem to be the most sensitive target 
organisms followed by A. rolfsii, whereas D. corticola was shown to be the most resistant one. 
Among the tested compounds, 32 showed high activity against P. cinnamomi, P. plurivora and 
A. rolfsii. In particular, it completely inhibited the mycelial growth of both oomycetes showing 
the same effectiveness of metalaxyl-M at 100 µg/mL. It also induced 83.2% inhibition of A. 
rolfsii and its effect magnitude is comparable to that of PCNB at 100 µg/mL. In addition, 
compound 32 exhibited negligible activity against D. corticola (19.8% inhibition growth). 
Moreover, the mycelial growth of D. corticola was only slightly inhibited by compound 24 
(54.5 inhibition percentage) and 34 (39.7 inhibition percentage). No antifungal and 
antioomycete activity was significantly shown by compound 33 at the concentration used.  
In the Artemia salina bioassay, diplopimarane (24), its derivatives (25-27, 29), 
sphaeropsidin A (32) and (+)-epiepoformin (34) caused more than 50% larval mortality at 
200 µg/mL after 36 h of exposure to the metabolites (Table 19). Sphaeropsidin C (33) was 
inactive. On the basis of these preliminary results, it could envisage a LC50 value of less than 
200 µg/mL. Thus, each of these metabolites, in particular 24 and its derivatives 25 and 29, 
could be screened against tumor cell lines and evaluated in more specific antitumor systems. 
Moreover, previous studies have shown significant cytotoxic activity of 
sphaeropsidin(Evidente et al., 1996; Wang et al., 2011). Interestingly, it inhibits not only 
cancer cell proliferation but also migration of metastatic breast cancer cell line. 
5.6 Synthesis and chemical characterization of oxysporones derivatives 
Eight derivatives of oxysporone were hemisynthesized in order to carry out a structure-
activity relationships study aimed to obtain compounds with improved activities and specificity. 
Firstly 35 was converted into the corresponding 4-O-acetyl derivative (38, Figure 13) by usual 
acetylation carried out with acetic anhydride and pyridine; 38 showed the reversible modification 
of the hydroxy group at C-4 of dihydropyran ring. A different modification of the same hydroxy 
group was obtained by conversion of 35 into the corresponding 4-O-p-bromobenzoyl derivative 
(41, Figure 13) by reaction with p-bromobenzoyl chloride carried out in CH3CN. 41 differed from 
38 for the aromatic and bulky nature of the acyl group. 
The dihydropyran ring was modified by catalytic hydrogenation of its double bond. The 
reaction was carried out both on oxysporone (35) and on its acetylated derivative (38), yielding 
the corresponding 2,3-dihydroderivative 39 and 43 (Figure 13). Oxysporone showed a different 
reactivity in respect to some oxidant reagents. In fact, when the reaction was conducted with 
Corey’s reagent (Corey and Suggs, 1975), the expected oxidation of secondary hydroxy group at 
C-4 was observed, yielding the corresponding α,β-unsaturated ketone (40, Figure 13). Instead, 
when the reaction was performed with Jones’s reagent (Bowers et al., 1953), the derivative 40 was 
not obtained and the only product of the oxidation was 2-(4-pyronyl) derivative of acetic acid (42, 
Figure 13). A probable reaction mechanism, which justify the conversion of 35 into 42, is in 
agreement with the literature data (Edwards et al., 2001). The strong acid conditions probably 
induced the enolization of the ketone group at C-4 of 6 and the protonation of the carbonyl of 
the furanone ring (Figure 76). This latter rearranged into the 2-(4- pyronyl)acetic acid (42) being 
the driving force the stability of the 4-pyrone ring. This compound, named xylaric acid, had been 
firstly isolated from Xylaria spp. (Salvatore et al., 1994). Then it was also isolated from Xylaria 
grammica (Mont.) Fr. along with grammicin (Edwards et al., 2001) and from Pestalotiopsis sp. HC02 
isolated from Chondracris rosee L. gut together pestalotines A and B (Zhang et al., 2008). The acid 
42 was converted into the corresponding methyl ester 45 (Figure 13) by reaction with an ethereal 
solution of diazomethane. 
As already observed for oxysporone, the oxidation conducted with Jones’s reagent on the 
2,3-dihydrooxysporone (39, Figure 13) gave the expected 2-(2,3-dihydro-4-pironyl)acetic acid 
(44), probably through a reaction mechanism similar to that hypothesized for formation of 42, 
44, also known as desoxypatulinic acid, was previously obtained by synthesis (Woodward and 
Singh, 1950) and by hydrogenation of patulin (Engel et al., 1949). It was also successively isolated 
from cultures of Penicillium patulum (Scott et al., 1972) and from an unidentified marine fungus 
reported as Penicillium sp. (Wu et al., 2010). The structures of all derivatives 38-45 were 
determined by comparing their spectroscopic data, essentially 1H NMR (Figures 77-85) and ESI 
and/or APCIMS, with those of oxysporone. Two bioassays were used to investigate the 
phytotoxic activity of oxysporone (35), its derivatives (35-45). In the leaf-puncture bioassay, the 
phytotoxicity was evaluated on holm oak, cork oakand grapevineleaves. As shown in Table 21, 
oxysporone (35) confirmed its strong toxicity on all species tested causing necrotic lesions 
ranging from 15.81 mm2 on cork oak leaves to 23.04 mm2 on grapevine leaves. Among 
oxysporone (35) derivatives compounds 38 and 40 retained the phytotoxicity, whereas the 
derivatives 39, 41-45 were inactive. Specifically, the monoacetyl derivative (38) of oxysporone 
exhibited the same moderate activity as that shown by 40 on all plant species tested (lesion sizes 
ranging from 3.50 to 7.83, and from 4.28 to 7.86 mm2, respectively). In tomato cuttings bioassay, 
the compounds 35, 38, and 40 were active. Oxysporone (35) caused wilting within 48 h from the 
application at 0.2 mg/mL. Stewing or wilting symptoms were also observed with this compound 
at 0.1 and 0.05 mg/mL. Both 38 and 40 caused stewing on stem at 0.2 and 0.1 mg/mL. None of 
the other compounds caused any visible symptoms in this bioassay at the highest concentration 
used. From the analysis of the structures and the activities displayed by all compounds, structure–
activity relationships and some structural features related to the phytotoxic activity can be 
extracted. 
The dihydrofuropyran carbon skeleton is a structural feature important for the activity 
considering that the oxidative opening of the dihydrofuran ring into the corresponding 2-
substituted acetic acid joined with the conversion of the pyran ring into the corresponding 
semiquinone as in 42 and 45 and the corresponding 2,3-dihydro derivative 44 determine the 
complete loss of activity. The double bond of the dihydropyran ring present in 35 appears to be 
also an important structural feature for phytotoxic activity. In fact, derivatives as 39 and 43 
lacking this double bond were inactive. This was also confirmed by the inactivity of derivative 43. 
The hydroxy group at C-4 seems also to be somehow associated with the phytotoxic effects. In 
fact, the acetylation of this functional group as in derivative 38 led to a decrease of activity, and 
the introduction of a bulky substituent in the same position as in derivative 41 resulted in the 
total loss of activity. The oxidation by Corey’s reagent of hydroxy group at C-4 seems only to 
decrease the bioactivity of 35 as observed testing derivatives 40. All compounds, with the 
exception of 44 and 45, obtained in small quantities, were preliminary screened for antifungal 
activities in vitro against four plant pathogens at 100 mg/mL (see experimental). The results 
summarized in Table 21 showed that among all the tested compounds only compound 41 
displayed significant activities (35.6–100% inhibition rates) against all pathogens tested at 100 
mg/mL. Oxysporone, the other derivatives 38-40 and 42-43 were inactive at the same 
concentration. Fungal sensitivity to 41 varied according to the species. Athelia rolfsii and 
Phytophthora plurivora appeared to be more sensitive (100% inhibition) to this compound. Diplodia 
corticola showed to be less sensitive (inhibition <40%), whereas on P. cinnamomi the inhibition rate 
was of 77.2%. In order, to more fully understand the activity of the active compound 41, its EC50 
was further evaluated (concentration which inhibits mycelial growth by 50%) towards the same 
pathogens used in the preliminary test, except D. corticola, in comparison with three specific 
commercial fungicides namely toclofos-methyl, PCNB and metalaxyl-M. As shown in Table 22, 
derivative 41 gave the highest activity against P. plurivora with EC50 value of 29.47 mg/mL, 
whereas it showed the lowest activity against P. cinnamomi with EC50 value of 43.5 mg/mL. 
Nevertheless, each fungal species showed sensitivity levels to compound 41 that were one or two 
orders of magnitude lower than those recorded for the commercial fungicides (Table 22). 
  
6. CONCLUSION 
- A new phytotoxic cyclohexenone, namely cyclobotryoxide was isolated from 
Neofusicoccum australe strain BOT48. 
- From the culture filtrates of Lasiodiplodia mediterranea strain BL101 were isolated and 
characterized three new jasmonic acid esters, namely lasiojasmonates A-C, and for 
the first time 16-O-acetyl derivatives of botryosphaerilactones A and C. Moreover 
(1R,2R)-jasmoinc and its methyl ester, botryosphaerilactone A and (3S,4R,5R)-4-
hydroxymethyl-3,5-dimethyl-dihydro-2-furanon and (3R,4S)-botryodiplodin were 
isolated and identified.  
- From the culture filtrates of Lasiodiplodia mediterranea strain B6 two new dimeric -
lactols namely lasiolactols A and B were isolated and cheracterized. Moreover 
botryosphaeriodiplodin, (5R)-5-hydroxylasiodiplodin, (1R,2R)-jasmoinc and 
(3S,4R,5R)-4-hydroxymethyl-3,5-dimethyl-dihydro-2-furanon were isolated and 
identified.  
- Neofusicoccum australe strain BL24 showed produced .three known metabolites: 
tyrosol, botryosphaerone D and (3S,4S)-3,4,8-trihydroxy-6-methoxy-3,4-dihydro-
1(2H)-naphthalenone. 
- A new 20-nor-ent-pimarane, named diplopimarane, having antifungal activity, was 
isolated together with sphaeropsidins A and C, and (+)-epiepoformin from organic 
crude extracts of Diplodia quercivora. 
- Structure-activity study on oxysporone showed that dihydrofuropyranone carbon 
skeleton and both the double bond the hydroxy group of dihydropyran ring 
appeared to be structural features important in conferring activity. 
- New derivative with antifungal activity was preparated from oxysporone  
 
  
7. REFERENCES 
1. Ahamad, P. Y. A.; Kunhi, A. A. M.; Divakar, S. J. Microbiol Biotechnol. 2001, 17, 371-
377. 
2. Aldridge, D.C., Galt, S., Giles, D., Turner, W.B. J. Chem. Soc. 1971, C 1623-1627. 
3. Altomare, A.; Burla, M. C., Cavalli, M., Cascarano, G. L., Giacovazzo, C., Guagliardi, 
A., Moliterni, A. G. G., Polidori G., Spagna R. J. Appl. Crystall. 1999, 32, 115119. 
4. Andolfi, A.; Mugnai, L.; Luque, J.; Surico, G., Cimmino, A.; Evidente, A. Toxins 2011, 
3, 1569-1605. 
5. Andolfi, A., Maddau, L., Cimmino, A., Linaldeddu, B.T., Franceschini, A., Serra, S., 
Basso, S., Melck D., Evidente A. J. Nat. Prod. 2012, 75, 1785-1791. 
6. Arsenault, G.P., Althaus, J.R. J. Chem. Soc. 1969, (D), Chem. Commun., 1414-1415. 
7. Au, T.K., Wallace, S.H.C., Leung, P.C. Plant Physiol. 1985, 77, 303-308. 
8. Au, T. K., Wallece, S.H.C., Leung, P.C. Life Sci. 2000, 67, 733-742. 
9. Barros, M. T., Maycock, C. D., Ventura, M. R. Chem. Eur. J. 2000, 6, 39913996. 
10. Berestetskiy, A. O. App. Biochem.Microbiol. 2008, 44, 453-465. 
11. Berger, S., Braun, S. In 200 and More Basic NMR Experiments: A Practical Course, first 
ed. Wiley-VCH, Weinheim, 2004. 
12. Bischoff, V., Cookson, S.J., Wu, S., Scheible, W.R. J. Exp. Bot. 2009, 60, 955-
965. 
13. Bowers, A., Halsall, T.G., Jones, E.R.H., Lemin, A.J., 1953. In The chemistry of 
the triterpenes and related compounds. Part XVIII.. J. Chem. Soc. 2548-2560. 
14. Breitmaier, E.; Voelter, In Spectroscopy VCH: Weinheim, 1987, pp 183-280. 
15. Brunner, H.G., Chemla, P., Dobler, M.R., O’Sullivan, A.C., Pachlatko, P., 
Pillonel, C., Stierli, D. Am. Chem. Soc. Ser. 2007, 948, 121-135.  
16. Burruano, S., Mondello, V., Conigliano, G., Alfonso, A., Spagnolo, A., Mugnai, 
L., Phytopathol. Mediterr. 2008, 47, 132. 
17. Bury, M., Novo-Uzal, E., Andolfi, A., Cimini, S., Wauthoz, N., Heffeter, P., 
Lallemand, B., Avolio, F., Delporte, C., Cimmino, A., Dubois, J., Van 
Antwerpen, P., Zonno, M.C., Vurro, M., Poumay, Y., Berger, W., Evidente, A., 
De Gara, L., Kiss, R., Locato V. Int. J. Oncol. 2013, 43, 575-585. 
18. Cabras A., Mannoni, M.A., Serra, S., Andolfi, A., Fiore, M., Evidente. A. Eur. J. 
Plant Pathol. 2006, 115, 187-193. 
19. Capasso, R.; Cristinzio, G.; Evidente, A.; Scognamiglio, F. Phytochemistry 1992, 
31, 4125–4128. 
20. Carreno, M. C., Merino, E., Ribagorda, M., Somoza, A., Urbano, A. Org. Lett. 2005, 
7, 14191422.  
21. Castillo-Pando, M., Somers, A., Green, C.D., Priest, M., Sriskanthades, M. Australas. 
Plant Pathol. 2001, 30, 59-63. 
22. Chai, C.L.L., Waring, P. Redox Rep. 2000, 5, 257-264. 
23. Cimmino, A.; Villegas-Fernández, A. M.; Andolfi, A.; Melck, D.;  Rubiales, D.; 
Evidente, A. J. Agric. Food Chem. 2011, 59, 9201-9206. 
24. Cimmino, A., Andolfi, A., Zonno, M.C., Avolio, F., Santini, A., Tuzi, A., 
Berestetskiy, A., Vurro, M., Evidente, A. J. Nat. Prod. 2013, 76, 12911297. 
25. Cimmino, A., Andolfi, A., Zonno, M.C., Avolio, F., Berestetskiy, A., Vurro, M., 
Evidente, A., Phytochemistry 2013, 96, 208213. 
26. Conti, P., Roda, G., Stabile, H., Vanoni, M.A., Curti, B., De Amici, M. Farmaco 2003, 
58, 683-690.  
27. Corey, E.J., Suggs, J.W., Tetrahedron Lett. 1975, 31, 2647-2650. 
28. Crous, P.W., Slippers, B., Wingfield, M.J., Rheeder, J., Marasas, W.F.O., Phillips, 
A.J.L., Alves, A.,. Burgess, T Barber, P., Groenewald, J.Z.. Stud. Mycol. 2006, 55, 235-
253. 
29. Cseke, C., Gerwick, B.C., Crouse, G.D., Murdoch, M.G., Green, S.B., Heim, 
D.R. Pestic. Biochem. Physiol. 1996, 55, 210-217. 
30. Denman, S., Crous, P.W., Taylor, J.E., Kang, J.Ch., Pascoe, I., Wingfield, M.J. 
Stud. Mycol. 2000, 45, 129-140. 
31. Djoukeng, J.D., Polli, S., Larignon, P., Mansour, E.A. Eur. J. Plant Pathol. 2009, 124, 
303-308. 
32. Duke, S.O., Wickliff, J.L., Vaughn, K.C., Paul, R.N. Physiol. Plant. 1982, 56, 387-398. 
33. Duke, S.O., Evidente, A., Fiore, M., Rimando, A.M., Vurro, M., Chistiansen, N., 
Looser, R., Grossmann, K. Pestic. Biochem. Physiol. 2011, 100, 41-50. 
34. Edwards, R. L., Maitland, D. J., Pittayakhajonwut, P., Whalley A.J.S., J. Chem. Soc. 
2001, 1, 1296-1299. 
35. Ellestad, G. A., Kunstmann, M. P., Mirando, P., Morton, G. O. J. Am. Chem. Soc. 
1972, 94, 6206-6208. 
36. Engel, B.G., Brzeski, W., Plattner, P.A., Helv. Chim. Acta 1949, 32, 1166-1175. 
37. Evidente, A., Sparapano, L., Motta, A., Giordano, F., Fierro, O., Frisullo, S. 
Phytochemistry 1996, 42, 1541-1546. 
38. Evidente, A., Sparapano, L., Giordano, F., Fierro, O., Motta, A. Phytochemistry 1997, 
45, 705-713. 
39. Evidente, A.; Sparapano, L.; Fierro, O.; Bruno, G.; Giordano, F.; Motta, A. 
Phytochemistry 1998, 48, 1139-1143. 
40. Evidente, A., Capasso, R., Cutignano, A., Taglialatela-Scafati, O., Vurro, M., Zonno, 
M.C., Motta, A. Phytochemistry 1998, 48, 1131-1137. 
41. Evidente, A, Sparapano, L, Fierro, O., Bruno, G., Motta, A. J. Nat. Prod., 1999, 62, 
253-256. 
42. Evidente, A., Sparapano, L., Fierro, O., Bruno, G., Giordano, F., Motta, A. 
Phytochemistry 2002, 59, 817-823. 
43. Evidente, A., Maddau, L., Spanu, E., Franceschini, A., Lazzaroni, S., Motta, A. J. Nat. 
Prod. 2003, 66, 313-315. 
44. Evidente, A., Sparapano, L., Andolfi, A., Bruno, G., Motta, A. Austral. J. Chem. 2003, 
56, 615-619. 
45. Evidente, A, Maddau, L, Spanu, E, Franceschini, A, Lazzaroni, S, Motta, A. J. Nat. 
Prod., 2003, 66, 313-315. 
46. Evidente, A., Fiore, M., Bruno, G., Sparapano, L., Motta, A. Phytochemistry 2006a, 67 
(10), 1019-1028. 
47. Evidente A., Andolfi, A., Fiore, M., Spanu, E., Maddau, L., Franceschini, A., Marras, 
F., Motta, A. J. Nat. Prod. 2006b, 69, 671-674. 
48. Evidente A., Andolfi, A., Fiore, M., Spanu, E., Franceschini, A., Maddau, L. Archivok 
2007, 7, 318-328. 
49. Evidente, A.; Punzo, B.; Andolfi, A.; Cimmino, A.; Melck, D.; Luque, J. Phytopathol. 
Mediterr. 2010, 49, 74-79. 
50. Evidente, A., Andolfi, A., Cimmino, A., Abouzeid, M. A. In: Sustainable Agriculture: 
Technology, Planning and Management (Salazar, A., Rias, I. Eds.), Nova Science 
Publishers Inc. ISBN: 2010, 978-1-60876-269-9 pp.177-234. 
51. Evidente, A., Punzo, B., Andolfi, A., Cimmino, A., Melck, D., Luque, J. Phytopathol. 
Mediterr. 2010, 49, 74-79. 
52. Evidente, A., Andolfi, A., Cimmino, A., Abouzeid, A. M. In Sustainable Agriculture: 
Technology, Planning and Management (Salazar, A., Rias, I. Eds.) Nova Science Publishers 
Inc. New York 2010, pp. 145-176. 
53. Evidente, A., Andolfi, A., Cimmino, A. Chirality 2011, 23, 674-693. 
54. Evidente, A., Maddau, L., Scanu, B., Andolfi, A., Masi, M., Motta, A., Tuzi, A. J. Nat. 
Prod. 2011, 74, 757-763. 
55. Evidente A., Venturi V., Masi M., Degrassi G., Cimmino A., Maddau L., Andolfi A. 
J. Nat. Prod. 2011a, 74, 2520-2525. 
56. Evidente, A., Maddau, L., Scanu, B., Andolfi, A., Masi, M., Motta, A., Tuzi, A. J. Nat. 
Prod. 2011b, 74, 757-763. 
57. Evidente, A., Masi M., Linaldeddu, B. T., Franceschini, A., Scanu, B., Cimmino, A., 
Andolfi, A., Motta, A., Maddau, L. Phytochemistry 2012, 77, 245-250. 
58. Evidente, A., Cimmino, A., Andolfi A. Chirality 2013, 25, 59-78. 
59. Farmer, E.E., Johnson, R.R., Ryan, C.A. Plant. Physiol. 1992, 98, 995-1002. 
60. Farr, D.F., Rossman, A.Y. 2011. Fungal Databases, Systematic Mycology and Microbiology 
Laboratory, ARS, USDA. Retrieved May 20, 2011, from http:// nt.ars-
grin.gov/fungaldatabases/fungushost/fungushost.cfm. 
61. Favilla, M., Macchia, L., Gallo, A., Altomare, C. Food Chem. Toxicol. 2006, 44, 1922-
1931. 
62. Feld, A., Kobek, K., Litchtenthaler, H.K. Brighton Crop Prot. Conf. Weeds 1989, 2, 479-
486. 
63. Fonne-Pfister, R., Chemla, P., Ward, E., Girardet, M., Kreuz, E., Honzatko, 
R.B., Fromm, H.J., Schar, H.P., Grutter, M.G., Cowan-Jacob, S.W. Proc. Natl. 
Acad. Sci. USA 1996, 93, 9431-9436. 
64. Franceschini, A., Corda, P., Maddau, L., Marras, F. IOBC Bulletin, 1999, 22, 5-
12. 
65. Frisvad, J. C., Andersen, B., Thrane, U. Mycol. Res. 2008, 112, 231-240. 
66. Fuska, J., Proksa, B., Uhrin, D., Folia Microbiol. 1988, 33, 238-240. 
67. Giorgio E., Maddau L., Spanu E., Evidente A., Rosini C. J. Org. Chem. 2005, 70, 
7-13. 
68. Gupta, R.S., Chandran, R.R., Divekar, P.V. Indian J. Exp. Biol. 1966, 4, 152-153. 
69. Halloin, J.M., De Zoeten, G.A., Gaard, G.R., Walker, J.C. Plant Physiol. 1970, 
45. 310-314. 
70. Hamid, K., Strange, R.N. Physiol. Mol. Plant Pathol. 2000, 56, 235-244. 
71. Hammerschlag F.A. In: Advances in agricultural Biotechnology  (G.B. Collins, J.G. 
Petolino, Eds.). Martinus Nijhoff/Dr W. Junk Publishers, 1984, 453-489. 
72. Hassal, K.A. In Biochemistry and Use of Pesticides. Verlag Chemie, Weinheim, 1990, 
pp. 58, 72, 304, 429, and 497. 
73. He, G., Matsuura, H., Yoshihara, T. Phytochemistry 2004, 65, 2803-2807. 
74. Heim, D.R., Cseke, C., Gerwick, B.C., Murdoch, M.G., Green, S.B. Pestic. 
Biochem. Physiol. 1996, 55, 210-217. 
75. Hewitt, R.D. In Compendium of Grape Diseases; The American Phytopathological 
Society (APS) Press: St. Paul, MN, USA, 1988; pp. 25-26. 
76. Husain, A., Ahmad, A., Agrawal, K. P. J.Nat. Prod. 1993, 56, 2008-2011. 
77. Iacobellis, N.S., Bottalico, A. Phytopathol. Medierr. 1981, 20, 129-132. 
78. Isaka, M., Yangchum, A., Auncharoen, P., Srichomthong, K., Srikitikulchai, P. 
J. Nat. Prod. 2011, 74, 300-302. 
79. Jacobs, K.A., Rehner, S.A. Mycologia 1998, 90, 601-610. 
80. Jernerèn, F., Eng, F., Hamberg, M., Oliw E. H., Lipids 2012, 47, 65-73. 
81. Kawaide H. Biosci. Biotechnol. Biochem. 2006, 70, 583-590. 
82. King, R.R., Calhoun, L.A. Phytochemistry 2009, 70, 833-841. 
83. Kitaoka, N., Nabeta, K., Matsuura, H. Biosci. Biotechnol. Biochem. 2009, 73, 1890-
1892. 
84. Knogge, W. The Plant Cell. 1996, 8, 1711-1722. 
85. Kuhn, S., Bussemer, J., Chigri, F., Vothknecht, U.C. Plant J. 2009, 58, 694-705. 
86. Xu, Y.X., Lu, C.H., Zheng, Z.H., Shen, Y.N. Helv. Chim. Acta 2011, 94, 897-
902. 
87. Lallemand, B., Masi, M., Maddau, L., De Lorenzi, M., Damd, R., Cimmino, A., 
Moreno y Banuls, L., Andolfi, A., Kiss, R., Mathieu, V., Evidente, A. Phytochem. 
Lett. 2012, 5, 770-775. 
88. Lamari, L. In Assess Image Analysis Software for Plant Disease Quantification, APS 
Press: St. Paul, MN, 2002. 
89. Larignon, P., Fulchic, R., Cere, L., Dubos, B. Phytopathol. Mediterr. 2001, 40, 
S336-S342. 
90. Li, X., Yao, Y.H., Zheng, Y.N., Lin, W.H., Sattler, I., Deng, Z.W. Zhongguo 
Tianran Yaowu  2007, 5, 20-23. 
91. Linaldeddu, B.T., Scanu, B., Schiaffino, A., Serra, S. Phytopathol. Mediterr. 2010, 
49, 417-420. 
92. Linaldeddu, B.T., Scanu, B., Maddau, L., Franceschini, A., Phytopathol. Mediterr. 
2011, 50, 473-477. 
93. Linaldeddu, B.T., Franceschini, A., Alves, A., Phillips, A. J. L. Mycologia 2013, 
105, 1266-1274. 
94. Linaldeddu, B.T., Deidda, A., Scanu, B., Franceschini, A., Serra, S., Berraf-
Tebbal, A., Zauaoui Boutiti, M., Ben Jamȃa, M.L., Phillips, A.J.L. Fungal Divers. 
2014, DOI 10.1007/s13225-014-0301-x. 
95. Martos, S., Andolfi, A., Luque, J., Mugnai, L., Surico, G., Evidente, A. Eur. J. 
Plant Pathol. 2008, 121, 451-461.  
96. Matsuura, H., Nakamori, K., Omer, E.A., Hatakeyama, C., Yoshihara, T. 
Phytochemistry 1998, 49, 579. 
97. Mazzeo, G., Santoro, E., Andolfi, A., Cimmino, A., Troselj, P., Petrovic, A. G., 
Superchi, S., Evidente, A., Berova, N. J. Nat. Prod. 2013, 76, 588-599. 
98. Mennucci, B., Claps, M., Evidente, A., Rosini, C. J. Org. Chem. 2007, 72, 6680-6691. 
99. Miersch, O., Preiss, G.S., Schreiber, K. Phytochemistry 1987, 26, 1037-1039. 
100. Miersch, O., Kramell, R., Parthier, B., Wasternack, C. Phytochemistry 1999a, 50, 353-
361. 
101. Miranda, C.C.B.O., Dekker, R.F.H., Serpeloni J.M., Fonseca, E.A.I., Cólus, I.M.S., 
Barbosa A.M. Int. J. Biol. Macrom. 2008, 42, 172-177. 
102. Mondello, V., Lo Piccolo. S., Conigliano, G., Alfonso, A., Torta, L., Burruano, 
S., Phytopathol. Mediterr. 2013, 52, 388. 
103. Nagasawa, H., Suzuki, A., Tamura, S. Agr. Biol. Chem. 1978, 42, 1303-1304. 
104. Nagata, T., Ando, Y. Agric. Biol. Chem. 1989, 53, 2811. 
105. Nakajima, M., Itoi, K., Takamatsu, Y., Kinoshita, T., Okazaki, T., Kawakubo, K., 
Shindo, M., Honma, T., Tohjigamori, M., Haneishi, T. J. Antiobiot. 1991, 44, 293-300. 
106. Nakamori, K., Matsuura, H., Yoshihara, T., Ichihara, A., Koda Y. Phytochemistry 1994, 
35, 835-839. 
107. Nakanishi, K., Solomon, P.H. In Infrared Absorption Spectroscopy (Holden Day: 
Oakland, Eds.II) 1977, pp 17-44. 
108. Nakai, N., Murata, M., Nagahama, M., Hirase, T., Tanaka, M., Fujikawa, T., Nakao, 
N., Nakashima, K., Kawanishi, S. Free Radic. Res. 2003, 37, 69-76. 
109. Natsumeda, Y., Ikegami, T., Olah, E., Weber, G. Cancer Res. 1989, 49, 88-92. 
110. Nielsen, K. F., Sumarah, M. W., Frisvad, J. C., Miller, J. D. J. Agric. Food Chem 2006, 
54, 3756-3763. 
111. Okamura, H., Shimizu, H., Yamashita, N., Iwagawa, T., Nakatani, M. Tetrahedron 
2003, 59, 10159-10164. 
112. Osbourn A.E. PNAS, 2001, 98(25), 14187-14188. 
113. Othani, I., Kusumi, T., Ishitsuka, M.O., Kakisawa, H. Tetrahedron Lett. 1989, 30, 3147-
3150. 
114. Ohtani, I., Kusumi, T., Kashman, Y., Kakisawa, H. J. Am. Chem. Soc. 1991, 113, 4092. 
115. Owens, L.D., Guggenheim, S., Hilton, J.L. Biochim. Biophys. Acta 1968, 158, 219-225. 
116. Owens, L.D., Lieberman, M., Kunishi, A. Plant Physiol. 1971, 48, 1-4. 
117. Owens, L.D. Weed Sci. 1973, 21, 63-66. 
118. Pandi, M., Manikandan, R., Muthumary, J. Biomed. Pharmcot. 2010, 64, 48-53. 
119. Pavlic, D., Slippers, B., Coutinho, T.A, Gryzenhout, M., Wingfield, M.J. Stud. 
Mycol. 2004, 50, 313-322. 
120. Phillips, A.J.L. Phytopathol. Mediterr. 2002, 41, 3-18. 
121. Phillips, A.J.L., Pennycook, S.R., Johnston, P.R., Ramaley, A., Akulov, A., 
Crous, P.W. Persoonia 2008, 21, 29-55. 
122. Pinkerton, F., Strobel, G. Proc. Natl. Acad. Sci. USA 1976, 73, 4007-4011. 
123. Phillips, A.J.L. J. Phytopathol. 1998, 146, 327-332. 
124. Phillips, A.J.L. Phytopathol. Mediterr. 2002, 41, 3-18. 
125. Pittayakhajonwut, P., Sohsomboon, P., Dramae, A., Suvannakad, R., Lapanun, S., 
Tantichareon, M. Planta Med. 2008, 74, 281-286. 
126. Pretsch, E.; Bühlmann, P.; Affolter, C. In Structure Determination of Organic Compounds-
Table of Spectral Data (Spinger-Verlag: Berlin Eds.III) 2000, pp, 161-243, 385-404. 
127. Ramezani, M., Shier, W.T., Abbas, H.K., Tonos, J.L., Baird, R.E., Sciumbato, G.L. J. 
Nat Prod. 2007, 70, 128-129. 
128. Ravi, B.N., Armstrong, R.W., Faulkner, D.J. J. Org. Chem 1979, 44, 3109-3113. 
129. Reimer, S., Selman, B.R. J. Biol. Chem. 1978, 253, 7249-7255. 
130. Rodriguez-Foneca, C., Amils, R., Garrett, R.A. J. Mol. Biol. 1995, 247, 224-235. 
131. Rodriguez-Suerez, R., Xu, D., Veillette, K., Davison, J., Sillaots, S., Kauffman, S., Hu, 
W., Bowman, H., Martel, N., Trosok, S., Wang, H., Zhang, L., Huang, LY., Li, Y., 
Rahkhoodaee, F., Ransom, T., Gauvin, D., Douglas, C., Youngman, P., Becker, J., 
Jiang, B., Roemer, T. Chem. Biol. 2007, 14, 1163-1175. 
132. Rouxel, T., Chupeau, Y., Fritz, R., Kollmann, A., Blouquet, J.F. Plant Sci. 1988, 57, 
45-53. 
133. Rukachaisirikul, R., Arunpanichlert, J., Sukpondma, Y., Phongpaichit, S., Sakayaroj, J. 
Tetrahedron 2009, 65, 10590-10595. 
134. Sakalidis, M. L.; Hardy, G. E. St. J.; Burgess, T. I. Australas. Plant Pathol. 2011, 
40, 510-521. 
135. Salvatore, M.J., Hensens, O.D., Zink, D.L., Liesch, J., Dufresne, C., Ondeyka, 
J.G., Jürgens, T.M., Borris, R.P., Raghoobar, S., McCauley, E., Kong, L., 
Gartner, S. E., Koch, G. E., Pelaéz, F., Diez, M.T., Cascales, C., Martin, I., 
Polishook, J.D., Balick, M.J., Beck, H.T., King, S.R., Hsu, A., Lingham R.B. J. 
Nat. Prod. 1994, 57, 755-760. 
136. Savocchia, S., Steel, C.C., Stodart, B.J., Somers, A. Vitis 2007, 46, 27-32. 
137. Schinko, E., Schad, K., Eys, S., Keller, U., Wohlleben, W. Phytochemisry 2009, 70, 
1787-1800. 
138. Scott, P. M., Kennedy, B., van Walbeek, W. Experientia 1972, 28, 1252. 
139. Scott A.I. In Interpretation of Ultraviolet Spectra of Natural Products Pergamon Press LTD 
Oxford, 1964, pp. 15-162. 
140. Schaller, A., Stinzi, A. Phytochemistry, 2009, 70, 1532-1538. 
141. Selman, B.R., Durbin, R.D. Biochim. Biophys. Acta 1978, 502, 29-37. 
142. Sheldrick, G. M. Acta Crystallogr. 2008, A64, 112-122. 
143. Shen, Y. Arch. Environ. Contam. Toxicol. 1998, 34, 229-34. 
144. Shier, W. T., Abbas, H., Baird, R., Ramezani, M., Sciumbato, G. Toxin Rev. 2007, 26, 
343-386. 
145. Siehl, D.L., Subramanian, M.V., Walters, E.W., Lee, S.F., Anderson, R.J., Toschi, 
A.G. Plant Physiol. 1996, 110, 753-758. 
146. Slavov, S. Biotechnol. Biotec. Eq. 2005, 19: sup3, 48-55. 
147. Sparapano, L., Bruno, G., Fierro, O., Evidente, A. Phytochemistry 2004, 65, 189-198. 
148. Steinberg, T.H., Burgess, R.R. J. Biol. Chem. 1992, 267, 20204-20211. 
149. Stierle, A., Upadhyay, R., Strobel, G. Phytochemistry 1992, 30, 2191-2192. 
150. Styer, C.H., Cutler, H.G. Plant Cell Physiol. 1984, 25, 1077-1082. 
151. Sultan, S., Sun, L., Blunt, J.W., Cole, A.L.J., Munro, M.H.G., Ramasamy, K., Weber, 
J.F.F. Tetrahed. Lett. 2014, 55, 453. 
152. Tachihara, T., Kitahara, T. Tetrahedron, 2003, 59, 1773-1780. 
153. Takken, F.L.W., Joosten, M.H.A.J. Eur. J. Plant Pathol. 2000, 106, 699-713. 
154. Tanaka, T., Hanato, K., Watanabe, M., Abbas, H.K. J. Nat. Toxins 1996, 5, 317-
329. 
155. Taylor, A., Hardy, G.E.S., Wood, P., Burgess, T. Australas. Plant Pathol. 2005, 
34, 187-195. 
156. Tsukada, K., Takahashi, K., Nabeta, K. Phytochemistry 2010, 71, 2019-2023. 
157. Turner, J.G. In Plant diseases: infection, damage and loss (Wood, R.K.S., Jellis, G.J. 
Eds.), Blackwell Scientific Publications, Oxford, 1984, 3-12. 
158. Úrbez-Torres, J.R., Gubler, W.D., Luque, J. Plant Dis. 2007, 91, 
doi:10.1094/PDIS-91-6-0772C. 
159. Úrbez-Torres, J.R. Phytopathol. Mediterr. 2011, 50, S5-S45. 
160. Van Goietsenoven, G., Mathieu, V., Andolfi, A., Cimmino, A., Lefranc, F., 
Kiss, R., Evidente, A. Planta Med. 2011, 77, 711-717. 
161. Van Niekerk, J.M., Fourie, P.H., Halleen, F., Crous, P.W. Phytopathol. Mediterr. 
2006, 45, S43-S54. 
162. Venkatasubbaiah, P., Sutton, T.B., Chilton, W.S. Phytopathology 1991, 81, 243-
247. 
163. Venkatasubbaiah, P., van Dyke, C.G., Chilton, W.S. Mycologia 1992, 84, 715-
723. 
164. Walters, E.W., Lee, S.F., Niderman, T., Bernasconi, P., Subramanian, M.V., 
Siehl, D.L. Plant Phyisol. 1997, 114, 549-555. 
165. Walton, J.D. Plant Cell. 1996, 8, 1723-1733. 
166. Wang, X.N., Bashyal, B.P., Wijeratne, E.M.K., U’Ren, J.M., Liu, M.X., 
Gunatilaka, M.K., Arnold, A.E., Gunatilaka, A.A.L. J. Nat. Prod. 2011, 74, 2052-
2061. 
167. Weber, H.A., Gloer, J.B. J. Nat. Prod. 1988, 51, 879-883. 
168. Weber, R.W., Kappe, R., Paululat, T., Mosker, E., Anke, H. Phytochemistry 2007, 
68, 886-889. 
169. Woodward, R.B., Singh, G. Nature 1950, 165, 928-930. 
170. Wright, J.M. Ann. Bot. 1951, 15, 493-499. 
171. Wu, H.H., Tiam, L., Feng, B.M., Li, Z.F., Zhang, Q.H., Pei, Y.H. J. Asian Nat. Prod. 
Res. 2010, 12, 15-19. 
172. Wunderlich, N., Steel, C.C., Ash, G., Raman, H., Savocchia, S. In Proceedings of the 6th 
International Workshop on Grapevine Trunk Diseases, Florence, Italy, 1-3 September 2008. 
173. Wyss, R., Tamm, C., Vederas, J.C. Helv. Chim. Acta 1980, 63, 1538-1541. 
174. Xu, Y.X., Lu, C.H., Zheng, Z.H., Shen, Y.N. Helv. Chim. Acta 2011, 94, 897-902. 
175. Yang, Q., Asai, M., Matsuura, H., Yoshihara, T. Phytochemistry 2000, 54, 489-494. 
176. Yoder, O.C. Ann. Rev. Phytopathol. 1980, 18, 103-129. 
177. Yukimune, Y., Hara, Y., Nomura, E., Seto, H., Yoshida, S. Phytochemistry 2000, 
54, 13-17. 
178. Zhang, Y.L., Ge, H.M., Li, F., Song, Y.C., Ta  
Table 1. Modes of action of microbially-producer phytotoxins 
Name Compound Surce Action mechanism 
Ascaulitoxin 
aglycone 
 
HOOC
COOH
NH2OH
NH2NH2
 
Ascochyta caulina Aminotransferases 
inhibition 
Rhizobitoxine 
O OH
O
NH2
O
HO
 
Bradyrhizobium spp. β-Cystathionase 
inhibition 
Acivicin  
N O
Cl NH2
OH
O
 
Streptomyces sviceu Glutamate-synthase 
Thaxtomin A 
N
OH
OH
O
O
HN
NO2
 
Streptomyces spp.  Cellulose synthesis 
inhibition 
Tentoxin 
HN
N
N
N
H
O
O
O
O
 
Alternaria alternata  Inhibition of 
chloroplast 
development 
Cyperin 
O
OH
O
OH
 
Ascochyta cypericola  Plant enoyl reductase 
Ophiobolin A 
OHC O
H
OH
O
H
 
Bipolaris spp, Drechslera 
gigantea 
Antagonism of 
calmodulin 
Cytochalasin B 
OHN
O
OH
O
H OH
 
Phoma exigua, 
Zygosporium masonii 
Actin polymerization 
inhibition  
Hydantocidin  
O
NH
H
N
O
O
HO
HO
HO
 
Streptomyces hygroscopis Adenylosuccinate 
synthetase inhibition  
Gliotoxin  
N
NS
S
O
OH
O
OH  
Leptosphaeria maculans Protein Binding 
Anhydro-D-
glucitol 
CH2OHHOH2C
HO
HO
O
 
Fusarium solani  Fructose-1,6-
bisphophate aldolase 
inhibition  
 
  
Table 2. Species of Botryosphaeriaceae currently known to infect grapevines. 
Botryosphaeriaceae species 
and authority 
Culture Anamorph-
Teleomorph 
connectiona 
Hosts 
No.b 
Botryosphaeria dothidea (Moug. ex Fr.) Ces. & 
De Not. 
CMW8000ee Fusicoccum aesculi 338  
Diplodia corticola A.J.L. Phillips, A. Alves & 
J. Luque 
CBS 112549  “Botryosphaeria” corticola 8  
Diplodia mutila (Fr.) Mont.  CBS 112553ee “Botryosphaeria” stevensii 26  
Diplodia seriata De Not.  CBS 112555ee “Botryosphaeria” obtusa 59  
Dothiorella iberica A.J.L. Phillips,  
J. Luque & A. Alves  
CBS 115035et  “Botryosphaeria” iberica 5  
Dothiorella americana J.R. Úrbez-Torres, F. 
Peduto & W.D. Gubler  
CBS128309 et  Unknown 2  
Guignardia bidwellii (Ellis) Viala & Ravaz  IMI 207141 et Unknown 19  
Lasiodiplodia crassispora T.I. Burgess & 
Barber  
CBS11874 et Unknown 6  
Lasiodiplodia missouriana J.R. Úrbez-Torres, 
F. Peduto & W.D. Gubler  
CBS128311 et Unknown 2  
Lasiodiplodia theobromae (Pat.) Griff. & 
Maubl.  
K(M)118158h “Botryosphaeria” rhodina 442  
Lasiodiplodia viticola J.R. Úrbez-Torres, F. 
Peduto & W.D. Gubler  
CBS128313 et  Unknown 2  
Neofusicoccum australe (Slippers, Crous & M.J. 
Wingf.) Crous, Slippers & A.J.L. Phillips  
CMW6838 et “Botryosphaeria” australe 30  
Neofusicoccum luteum (Pennycook & Samuels) 
Crous, Slippers & A.J.L. Phillips  
CBS 110299 et “Botryosphaeria” lutea 16  
Neofusicoccum macroclavatum (T.I. Burgess, 
Barber & Hardy) T.I. Burgess, Barber & 
Hardy  
CBS 118223 et Unknown 3  
Neofusicoccum mediterraneum Crous, M.J. 
Wingf. & A.J.L. Phillips  
CBS 121718 et Unknown 13  
Neofusicoccum parvum (Pennycook & 
Samuels) Crous, Slippers & A.J.L. Phillips  
CMW9081 et  “Botryosphaeria” parva 34  
Neofusicoccum ribis (Slippers, Crous & M.J. 
Wingf.) Crous, Slippers & A.J.L. Phillips  
CMW7772 et Unknown 242  
Neofusicoccum viticlavatum (Van Niekerk & 
Crous) Crous, Slippers & A.J.L. Phillips  
CBS 112878 et Unknown 1  
Neofusicoccum vitifusiforme (Van Niekerk & 
Crous) Crous, Slippers & A.J.L. Phillips  
CBS 110887 et Unknown 1  
Phaeobotryosphaeria porosa (Van Niekerk & 
Crous) Crous & A.J.L. Phillips  
CBS 110496 et Unknown 1  
Spencermartinsia viticola (A.J.L. Phillips & J. 
Luque) A.J.L. Phillips, A. Alves & Crous  
CBS 117009 et Dothiorella viticola 4  
a Robert et al., 2005.  
b Number of different plant hosts, including Vitis spp., described for each Botryosphaeriaceae species Retrieved 
from Farr and Rossman, July 2011: http://nt.ars-grin.gov/fungaldatabases/fungushost/fungushost.cfm Acronyms 
of cultures collections: CMW: Culture Collection Forestry and Agricultural Biotechnology Institute, University of 
Pretoria, South Africa; WAC: Department of Agriculture Western Australia, Plant Pathogen Collection; CBS: 
Centraalbureau Schimmelcultures, Utrecht, Netherlands; IMI: CABI Filamentous Fungi Database (Formerly IMI), 
Egham, United Kingdom.  
ee Ex-epitype  
et Ex-type  
h Holotype 
  
 
Table 3. Secondary metabolites by Botryosphaeriaceae involved in grapevine trunk 
 diseases  
 
Name Compound  Surce 
(R)-Mellein 
O
H
OH O  
Botryosphaeria obtusa 
 
(3R,4R)-4-
hydroxymellein 
O
HO H
H
OH O  
B. obtusa 
Neofusicoccum parvum 
 
(3R,4S)-4-
hydroxymellein 
O
H OH
H
OH O  
N. parvum 
 
(3R)-7-
Hydroxymellein 
O
H
OH O
HO
 
B. obtusa 
(3R,4R)-4,7-
Dihydroxy-mellein 
O
HO H
H
OH O
HO
 
B. obtusa 
Isoscleron OHO
OH  
N. parvum 
Tyrosol OH
OH  
N. parvum 
Table 4. Secondary metabolites by Botryosphaeriaceae involved in forest plant diseases  
Name Compound Surce  Host 
Sphaeropsidin (Sph) 
A 
OH
O
O
O
OH
H
 
Diplodia cupressi 
D. corticola 
D. africana 
Cupressus spp. 
Cork oak 
Phoenicean 
juniper 
Sph B 
OH
O
O
OH
H
H
OH
 
D. cupressi 
D. corticola 
“ 
Sph C 
HOOC
O
OH
H  
D. cupressi 
D. corticola 
“ 
Sph D 
OH
O
O
O
OH
H
OH
H
 
D. cupressi Cupressus spp. 
Sph E 
H
OH
H
OH
H  
D. cupressi “ 
Sph F 
H
OH
H
HO H
OHH
OH
 
D. cupressi “ 
Sphaeropsidone 
OCH3
O
O
H OH
 
D. cupressi Cupressus spp. 
epiSphaeropsidone 
OCH3
O
O
HO H
 
D. cupressi 
D. africana 
Cupressus spp. 
Phoenicean 
juniper 
Sapinofuranone A H OH
O O 
Sphaeropsis sapinea Cupressus spp. 
Sapinofuranone B HO H
O O 
S. sapinea 
D. corticola 
Cupressus spp. 
Cork oak 
Sapinopyridione 
N
H
O
O
O
O
 
S. sapinea Cupressus spp. 
 
Diplobifuranilone A 
O
O
H
H
OH
OH
 
D. corticola Cork oak 
Diplobifuranilone B 
O O
O
H
OH
H
H  
D. corticola Cork oak 
(R)-Mellein 
O
H
OH O  
D. africana 
S. sapinea 
 
Cork oak 
Pine 
(3R,4R)-4-
hydroxymellein 
O
HO H
H
OH O  
D. corticola 
D. africana 
S. sapinea 
 
Cork oak 
Cork oak 
Pine 
(3R,4S)-4-
hydroxymellein 
O
H OH
H
OH O  
D. corticola 
D. africana 
S. sapinea 
 
Cork oak 
Cork oak 
Pine 
Diplopyrone  
O
O O
HO
H
 
D. corticola 
D. mutila 
Cork oak 
Cork oak 
Diplofuranone A 
O OH
H
OH
 
D. corticola Cork oak 
Diplofuranone B 
O OH
OH
 
D. corticola Cork oak 
Oxysporone 
O O
H
H
OH
O
 
D. africana Cork oak 
Afritoxinone A 
O O
H
H
O
H3CO  
D. africana Cork oak 
Afritoxinone B 
O O
H
H
O
H3CO  
D. africana Cork oak 
 
Table 5. Botryosphaeriaceae  involved in GTDs and canker and dieback in forest plants object of 
thesis. 
 
Species 
 
Code 
 
Host 
 
Isolation site 
ITS 
Accessor 
number 
 
Neofusicoccum australe 
 
 
 
BOT48 
 
Vitis vinifera L. 
 
Northern Sardinia 
 
HQ011406 
Neofusicoccum australe 
 
 
BL24 Juniperus phoenicea. L. Caprera island JX312356 
Lasiodiplodia mediterranea 
 
 
BL101 Vitis vinifera L. Northern Sardinia KJ170150 
KJ170151c 
Lasiodiplodia mediterranea 
 
 
B6 Vitis vinifera L. Sicily KP178596 
KJ638331c 
Diplodia quercivora 
 
 
BL9 Quercus canariensis Willd. Tunisia JX894206 
JX894230c 
Diplodia africana 
 
 
DA1 Juniperus phoenicea. L. Sardinia JF302648 
JN157807c 
aBOT/BL/DA1: sequence depositated in Sardinia 
bB6:sequence depositated in Sicily 
cAccess number EF1-α (elongation factor 1-α) 
  
Table 6. 1H and 13C NMR Data and HMBC correlations for cyclobotryoxide (1) in 
CDCl3
a,b 
Position δCc δH (J in Hz) HMBC 
1 52.1 d 3.45 (1H) d (3.0 ) H-3, H-5, H-6  
2 194.3 s - H-1, CH3 
3 165.5 s -   CH3, OH, H-1, 
OCH3, H-5  
4 112.0 s - H-5, OH, CH3 
5 60.9 d 4.88 (1H) m H-6, OH, CH3 
6 54.2 d  3.79 (1H) dd (3.0, 1.0) H-5, H-1 
OCH3 56.1 q 4.05 (3H) s H-5 
CH3 7.9 q 1.26 (3H) br s  
OHd - 3.60 (1H) d (11.0)  
aThe chemical shifts are in δvalues (ppm) from TMS.  
b2D 1H, 1H (COSY) 13C, 1H (HSQC) NMR experiments delineated the 
correlations of all the protons and the corresponding carbons. 
cMultiplicities were assigned by DEPT spectrum. 
dThe shift is variable; this value was observed in CDCl3 at room temperature. 
  
Table 7. NMR Data of lasiojasmonate A (5)a,b  
Position 5   
δCc δH (J in Hz) HMBC 
1 37.6 d 2.10 (1H) m H-2, H2-5, H2-6 
2 53.9 d 1.90 (1H) ddd (10.2, 5.3) H2-4, H2-8, H-9  
3 218.3 s - H-1, H2-5, H-8 
4 38.7 t 2.74 (1H) dd, (20.0, 8.2) 
2.37 m 
H2-5 
5 27.2 t 2.33 m  
1.50 (1H) m 
H-1, H2-4 
6 37.9 t 2.32 m  
7 171.7 s - H2-5, H2-6, H-8’ 
8 25.5 t 2.37 m H-9, H-10 
9 124.9 d 5.26 (1H) m H2-8, H-11 
10 134.2 d 5.45 (1H) m H2-8, H2-11, Me-12 
11 20.6 t 2.04 (2H) m Me-12 
12 14.1 q 0.95 (3H) t (7.4) H2-11 
2’ 177.6 s - H-3’, Me-7’, H-8’B 
3’  38.6 t 2.49 (1H) dq  (11.0, 7.1) Me-7’ 
4’ 50.5 d 2.04 (1H) m  H-3’, Me-6’, Me-7’  
5’ 77.0 d 4.26 (2H) m Me-6’, H2-8’ 
6’ 19.9 q 1.47 (3H) d  (6.1) H-3’ 
7’ 14.1 q 1.28 (3H) d (7.1) H-3’ 
8’ 62.5 t 4.26 (2H) m 
4.21 (1H) dd (11.0, 5.7) 
H-3’, H-5’A  
a The chemical shifts are in δ values (ppm) from TMS.  
b 2D 1H, 1H (COSY) 13C, 1H (HSQC) NMR experiments delineated the 
correlations of all the protons and the corresponding carbons. 
c Multiplicities were assigned by DEPT spectrum 
  
Table 8. 1H NMR Data of 16-O-acetylbotryosphaerilactones A and C (6 and 7)a 
Position 6  7 
δH (J in Hz)  δH (J in Hz) 
2    
3 2.53 (1H) dq (9.2, 6.7)  2.57 (1H) dq (11.3, 7.1) 
4 1.90 (1H) m  1.91 (1H) m 
5 4.29 (1H) dq (8.4, 6.0)  4.32 (1H) dq (9.2, 6.2) 
6 1.43 (3H) d  (6.2)  1.45 (3H) d (6.2) 
7 1.26 (3H) d (7.1)  1.26 (3H) d (7.1) 
8 3.83 (1H) dd (10.3, 4.3) 
3.41 (1H) dd (10.3, 4.8) 
 3.84 (1H) dd (10.0, 5.4) 
3.41 (1H) dd (10.2, 4.8) 
10 4.67 (1H) d (2.3)  4.79 (1H) d (4.6) 
12 3.91 (1H) dq (12.3, 6.2)  3.97 (1H) dq (12.3, 6.2) 
13 1.51 (1H)  m  1.51 (1H) m 
14 2.03 (1H) m  2.05 (1H) m 
15 1.13 (3H) d (7.0)  1.04 (3H) d (7.0) 
16 4.15 (1H) dd (11.0, 5.6) 
4.04 (1H) dd (11.0, 7.9) 
 4.21 (1H) dd (11.3, 4.5) 
4.06 (1H) dd (11.3, 7.6) 
17 1.31 (3H) d (6.2)  1.30 (3H) d (6.2) 
COCH3 2.06 (3H) s  2.07 (3H) s 
a The chemical shifts are in δ values (ppm) from TMS.  
  
Table 9.1H NMR Data of lasiojasmonates B and C (8 and 9)a 
Position 8  9 
δH (J in Hz)  δH (J in Hz) 
1 2.13 dq (17.5, 9.8)  2.13 dq (15.5, 9.8) 
2 1.91 m  1.91 m 
4 2.70 dd  (17.5, 6.1) 
2.25 m 
 2.70 dd (17.5, 6.1) 
2.25 m 
5 2.37 m 
1.63 ddd  (14.3, 6.9, 4.6) 
 2.37 m 
1.63 ddd (14.3, 6.9, 4.6) 
6 2.37 m  2.37 m 
8 2.37 m  2.37 m 
9 5.25 m  5.25 m 
10 5.46 m  5.46 m 
11 2.04 dq  (7.5, 1.0)  2.04 dq (7.5, 1.0) 
12 0.96 t  (7.5)  0.96 t (7.5) 
3’ 2.54 m  2.54 m 
4’ 2.00 m  2.00 m 
5’ 4.30 (m)  4.30  m 
6’ 1.44 d, (6.2)  1.45 d (6.2) 
7’ 1.26 d  (7.1)  1.26 d (7.1) 
8’ 3.86 dd (10.0, 4.3) 
3.41 dd (10.0, 5.6) 
 3.87 dd (10.0, 4.3) 
3.41 dd (10.0, 5.3) 
10’ 4.68 d  (2.0)  4.80 d (4.5) 
12’ 3.90 dq (12.3, 6.1, 2.8)  3.96 dq (12.6, 6.2, 1.6) 
13’ 1.50 m  1.50 m 
14’ 2.03 m  2.03 m 
15’ 1.13 d (7.2)  1.05  d (7.0) 
16’ 4.17 dd (11.0, 6.9) 
4.10 dd (11.0, 7.2) 
 4.23 dd (11.3, 4.5) 
4.07 dd ( 11.3, 5.8) 
17’ 1.32 d (6.1 )  1.30 d (6.2) 
a The chemical shifts are in δ values (ppm) from TMS.  
  
Table 10. 1H- and 13C-NMR Data, and HMBC correlations of 15 and 16a. Atom numbering as 
indicated in Figure 2. 
Position 
15 16  
δ(C)b δH (J in Hz) δ(C)b δH (J in Hz) HMBC  
2 103.8 d 5.06 (1H) brs 99.6 d 5.24 (1H) d (4.1) H-3, H-7 
3 43.9 d 2.10 (1H) ddq (8.5, 7.2, 
6.0) 
41.5 d 2.04 (1H) ddq (6.8, 5.0, 
4.1) 
H-2, H-4, H-
5, H-7 
4 54.9 d 1.56 (1H) m 52.2 d 1.82 (1H) m H-2, H-5, H-
3, H-8 
5 76.5 d 4.20 (1H) dq (7.0, 6.1) 76.5 d 4.02 (1H) dq (8.2, 6.1) H-3, H-4, H-
6,  
6 21.4 q 1.33 (3H) d (6.1) 23.2 q 1.39 (3H) d (6.1) H-4, H-5 
7 19.2 q 1.14 (3H) d  (7.2) 11.9 q 1.07 (3H) d (6.8) H-2, H-3, H-4  
8 62.7 t 3.75 (1H) dd (10.4, 4.6) 
3.71 (1H) dd (10.4, 4.0) 
62.5 t 3.75 (1H) dd (10.4, 4.6) 
3.71 (1H) dd (10.4, 4.0) 
H-4 
OH  3.60 (1H) brs  2.38 (1H) brs  
a 1H, 1H (COSY) 13C, 1H (HSQC) NMR experiments delineated the correlations 
of all the protons and the corresponding carbons. The chemical shifts are in δ 
values (ppm) from TMS.  
b Multiplicities were assigned by DEPT spectrum. 
  
 
Table 11. HRESIMS Data of 15 and 16 
Ion peak  
m/z 
Calculated Molecular 
Formula 
Description 
313.1456 313.1417 C14H26KO5 [M+K]
+ 
297.1649 297.1668 C14H26NaO5 [M+Na]
+ 
169.0818 169.0823 C7H14NaO3 [M-C7H13O2+H+Na]
+ 
129.0897 129.0878 C7H13O2 [M-C7H13O3]
+ 
 
  
 Table 12. 1H-NMR Data of 13-O-Methylbotryosphaeriodoplodin, and its 7-O-(S)-, and 7-O-(R)-
MTPA Esters (19-21 respectively). Atom numbering as indicated in Figure7. 
aThe chemical shifts are in δ values (ppm) from TMS 
 
 
  
Position 19 20 21 
δHa (J in Hz) δH (J in Hz) δH (J in Hz) 
3 
 
5.23 dq (6.4, 3.1)  5.222 (1H) dq (6.0, 3.2)  5.260 (1H) dq (6.1, 3.0)  
4 
 
1.97 (Ha) m; 1.63 (Hb) m 2.001 (Ha)  m; 1.688 (Hb) 
m  
2.028 (Ha) m; 1.767 (Hb) m 
5 
 
1.69 (Ha) m ; 1.55 (Hb) m 1.736 (Ha) m; 1.579 (Hb) 
m 
1.792 (m, Ha); 1.582 (Hb) 
m 
6 
 
1.63 (Ha) m; 1.53 (Hb) m 1.638 (Ha) m; 1.601 (Hb) 
m 
1.682 (Ha) m; 1.607 (Hb) m 
7 
 
3.80 m 5.341 m 5.331 m 
8 1.49 (Ha) m; 1.33 (Hb) m 1.508 (Ha) m; 1.389 (Hb) 
m 
1.502 (Ha) m; 1.374 (Hb) m 
9 1.94 (Ha) m; 1.55 (Hb) m   1.983 (Ha) m; 1.473 (Hb) 
m 
1.983 (Ha) m; 1.451 (Hb) m 
10 2.73 (Ha) ddd (14.0, 9.3, 
6.2); 2.57 (Hb) ddd (14.0, 
6.2)  
2.813 (1H) ddd (13.8, 9.0, 
6.0); 2.587 (1H) ddd (13.8, 
6.0) 
2.714 (1H) ddd  (13.8, 9.0, 
6.0); 2.485 (1H) ddd (13.8, 
6.0) 
12 6.32 d (2.0) 6.308 (1H) brs 6.302 (1H) d (1.9) 
14 6.30 d (2.0) 6.308 (1H) brs 6.269 (1H) d (1.9) 
17 1.33 d (6.4) 1.334 (3H) d (6.0) 1.356 (3H) d (6.1) 
CH3O-15 3.78 s 3.798 (3H) s 3.783 (3H) s 
CH3O-13 3.80 s 3.785 (3H) s 3.783 (3H) s 
Ph - 7.535-7.404 (5H) m 7.548-7.407 (5H) m 
CH3O - 3.549 (3H) s 3.575 (3H) s 
Table 13. 1H and 13C NMR Data and HMBC of Diplopimarane (24)a,b 
position δCc δH (J in Hz) HMBC 
1 
 
27.9 CH2 2.44 (2H) m H2-2 
2 
 
19.8 CH2 1.72 (2H) m H2-1 
3 
 
41.7 CH2 1.60 (2H) m  H2-2 
4 33.9 C  H2-1, H2-2, H2-3, Me-18, Me-
19 
5 119.6 C  H2-1, H2-3, HO-6 
6 142.2 C  HO-6 
7 141.5 C  HO-7, H-14 
8 131.2 C  H-1, HO-7, Me-17 
9 124.5 C  H2-1, H2-2, H2-11, H-14 
10 127.0 C  H2-1, H2-11 
11 
 
23.2 CH2 2.54 (1H) ddd (17.2, 11.2, 5.6) 
2.52 (1H) ddd (17.2, 6.1, 3.2) 
H2-12 
12a 
12b 
33.1 CH2 1.88 (1H) ddd  (13.6, 5.6, 3.2) 
1.75 (1H) m 
H2-11, H-15, Me-17 
13 40.2 C - H-14, H-15, H2-16 
14 76.0 CH 4.70 (1H) d (9.9) H2-11, H2-12, H-15, H2-16, 
Me-17, OH-14 
15 139.1 CH 6.04 (1H) dd (17.6, 11.0) H2-12, H-14, H2-16, Me-17 
16 118.7 CH2 5.34 (1H)  brd  (11.0) 
5.31 (1H) brd (17.6) 
H-14 
17 23.2 CH3 1.25 (3H) s H2-12, H-14, H-15 
18d 27.6 CH3 1.42 (3H) s H2-3 
19 d 28.6 CH3 1.45 (3H) s H2-3 
HO-14  2.18 (1H) d (9.9)  
HO-7 - 5.85 (1H) s  
HO-6 - 8.55 (1H) s  
aThe chemical shifts are in δ values (ppm) from TMS.  
b2D 1H, 1H (COSY), and 2D 13C, 1H (HSQC) NMR experiments delineated the correlations of all 
the protons and the corresponding carbons.  
cMultiplicities were assigned by DEPT spectrum.  
dThe attributions of these signals could be inverted  
 
  
Table 14. 1H NMR Data of diplopimarane derivativesa 
position 
25 26 27 28 29c 
δH (J in Hz) δH (J in Hz) δH (J in Hz) δH (J in Hz) δH (J in Hz) 
1 2.46 (2H) md 2.47 (2H) m 2.54 (3H) md 2.48 (3H) md 2.09 (2H) m 
2 1.73 (3H) md 1.74 (3H) md 1.80 (3H) md 1.78 (3H) md 1.74 (2H) m 
3 1.59 (2H) m 1.57 (2H) m 1.64 (2H) m 1.57 (2H) m 1.02 (2H) m 
11 2.67 (1H) ddd (14.9, 6.3, 3.7) 
2.46 (3H) md 
2.65 (1H) ddd (17.8, 6.4, 2.6) 
2.46 (3H) m 
2.76 (1H) ddd (17.9, 5.8, 1.0) 
2.54 (3H) md 
2.62 (1H) ddd (17.2, 10.8,1.2) 
2.48 (3H) md 
1.69 (2H) m 
 
12 
 
2.13 (1H) ddd (17.8, 11.2, 6.3) 
1.73 (3H) md 
2.09 (1H) ddd (17.3, 10.9, 6.4) 
1.74 (3H) md 
2.10 (1H) m 
1.80 (3H) md 
1.89 (1H) ddd (17.2, 10.8, 6.3) 
1.78 (3H) md 
1.29 (1H) m 
1.20 (1H) m 
 
14 4.56 (1H) d  (3.0) 4.59 (1H) d (1.2) 5.80 (1H) brs 4.71 (1H) d (9.3)  
15 6.08 (1H) dd (17.5, 11.1) 6.10 (1H) dd (17.5, 11.1) 5.88 (1H) dd (17.5, 10.9) 6.05 (1H) dd  (17.6, 11.4) 1.04 (2H) q 
(7.4) 
16 5. 24 (1H)  dd (1.1, 1.2) 
5.20 (1H)  dd (17.5, 1.2) 
5.21 (1H)  dd (11.1, 1.2) 
5.19 (1H,  dd (17.5, 1.2) 
5.08 (1H)  dd (17.5, 1.0) 
5.06 (2H)  dd (10.9, 1.0) 
5.36 (1H) dd (11.4, 1.0) 
5.32 (1H)  dd (17.6, 1.0) 
0.71 (3H) t 
(7.4) 
17 0.95 (3H) s 0.97 (3H) s 0.97 (3H) s 1.24 (3H) s 0. 62 (3H) s 
18b  1.42 (3H) s 1.39 (3H) s 1.33 (3H) s 1.32 (6H) sd 1.34 (3H) s 
19b 1.40 (3H) s 1.38 (3H) s 1.28 (3H) s 1.32 (6H) sd 1.32 (3H) s 
HO-14 2.17 (1H) d (3.0) 2.3 (1H) d (1.2)  2.24 (1H) d (9.3)  
HO-7 5.75 (1H) s     
HO-6    8.64 (1H) s  
MeO-6 3.88 (3H) s 3.88 (3H) s    
MeO-7  3.86 (3H) s    
COCH3   2.29 (3H) s 
2.24 (3H) s  
1.92 (3H) s 
  
2’-6’    8.11 (2H) d (8.4)  
3’-5’    7.65 (2H) d (8.4)  
aThe chemical shifts are in δ values (ppm) from TMS.  
bThe attributions of these signals could be inverted.  
cThis spectrum was recorded in C6D6.  
dThese signals were overlapped. 
  
 
Table 15. 1H NMR Data of 14-O-(S)-, 14-O-(R)-MTPA esters of 6,7-
O,O’-Dimethyldiplopirane (30 and 31, respectively)a 
 
position 30 31 
 δH (J in Hz) δH (J in Hz) 
1 
 
2.472 (3H) mb 2.468 (3H) mb 
2 
 
1.735 (3H) m b 1.746 (3H) mb 
3 
 
1.603 (2H) m 1.567 (2H) m 
11 
 
2.647 (1H) dd (16.5, 8.3) 
2.472 (3H) mb 
2.662 (1H) dd (19.0, 5.3) 
2.468 (3H) mb 
12 
 
1.915 (1H) m 
1.735 (3H) mb 
2.006 (1H) m 
1.746 (3H) mb 
14 6.199 (1H) s 6.185 (1H) s 
15 5.934 (1H) dd (17.6, 11.5) 6.086 (1H) dd  (16.7, 11.9) 
16 5.024 (1H) dd (17.6, 1.0) 
4.992 (1H)  dd (11.5, 1.0) 
5.117 (1H)  dd (16.7, 1.0) 
5.113 (1H)  dd (11.9, 1.0) 
17 0.994 (3H) s 1.026 (3H) s 
18 1.387 (6H) sb 1.346 (3H) sc 
19 1.387 (6H) sb 1.339 (3H) sc 
CH3O-6 3.794 (3H) s 3.746 (3H) s 
CH3O-7 3.756 (3H) s 3.642 (3H) s 
Ph 7.528-7.300 (5H) m 7.602-7.306 (5H) m 
aThe chemical shifts are in δ values (ppm) from TMS. 
bThese signals were overlapped. 
cThe attributions of these signals could be inverted. 
 
  
 
 
 
 
 
Table 16. 1H NMR Data of oxysporone (35) and its derivatives (38-45)a 
No. 35 38 39 40 41 42 43b 44c 45 
δH (J in Hz) δH (J in Hz) δH (J in Hz) δH (J in Hz) δH (J in Hz) δH (J in Hz) δH (J in 
Hz) 
δH (J in Hz) δH (J in Hz) 
2 6.46 d (5.9) 6.52 d (6.1) 3.97 dt (11.8, 
4.2) 
3.85 ddd (11.8, 
10.3, 2.6) 
6.75 dd 
(10.0, 4.2) 
6.59 d (6.2) 7.75 dd (5.7, 0.7) 3.90 t (5.2) 4.55 t (7.0) 7.74 dd (5.8, 1.0) 
3 5.07 ddd (5.9, 
5.4, 1.0) 
5.06, brdd (6.1, 
5.3) 
1.98 m 
1.73 m 
6.17 dd 
(10.0, 1.5) 
5.14 dd (6.2 
5.4) 
6.30 d (5.7) 2.05 m 
1.73 m 
2.62 t (7.0) 6.38 d (5.8) 
4 4.14 dd (5.4, 
1.9) 
5.13 d (5.3) 3.78 ddd (10.0, 
7.9, 4.2) 
- 5.35 d (5.4) - 4.94 m   
5 2.90 m 2.90 m 2.32  m 3.40 m 3.04 m  2.54, m   
6 5.90 d (4.9) 5.86 d (4.8) 5.83 d (4.4) 6.30 d (5.2) 5.94 d (4.8) 7.83 brs 5.75 d (3.9) 7.52 s 7.8 brd (1.0) 
7 2.59 dd (17.1, 
8.1) 
2.39 dd (17.1, 
12.2) 
2.69 dd (17.1, 
8.3) 
2.41 dd (17.1, 
12.6) 
2.74 dd (17.3, 
4.1) 
2.67 dd (17.3, 
6.5) 
2.97 dd 
(17.5, 9.3) 
2.62 dd 
(17.5, 6.4) 
2.72 dd 
(17.1, 8.4) 
2.46 dd 
(17.1, 12.6) 
2.00 s 2.60 m 3.09 s 3.39 d (1.0) 
2’ and 6’     7.87 d (8.5)     
3’ and 5’     7.61 d (8.5)     
COCH3  2.09 s     2.10 s  3.72 s 
aThe chemical shifts are in δ values (ppm) from TMS  
bThe spectrum is very similar to that previously recorded (Salvatore et al., 1994) 
cThe spectrum is very similar to that previously recorded (Wu et al., 2010) 
 
  
 
Table 17. Phytotoxicity of compounds 1-4 evaluated at different concentrations 
on three plant species. area lesions (mm2) + SE. 
 
Compound Species 
Concentration 
(mg/mL) 
1 0.5 0.25 0.125 
1 
Cork oak 53.1 + 
1.7 
22.4 + 
4.3 
4.5 + 1.3 n.a. 
Holm 
oak 
27.7 + 
4.9 
5.5 + 1.9 1.9 + 0.7 n.a. 
Grapevin
e 
24.3 + 
1.1 
5.2 + 0.3 1.2 + 0.2 0.9 + 
0.06 
      
2 
Cork oak 13.1 + 
1.6 
5.2 + 1.7 2.4 + 0.9 n.a. 
Holm 
oak 
19.4 + 
2.8 
3.5 + 1.9 1.4 + 0.4 n.a. 
Grapevin
e 
6.9 + 0.4 3.4 + 0.4 1.3 + 0.2 0.8 + 
0.06 
      
3 
Cork oak 1.0 + 0.1 n.a. n.a. n.a. 
Holm 
oak 
1.0 + 0.1 n.a. n.a. n.a. 
Grape 4.9 + 0.9 1.9 + 0.5 1.0 + 0.2 n.a. 
4 
     
Cork oak 0.9 + 0.2 n.a. n.a. n.a. 
Holm 
oak 
0.8 + 
0.05 
n.a. n.a. n.a. 
 Grape 8.3 + 
1.3+ 
n.a. n.a. n.a. 
 
  
  
 
 
Table 18. Phytotoxicity of compounds 22 and 23 evaluated at different 
concentrations on three plant species. area lesions (mm2) + SE. 
 
Compound Species 
Concentration 
(mg/mL) 
1 0.5 0.25 0.125 
22 
Cork oak 4.8 + 1.6 2.3 + 0.5 0.8 + 0.3 n.a. 
Holm oak 3.3 + 0.6 n.a. n.a. n.a. 
Grape 11.9 + 
2.3 
2.5 + 0.3 0.6 + 0.1 n.a. 
      
23 
Cork oak n.a. n.a. n.a. n.a. 
Holm oak n.a. n.a. n.a. n.a. 
Grape n.a. n.a. n.a. n.a. 
 
  
  
 
 
 
Table 19. Phytotoxicity and zootoxicity data for diplopimarane (24), its derivatives (25-27, 29), 
sphaeropsidin A (32), sphaeropsidin C (33) and (+)-epiepoformin (34) 
compound 
leaf puncture bioassaya cuttingsb 
% Artemia 
salina larval 
mortalityc  
holm oak cork oak tomato tomato  
1 na na na stewing 70.8 
2 na na na stewing 100 
3 na na na na 94.6 
4 na na na na 79.5 
5 nt nt nt nt nt 
6 nt nt nt stewing 98.6 
9 10.85 + 1.34 15.03 + 4.40 120.92 + 13.37 stewing 85.6 
10 na na na stewing na 
11 6.68 + 0.88 9.49 + 2.33 13.49 + 1.98 stewing/wilting 78.8 
aThe compounds were tested at concentration of 1 mg/mL. Data are expressed as median area 
lesions + error standard (mm2).  
bSymptoms developed within 3 days on tomato cuttings at 0.1 mg/mL.  
cThe compounds were tested at concentration of 200 µg/mL. The activity was evaluated after 36 h 
of exposure. na = inactive. nt = not tested 
 
  
  
 
 
 
Table 20. Inhibitory activity of diplopimarane (24), sphaeropsidin A (32), 
sphaeropsidin C (33) and (+)-epiepoformin (34) against agrarian and forest 
phytopathogens at 100 µg/mL 
 Mycelial growth inhibition (%) 
Compound 
Athelia 
rolfsii 
Diplodia 
corticola 
Phytophthora 
cinnamomi 
Phytophthora 
plurivora 
1  55 54,5 53,5 51,3 
9  83,2 19,8 100 100 
10  na na na na 
11 41,9 39,7 72,3 62,1 
PCNB 87,2 81,01 nt nt 
Metalaxyl-M nt nt 100  100  
na = inactive. nt = not tested 
 
  
  
 
 
Table 21. Biological data for oxysporone (35) and its derivatives (38-45)  
 
Bioassay Leaf puncture bioassaya Cuttingsb Antifungal activityc 
Target Holm oak Cork oak 
Grapevin
e 
Tomato 
Diplodia 
corticola 
Phytophthor
a 
cinnamomi 
Phytophth
ora 
plurivora 
Athelia 
rolfsii 
Compound         
1 
19.58+ 
1.62 
15.81 + 
1.75 
23.04+ 
0.97 
Wilting na na na na 
4 
4.05 + 
0.53 
3.50 + 
0.47 
7.83+ 
1.85 
Stewing na na na na 
5 na na na na na na na na 
6 
4.28 + 
0.37 
4.42 + 
0.92 
7.86+ 
0.66 
Stewing na na na na 
7 na na na na 35.6 77.2 100 100 
8 na na na na na na na na 
9 na na na na na na na na 
10 na na na na nt nt nt nt 
11 na na na na nt nt nt nt 
a The compounds were  tested at concentration of 1mg/ml. Data are expressed as median area lesions + 
error standard  (mm2)  
bSymptoms developed within 2 days on tomatao at 0.2 mg/ml;  
cData expressed as percentage of linear growth inhibition at 100 µg/ml 
na = inactive; nt = not tested 
 
 
  
  
 
 
 
Table 22. EC50 Values of derivative 41, toclofos-methyl, PCNB and  
metalaxyl-M against three pathogens belonging to Oomycetes and  
Basidiomycetes 
 
 Target ED50 (μg/ml) 
Phytophthora 
cinnamomi 
Phytophthora 
plurivora 
Athelia 
 rolfsii 
Compound       
Derivative 5 43,5 29,47 37,12 
Toclofos-methyl nt  nt  1,02 
PCNB  nt nt  11,47 
Metalaxyl-M 0,49 0,41 nt  
nt=not tested. 
  
  
 
 
 
 
 
 
 
 
 
Scheme 1. Purification scheme of  Neofusicoccum australe strain BOT48. 
  
  
 
 
 
 
 
 
Scheme 2. Purification scheme of  Lasiodiplodia mediterranea strain BL101. 
  
  
 
 
 
 
 
Scheme 3. Purification scheme of Lasiodiplodia mediterranea strain B6. 
  
  
 
 
 
 
 
 
 
Scheme 4. Purification scheme of  Neofusicoccum australe strain BL24 (haplotype H1). 
  
  
 
 
 
 
 
 
 
Scheme 5. Purification scheme of Diplodia quercivora strain BL9. 
 
 
 
      
 
Figure 1. Symptoms of grapevine affected with various species of Botryosphaeriaceae. (A) Stunting 
early in the season; (B) Foliar chlorosis; (C) wedge-shaped necrosis in a trunk cross-section. 
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Figure 2. Structures of cyclobotryoxide and its acetyl derivative,  
3-methylcatechol, tyrosol, (1-4) produced by N. australis from  
grapevine. 
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Figure 3. Structures of 16-O-acetylbotryosphaerilactone A and C, (-)-jasmonic acid and its 
methyl ester, botryosphaerilactone A, 4-hydroxymethyl-3,5-dimethyldihydro-2-furanone and 
(3R,4S)-botryodiplodin (6,7, 10-14) produced by Lasiodiplodia mediterranea. 
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Figure 4. Structures of  Lasiojasmonates A-C (5, 8 and 9), new metabolites produced by 
Lasiodiplodia mediterranea. 
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Figure 5. Structures of botryosphaeriodiplodin, (5R)-5-hydroxylasiodiplodin (18), (-)-jasmonic 
acid (10), 4-hydroxymethyl-3,5-dimethyldihydro-2-furanone (14), 13-O-
methylbotryosphaeriodiplodin (17). 
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Figure 6. Structures of lasiolactols A and B (15 and 16), new metabolites produced by 
Lasiodiplodia sp. 
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Figura 7. Reagent and condition to convert 17 into 19-21: (a) CH2N2, MeOH, rt, 6 h; (b) (R)-(-)-
MPTA-Cl, pyridine, rt, o.n.; (c) (S)-(+)-MPTA-Cl, pyridine, rt, o.n. 
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Figure 8. Structures of  tyrosol, botryosphaerone D and (3S,4S)-3,4,8-trihydroxy- 
6-methoxy-3,4-dihydro-1(2H)-naphthalenone (4, 22 and 23) produced by N. australe  
from juniper. 
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Figure 9. Reagent and condition to convert 24 into 25-29: (a) CH2N2, MeOH, rt, 78 h; (b ) 
Ac2O, pyridine, rt, 1 h; (c) p-Br-BzCl, DMAP, MeCN, rt, 2 h; (d)H2, Pd/C 10%, MeOH, rt, o.n. 
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Figure 10. Structures of Sphaeropsidins A and C, and  
(+)-epiepoformin (32-34) 
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Figure 11. Reagent and condition to convert 26 into 30 and 31: (a) (R)-(-)-MPTA-Cl,  
pyridine, rt, 2 h; (b) (S)-(+)-MPTA-Cl, pyridine, rt, 2 h 
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Figure 12. Structures of oxysporone, and afritoxinones A and B (35, 36 and 37,  
respectively) 
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Figure 13. Reagent and condition to convert 35 into 38-45: (a) Ac2O, pyridine, rt, 2 h; (b) H2, Pt 
5%, MeOH, rt, 4 h; (c) Corey's reagent, CH2Cl2, rt, 1 h; (d) p-Br-BzCl, DMAP, MeCN, rt, 4 h; (e) 
Jones's reagent, Me2CO, 0 °C, 10 min; (f) H2, Pt 5%, MeOH, rt, 5 h; (g) Jones reagent, Me2CO, 0 
°C, 10 min; (h) CH2N2, MeOH, rt. 
  
  
 
 
 
 
 
 
 
 
Figure 14. Grapevine diseases symptoms associated with Neofusicoccum australe strain Bot48. 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22. CD spectra of cyclobotryoxide recorded in EtOH. 
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Figure 24. Phytotoxic activity of cyclobotrioxide by leaf drop assays 
 at concentration of 0.25 mg /mL on leaves of greaevine (a), holm oak (b) 
 and tomato (c).  
 
 
  
  
   
          
 
 
           Figure 25. Grapevine diseases symptoms associated 
           with Lasiodiplodia mediterranea. 
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Figure 39. Mechanisms of fragmentation observed for 6-9 in the APCIMS (+). 
  
  
 
 
 
Figure 41. 1) Brown necrosis caused by L. mediterranea extending along a large part of the trunk 
in longitudinal section (a) and cross section (b). 2) Absence of xylematic symptom in the control 
in longitudinal section (a) and cross section (b). 
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Figure 53. Structures of 7-O-S- and 7-O-R-MPTA esters of  
13-O-methylbotriosphaeriodiplodin (20 and 21), reporting the 
 Δδ value obtained by comparison(20 and 21) of each proton system. 
 
  
  
 
 
 
 
Figure 54. Linear association between necrotic area (NA) and concentration  
(Ct) of assayed compounds. 15-16: NA = 0.198+0.644Ct R2 = 0.947 P<0.001; 
 10: NA = 0.590+5.312Ct R2 = 0.978 P < 0.001; 17: NA = 0.147+0.653Ct R2 = 0.985 
 P < 0.001; 14: NA = 0.189+0.362Ct R2 = 0.8709 P < 0.001. 
  
  
 
 
 
 
 
 
Figure 55. Juniper diseases symptoms associated with  
Neofusicoccum australe strain BL24.  
  
  
 
 
 
 
 
 
 
Figure 58. ECD spectra of botryosphaerone D (22) recorded in EtOH. 
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Figure 59. Quercus diseases symptoms associated with Diplodia 
 quercivora strain BL9. 
 
 
  
  
 
 
 
 
 
 
 
Figure 70. ORTEP view of diplopimarane (24) showing  
atomic labelling. Displacement ellipsoids are draw at the  
30% probability level. 
  
  
 
 
 
 
 
 
Figure 74. Structures of 14-O-S- and 14-O-R-MPTA esters of 
 6,7-O,O’-dimethyldiplopimarane (30 and 31), reporting the Δδ  
value obtained by comparison (30 and 31) of each proton system.  
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Figure 75. Probable mechanism of biosynthetic conversion of sphaeropsidin A (32) into 
diplopimarane (24)  
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Figure 76. Reaction mechanism probably involved in the  
conversion of 35 into 42 in strong acid conditions 
  
  
 
 
 
 
 
Figure 15. UV spectrum of cyclobotryoxide (1) recorded in MeCN. 
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Figure 16.1H NMR spectrum of cyclobotryoxide (1) recorded in CDCl3 at 400 MHz. 
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Figure 17.COSY spectrum of cyclobotryoxide (1) recorded in CDCl3 at 400 MHz. 
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Figure 18. 13C NMR spectrum of cyclobotryoxide (1) recorded in CDCl3 at 100 MHz. 
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Figure 19. HMBC spectrum of cyclobotryoxide (1) recorded in CDCl3 at 400 MHz.  
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Figure 20. HSQC spectrum of cyclobotryoxide (1) recorded in CDCl3 at 400 MHz. 
  
ppm (t2)
0.05.0
0
50
100
150
200
ppm (t1)
148 
 
 
Figure 21. NOESY spectrum  of cyclobotryoxide (1) recorded in CDCl3 at 400 MHz. 
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Figure 23. 1H NMR spectrum of 5-O-acetyl cyclobotryoxide (2) recorded in CDCl3 at 400 MHz. 
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Figure 26. 1H NMR spectrum of (1R,2R)-jasmonic acid (10) recorded in CDCl3 at 400 MHz. 
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Figure 27. 1H NMR spectrum of (1R,2R)-methyl jasmonate (11) recorded in CDCl3 at 400 MHz. 
 
  
ppm (t1)
1.02.03.04.05.06.07.0
0
50000000
100000000
150000000
200000000
152 
 
 
 
Figure 28. 1H NMR spectrum of botryosphaerilactone A (12) recorded in CDCl3 at 400 MHz. 
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Figure 29. 1H NMR spectrum of (3S,4R,5R)-4-hydroxymethyl-3,5-dimethyldihydro-2-furanone (13) recorded in 
CDCl3 at 400 MHz. 
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Figure 30. 1H NMR spectrum of (3R,4S)-botryodiplodin (14) recorded in CDCl3 at 400 MHz. 
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Figure 31. 1H NMR spectrum of lasiojasmonate A (5) recorded in CDCl3 at 400 MHz. 
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Figure 32. 13C NMR spectrum of lasiojasmonate A (5) recorded in CDCl3 at 100 MHz. 
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    Figure 33. IR spectrum of lasiojasmonate A (5) recorded as glassy film. 
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     Figure 34. UV spectrum of lasiojasmonate A (5) recorded in MeCN. 
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Figure 35. COSY spectrum of lasiojasmonate A (5) recorded in CDCl3 at 400 MHz. 
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Figure 36. HSQC spectrum of lasiojasmonate A (5) recorded in CDCl3 at 400 MHz. 
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Figure 37. HMBC spectrum of lasiojasmonate A (5) recorded in CDCl3 at 400 MHz. 
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Figure 38. 1H NMR spectrum of 16-O-acetylbotryosphaerilactone A and C (6 and 7) recorded in CDCl3 at 400 MHz. 
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Figure 40.  1H NMR spectrum of lasiojasmonates B and C (8 and 9) recorded in CDCl3 at 400 MHz. 
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Figure 42. 1H NMR spectrum of botryosphaeriodiplodin (17) recorded in CDCl3 at 400 MHz. 
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Figure 43. 1H NMR spectrum of (5R)-5-hydroxylasiodiplodin (18) recorded in MeOD at 400 MHz. 
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Figure 44. 1H NMR spectrum of lasiolactols A and B (15 and 16) recorded in CDCl3 at 400 MHz. 
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Figure 45. 13C NMR spectrum of lasiolactols A and B (15 and 16) recorded in CDCl3 at 100 MHz. 
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Figure 46. IR spectrum of lasiolactols A and B (15 and 16) recorded as glassy film. 
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Figure 47. UV spectrum of lasiolactols A and B (15 and 16) recorded in MeCN. 
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Figure 48. COSY spectrum of lasiolactols A and B (15 and 16) recorded in CDCl3 at 400 MHz. 
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Figure 49. NOESY spectrum of lasiolactols A and B (15 and 16) recorded in CDCl3 at 400 MHz. 
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Figure 50. 1H NMR spectrum of 13-O-methylbotryosphaeriodiplodin (19) recorded in CDCl3 at 400 MHz. 
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Figure 51. 1H NMR spectrum of 7-O-(S)-α-methoxy-α-trifluoromethyl-α-phenylacetate (MTPA) of 17 (20)  
recorded in CDCl3 at 400 MHz. 
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Figure 52. 1H NMR spectrum of 7-O-(R)-α-methoxy-α-trifluoromethyl-α-phenylacetate (MTPA) of 17 (21)  
recorded in CDCl3 at 400 MHz. 
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Figure 56. 1H NMR spectrum of botryosphaerone D (22) recorded in CDCl3 at 400 MHz. 
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Figure 57. 1H NMR spectrum of 3,4,8-trihydroxy-6-methoxy-3,4-dihydro-1(2H)-naphthalenone (23) recorded in 
MeOD at 400 MHz. 
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Figure 60. 1H NMR spectrum of diplopimarane (24) recorded in CDCl3 at 400 MHz. 
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Figure 61. 13C NMR spectrum of diplopimarane (24) recorded in CDCl3 at 100 MHz. 
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Figure 62. COSY spectrum of diplopimarane (24) recorded in CDCl3 at 400 MHz. 
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Figure 63. HMBC spectrum of diplopimarane (24) recorded in CDCl3 at 400 MHz. 
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Figure 64. HSQC spectrum of diplopimarane (24) recorded in CDCl3 at 400 MHz. 
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Figure 65. 1H NMR spectrum of 6-O-methyldiplopimarane (25) recorded in CDCl3 at 400 MHz. 
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Figure 66. 1H NMR spectrum of 6-O,7-O-dimethyldiplopimarane (26) recorded in CDCl3 at 400 MHz. 
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Fgure 67. 1H NMR spectrum of 6-O,7-O,14-O-triacetyldiplopimarane (27) recorded in CDCl3 at 400 MHz. 
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Figure 68.1H NMR spectrum of 6-O-p-bromobenzoyl ester of diplopimarane (28) recorded in CDCl3 at 400 MHz. 
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Figure 69. 1H NMR spectrum of 15,16-dihydrodiplopimarane (29) recorded in CDCl3 at 400 MHz. 
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Figure 71. NOESY spectrum of diplopimarane (24) recorded in CDCl3 at 400 MHz. 
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Figure 72.  1H NMR spectrum of 14-O-(S)-α-methoxy-α-trifluoromethyl- α -phenylacetate (MTPA) ester of  
6-O,7-O-dimethyldiplopimarame (30) recorded in CDCl3 at 400 MHz. 
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Figure 73. 1H NMR spectrum of 14-O-(R)-α-methoxy-α-trifluoromethyl-α-phenylacetate (MTPA) ester of  
6-O,7-O-dimethyldiplopirane (31) recorded in CDCl3 at 400 MHz.  
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Figure 77. 1H NMR spectrum of oxysporone (35) recorded in CDCl3 at 400 MHz. 
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Figure 78. 1H NMR spectrum of 4-O-acetyloxysporone (38) recorded in CDCl3 at 400 MHz. 
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Figure 79. 1H NMR spectrum of 2,3-dihydrooxysporone (39) recorded in CDCl3 at 400 MHz. 
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Figure 80. 1H NMR spectrum of 4,O-dehydrooxysporone (40) recorded in CDCl3 at 400 MHz. 
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Figure 81. 1H NMR spectrum of 4-O-p-bromobenzoyloxysporone (41) recorded in CDCl3 at 400 MHz. 
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Figure 82. 1H NMR spectrum of 2-(4-pyronyl)acetic acid (42) recorded in CDCl3 with 10 µL of MeOD at 400 MHz. 
  
ppm (t1)
0.01.02.03.04.05.06.07.08.0
0
10000000
20000000
30000000
40000000
50000000
196 
 
 
Figure 83. 1H NMR spectrum of 4-O-acetyl-2,3-dihydrooxysporone (43) recorded in CDCl3 at 400 MHz. 
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Figure 84. 1H NMR spectrum of 2-(2,3-dihydro-4-pyronyl)acetic acid (44) recorded in CDCl3 at 400 MHz. 
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Figure 85. 1H NMR spectrum of methyl ester of 2-(4-pyronyl)acetic acid (45) recorded in CDCl3 at 400 MHz. 
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